Basic Studies in Andrology: Spermatogenesis and Sperm Maturation in Rodents and Men by Roijen, J.H. (Jan Herman) van
Basic Studies in Andrology 
Spermatogenesis and Sperm Maturation in Rodents and Men 
Aan mijn ouders 
Aan Sophie 
ISBN 90-9012625-2 
Basic Studies in Andrology 
Spermatogenesis and Sperm Maturation in Rodents and Men 
Basale Studies in de Andrologie 
Spermatogenese en Ztltldcelrijping in het Knaagdier en de i'dens 
Proefschrift 
Ter verkrijging van de graad van doctor 
aan de Erasmus Universireir Rotterdam 
op gezag van de Rector Magnificus 
Ptof. Dr P.Wc. Akkermans, M.A. 
en volgens besluit van het college voor ptomoties. 
De openbare verdediging zal plaatsvinden op 
woensdag 21 april 1999 om 11.45 uur 
door 
Jan Herman van Roijen 
geboren te 's-Gravenhage 
Promotiecommissie 
Promotor Prof Dr J.A. Grootegoed 
Overige leden Prof. Dr Th. H. van der Kwast 
Prof Dr F.H.S. Schroder 
Prof. Dr F.H. Comhaire 
Co-promotores Dr J.T.M. Vreeburg 
Dr R.F.A. Weber 
Dit proefschrift werd bewerkt binnen de afdeling Endocrinologie & Voortplanting, 
Faculreir der Geneeskundc en Gezondheidswetenschappen, Erasmus Univcrsiteit 
Rotterdam en binnen de PolildinieklLaboratorium Andrologie, Academisch Ziekenhuis 
Rotterdam, Dijkzigt. 
Dc uitgave van dit proefschrift is mede mogelijk gemaakt dankzij een financiele bijdrage 
van Yamanouchi Nederland B.Y. Merck Sharp & Dohme B.Y., Hoechst Marion Roussel 
B.Y., BykNederland B.Y. en Christiaens B.Y. 
Contents 
Chapter I General Introduction: the male reproductive system 
Part I: 
Basic Studies on Spermatogenesis and Sperm Maturation 
Chapter 2 Androgen control of spermatogenesis and sperm 
maturation 
Chapter 3 Comparison of the response of rat testis and accessory 
sex organs to treatment with testosterone and the 
9 
41 
synthetic androgen methyltrienolone (RI881) 63 
Chapter 4 Androgen receptor expression and androgen-dependent 
protein synthesis in rhe rar epididymis 83 
Part II: 
Towards Clinical Andrology 
Chaprer 5 Spermatogenic disorders 105 
Chapter 6 Androgen recepror immunoexpression in rhe testes of 
subfertile men 125 
Chapter 7 Immunoexpression of testis-specific histone 2B (TH2B) 
in human spermatozoa and testis tissue 139 
Chapter 8 Discussion 157 
Summary 
Samenvatting 
References 
Curriculum vitae 
List of publications 
Dankwoord 
179 
183 
189 
219 
221 
223 
List of Abbreviations 
ABP 
ACTH 
AlS 
AMHRII 
AMH 
AR 
AZF 
cAMP 
CFTR 
CRE 
CREM 
CRF 
DAZ 
DFFRY 
DHT 
DNA 
EDS 
EGF 
FSH 
FRA-J 
GnRH 
GnRHa 
GTP 
H2A 
H2B 
HCG 
HMG 
HR6A 
HR6B 
ICSI 
IGF 
l.p. 
IVF 
kDa 
LH 
MEP 10 
Androgen binding protein 
Adrenocorticotropic hormone 
Androgen insensitivity syndrome 
AMH type II receptor 
Anti-Mullerian hormone 
Androgen receptor 
Azoospermia factor 
Adenosine cyclic-3':5'-monophosphatc 
Cystic fibrosis transmembrane conductance regulator 
cAMP-response clement 
cAMP-response element modulator 
Corticotropin hormone releasing factor 
Deleted in azoospermia 
Drosophila fot focets related Y gene 
Dihydrotestosterone 
Deoxyribonucleic acid 
Ethane dimethane sulphonate 
Epidermal growth factor 
Follicle-stimulating hormone 
Fos-related antigen 
Gonadotropin-releasing hormone 
Gonadotropin-releasing hormone antagonist 
Guanosine triphosphate 
Histone 2A 
Histone 2B 
Human chorionic gonadotropin 
High mobility group 
Homolog A of RAD6 
Homolog B ofRAD6 
Intracytoplasmatic sperm injection 
Insulin-like growth factor 
Intraperitoneally 
In vitro fertilisation 
Kilo Dalton 
Luteinizing hormone 
Mouse epididymal protein J 0 
MESA 
mRNA 
POMC 
PSA 
R!SS! 
RBM 
rec-hFSH 
RNA 
ROS 
S,c. 
SCF 
SDS 
SP!97 
SRY 
StAR 
T 
TDF 
TESE 
Tfm 
TGF 
TH2A 
TH2B 
TP 
TSH 
WHO 
Microsurgical epididymal sperm aspiration 
Messenger ribonucleic acid 
Pro-opiomelanocortin 
Prostate-specific antigen 
Methyltrienolone 
Ribonucleic acid binding motif 
Recombinant human FSH 
Ribonucleic acid 
Reactive oxygen species 
Subcutaneously 
Stem cell factor 
Sodium dodecyl sulphate 
Antibody targeting the androgen receptor 
Sex-determining gene on the Y chromosome 
Steroidogenic acute regulatory protein 
Testosterone 
Testis-determining factor 
Testicular sperm extraction 
Testicular feminization 
Transforming growth factor 
Testis-specific histone 2A 
Testis-specific histone 2B 
Testosterone propionate 
Thyrotropin-releasing hormone 
World Health Organisation 

General Introduction: 
The male reproductive system 
9 
Chapter 1 
Sex Determination 
During early embryonic development in mammals, there is no apparent 
phenotypic sex. Male and female embryos both have a double set of 
rudimentary genital ducts, and indifferent gonads that can evolve into either 
testes or ovanes. Gonadal sex determination involves a series of 
developmental changes that precedes differentiation of other primary sexual 
characteristics (for review see Hunter, 1995). In mammalian species, the 
initial step towards male or femaleness is distinctly genetic. It has been 
recognized since 1959 that individuals who have developed into males carry a 
Y chromosome, and that those who have developed as females do not (Ford 
et aI., 1959; Jacobs and Strong, 1959; Welshons and Russell, 1959). 
Generally, human males display a 46,XY karyotype while females have two X 
chromosomes. The study of rare cases of human individuals with a 45,XQ, 
46,XX or 47,XXX karyotype (females) versus those with 46,XY, 47,XXY and 
48,XXXY karyotypes (males) demonstrated that the presence of a single Y 
chromosome is not only a conditio sine qua 11011 for male sex determination, 
but also that no amount of surplus X chromosomes can override its influence 
(Davis, 1981). As the male phenotype is the result of the actions of testis-
derived hormones (testosterone and anti-Mullerian hormone), it was 
postulated that the Y chromosome contains a dominant locus derermining 
the formation of a testis from the bipotential gonad. A small .'35 kilobase 
chromosome fragment adjacent to the pseudoautosomal region of the Y 
chromosome was apparently able to induce maleness. Within this region, a 
gene named SRY in man and Sry in mice was located (Gubbay et aI., 1990; 
Sinclair et aL, 1990). Subsequently Sty was shown to induce maleness in 
genetic female mice when introduced into newly fertilized XX eggs 
(Koopman et aL, 1991). These experiments demonstrate that SRYlSry is a 
genetic switch that induces male sex determination, and that all other genes 
necessary for the formation of the male phenotype can also be activated in XX 
ferrules. An important exception is, however, spermatogenesis. Spermato-
genesis requires not only the formation of testes, but also expression of a 
number of genes on the long arm of the Y chromosome (i.e. AZFa, AZFb and 
AZFc). Furthermore, spermatogenesis can occur only in the presence of one 
copy of the X chromosome (Koopman et aL, 1991; Vogt et aL, 1996; Vogt, 
1997). 
It has been shown that binding of SRY to DNA bends this DNA, thereby 
possibly creating a three-dimensional conformation facilitating the assembly 
of a transcription regulatory protein complex (Ferrari et al., 1992; Giese et al., 
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1992). SRYs function as a switch in sex determination implicates a cascade of 
events 'downstream' from its activity. Although the DNA sequences that bind 
SRY with high affinity (Giese et aI., 1992; Harley et aI., 1992; Harley et aI., 
1994) have been identified, there is stilllittlc informarion about genes which 
are regulated by this protein. As the events after male sex determinarion 
dictate the presence of factors that induce formation of the testis (Sertoli cells, 
Leydig cells, peri tubular myoid cells etc.), the Wolffian duct-derived organs, 
and involution of the Mullerian ducts, downstream genes will invariably play 
an important role in these events. Indeed, a peptide corresponding to the 
HMG domain of SRY has been shown to bind with high affinity to the 
promoter regions of the genes encoding anti-Mlillerian hormone (AMH) and 
P450 aromatase (Haqq et aI., 1993). Whether these in vitro observations 
actually have any bearing on the actual order of events during gonadogenesis 
remains to be elucidated. In addition, it has been proposed that SRY may act 
as an inhibitor of a male sex determination inhibitory gene (McElreavey et aI., 
1993). In that scenario, SRY binding would result in direct competition with 
a 'female determining protein', for binding to specific DNA sequences. 
Differentiation of the Male Gonad 
Prior to gonadal sex determination, primordial germ cells, probably derived 
from the epiblast (Snow and Monk, 198;3; Ginsburg et al., 1990), move to 
the posterior extra-embryonic mesoderm at 7 days post coitum (pc) in the 
mouse (Ginsburg et aI., 1990). Subsequently, a number of primordial germ 
cells, having reached the yolk sac, migrate via the hindgut epithelium, 
mesenteries and the ventral mesonephros into the primit.ive, undifferentiated 
gonad (Witschi, 1948; Byskovand Hoyer, 1994). The number of primordial 
germ cells is initially very low [some authors have even suggested a 
population of only 8 cells at the 7 day pc stage in the mouse (Resnick et aI., 
1992)], but during migration these diploid cells undergo a number of 
mitoses. On arrival at the primordial gonad, however, the mitotic rate 
increases such that at day 13 pc the mouse gonads may contain> 10,000 
germ cells (Tam and Snow, 1981). Migration of the primordial germ cells 
depends on interaction of stem cell £~ctor (SCF) with the Kit receptor: a 
transmembrane receptor with intrinsic tyrosine kinase activity. Activation of 
the Kit receptor in primordial germ cells results in stimulation of survival and 
proliferation (Fleischman, 1993). 
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The first morphological sign of male sexual development is the formation of 
testicular cords and the appearance of pre-Sertoli cells at 12.5 day pc in the 
mouse (Byskov and Hoyer, 1994). The primordial Settoli cells, together with 
the germ cells, are rapidly enclosed by a basal lamina and a layer of 
peritubular myoid cells, which form the initial boundary between tubular 
and interstitial testis tissue (Pelliniemi, 1976; Magre and Jost, 1983; 
Wattenberg et al., 1991). In the interstitial tissue, Leydig cells, derived from 
the mesonephric region, undergo differentiation and first show active 
steroidogenesis at day 13.5 pc (as monitored by 3il-hydroxysteroid 
dehydrogenase acrivity) in the mouse (McLaren, 1991). Within the testicular 
cords, Sertoli cell numbers increase through mitosis, resulting in a tortuous 
cluster of elongated tubuli. Onser of spermatogenesis and meiosis in the germ 
stem cells enclosed in these tubuli does not occur until shortly before puberty 
(Byskov, 1986). 
Testis formation is initially not dependent on gonadotropins or steroid 
hormones, but rather the activities of pre-Sertoli cells (which may include the 
secretion of a factor which activates the differentiation of Leydig cells) and 
peritubular myoid cells seem to be responsible. It is clear that the presence of 
germ cells is not a prerequisite for testis formation (Mintz and Russell, 1955; 
Merchant, 1975; McCoshen, 1982). In the series of events that follows testis 
determination and differentiation, however, testosterone produced by the 
Leydig cells and anti-Mullerian hormone (AMH) produced by the Sertoli 
cells are of critical importance in the development of the primary (and later 
secondary) male characteristics, including the prominent role of testosterone 
in the initiation of spermatogenesis at puberty and maintenance of spermato-
genesis in the adult. 
Differentiation of the Genital Ducts 
AMH 
The classic experiments of the late Alfred Jost have implied the existence not 
only of an active virilizing hormone, testosterone, but also of an active 
defelninization hormone that is instrumental in the regression of the 
Mullerian ducts (Jost, 1947). This latter factor, anti-Mullerian hormone, has 
been shown to be a 140,000 dalton protein composed of two identical 
subunits linked by disulphide bonds, produced by fetal Sertoli cells (Josso et 
aI., 1977; Vigier etal., 1983). AMH has been shown to be responsible for the 
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Figure 1. Schematic representation of the development of the male and female genital ducts. In the 
indifferent scage, the bipotemial gonads are formed together with the Wolff-Ian and MUlterian ducts. 
In the male, the gonads develop into testes which secrete anti-Mlillerian hormane (AMH) and 
testosterone. AMH causes the regression of the Mlillerian ducts, while testosterone stimulates the 
development and differentiation of the Wolman ducts into the epididymides, the ductus deferens, 
and the seminal vesicles. In the female, lack of testosterone secretion results in regression of the 
Wolman ducts, while the absence of AMH results in the development of the Mullerian ducts into 
Fallopian tubes, uterus, and upper part of the vagina. 
regression of the Mullerian ducts, which in female embryos, in the absence of 
AMH production by the ovaries, evolve into the Fallopian tubes, the uterus, 
the cervix, and the upper portion of the vagina (Wilson et al., 1981). 
The testicular pre-Sertoli cells fitst produce AMH at day 12 of gestation in 
the mouse and at 7 weeks of gestation in man (Josso et al., 1993; Taketo et al., 
1993). Its action, presumably mediated by a complex of transmembrane 
receptors of the serinelthreonine kinase family (Baarends et al., 1994; Oi 
Clemente et al., 1994; Grootegoed et al., 1994), is responsible for the 
regression of the Mullerian ducts in the male fetus. Although indications exist 
concerning direct action of AMH on testis formation and function (Vigier et 
al., 1987; Vigier etal., 1989; Behringer etal., 1990; Behringer etal., 1994), 
the importance of this action is probably limited, as male patients lacking 
AMH activity due to mutation of one of the genes encoding ligand or 
receptor have fully developed testes (albeit not descended, resulting in 
spermatogenic impairment) (Knebel mann et al., 1991). Interestingly, AMH 
secretion is quite protracted (ceasing at 4-20 days post partum in the rat, and 
at some point between the age of 2 years and the onset of puberty in man), 
while its action during a very narrow window of time (at 15 days pc in the rat 
and at 8 weeks of gestation in man) determines Mullerian duct regression. 
Exposure of the Mullerian ducts to AMH prior to or after this time window 
will not result in regression (Taguchi et al., 1984). Even more puzzling in this 
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respect is the expression pattern of the AMH type II receptor mRNA 
(AMHRII) before and after birth in the rat. Before birth, the AMHRII 
mRNA is expressed in the genital ridges of the male (15 days pc) and female 
(15-16 days pc) rats. At 16 days pc, in the male rat, AMHRII mRNA 
exptession has regressed to a small area including the cells associated with the 
degenerating Mullerian duct, in accordance with its role in Mulletian duct 
regression. However, AMHRII mRNA expression is also high in the ptenatal 
ovaries, while expression in the prenatal testes is lower. Abour 7 days after 
birth, AMHRII mRNA expression in the rat testis shows a pronounced 
inctease, when the AMH mRNA level is very low. In the postnatal tat ovary, 
AMH mRNA is produced at an increasingly high level (in the granulosa cells) 
in the continuous presence of a high AMHRII mRNA level (Kuroda.T et aL, 
1990; Haqq et ai, 1992; Hirobe et aI., 1992; Baarends et aI., 1994; Baarends 
et aI., 1995; Baatends et ai, 1995). From this it has been suggested that there 
might be some tole for AMH in the adult testis, and in particular in 
development and function of adult ovaries. 
Testosterone 
The production of testosterone by the testicular Leydig cells is instrumental 
in the development of the male genital ducts and other male characteristics 
(Greene et aI., 1939; Jost, 1947). The Wolffian duct develops into 
epididymis, vas deferens, and seminal vesicles. Further distal, the urogenital 
sinus develops into the prostate, the prostatic urethra, the penis and scrotum. 
Interestingly, while the Wolffian duct-derived accessory sex organs ate 
directly dependent on testosterone for development, the urogenital sinus-
derived organs and structures tequire modulation of the androgen signal 
through the enzyme Sa-reductase, transfotming testosterone into dihydro-
testosterone (DHT) (Griffin and Wilson, 1989). Testosterone and DHT 
bind to the same androgen receptor, albeit with different dynamics: DHT has 
a 10-fold greater potency in vitro (Grino et aI., 1990). Individuals with 
defective Sa-reductase activity, due to a Sa-reductase type 2 enzyme 
deficiency, display male pseudohermaphroditism and develop a syndrome 
called pseudovaginal perineoscrotal hypospadias: a partial or more complete 
failure in the virilization of the external genitalia while rhe Wolffian duct 
derivatives are well developed (Imperato-McGinley et al., 1974; Walsh et aI., 
1974). Why the presence of two hormones that bind to the same receptor is 
14 
Ceneml Introduction 
necessary for formation of the male phenotype, is still somewhat of an 
enigma. It has been proposed that the close proximity of the Wolffian duct 
system to the testis results in the exposure to a higher testosterone level, as 
compared to a lower testosterone level in the more peripheral position of the 
urogenital sinus organs. Reduction of testosterone to DHT would thus serve 
to amplifY the testicular virilization signal. Although one could argue that the 
seminal vesicles and the prostate develop in close proximity to each other, and 
would thus not require diffetential androgen stimularory action, it has been 
shown that testosterone transport through the lumen of the Wolffian duct 
may be instrumental in creating a high local testosterone level (Veyssiere et 
ai., 1982). Indeed, human hermaphrodites with one testis develop only one 
vas deferens at the side of the testis (Grumbach and Wijk, 1955). In 
adulthood, all Wolffian duct-derived organs have been shown to contain 5a-
reductase activity, and indeed to depend highly on DHT for adequate 
function (Robaire and Hermo, 1988). 
Spermatogenesis 
The adult testis has two major functions: one is its endocrine function as a 
gland that produces testosterone, necessary for the development and 
maintenance of the primary and secondary male sex characteristics. The other 
comprises the production of a huge number of highly specialized 
spermatozoa from a pool of undifferentiated stem cells (spermatogonia) that 
teside in the basal compartment of the seminiferous rubuli. The human male 
may produce as many as 2x1012 spermatozoa in his lifetime (Grootegoed, 
1996). Not only in numbers is this an extraordinary feat, the testes and the 
epididymides nurse the development and maturation of the only cells that are 
designed to live and function outside the male body. The dual function of the 
testis, steroidogenic and gametogenic, is a uniquely fine-tuned process 
encompassing the interregulation of a considerable number of cells. 
The hypothalamus-pituitary-testis axis 
The intricately regulated processes mentioned above, depend on the highly 
controlled secretion of a number of messenger molecules (hormones) which 
will each generate their specific endocrine, paracrine and autocrine effects. At 
15 
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Figure 2. Schematic representation of (he hypothalamus-pituitary-testis axis. Hypothalamic CnRH 
stim.ulates the pituitary secretion of LH and FSH. LH stimulates testicular Leydig cells, resulting in 
synthesis and secretion of testosterone. FSH and testosterone directly stimulate Sertoli cells, which 
in turn, regulate germ cell development. CnRH is under negative feedback control by testosterone, 
while pituitary secretion of LH and FSH is under feedback control by testosterone, and inhibin 
causes selective inhibition ofFSH production. 
the basis of this scheme of events is the hypothalamus-pituitary-testis axIS. 
The hypothalamus secretes gonadotropin-releasing hormone (GnRH) which, 
through the portal vascular system, reaches the pituitary gland to stimulate 
production and secretion of luteinising hormone (LH) and follicle-
stimulating hormone (FSH). LH and FSH bind to cell surface trans-
membrane receptors on different testicular cell types. Hypothalamus and 
pituitary functions are regulated via a feed-back mechanism, where 
testosterone (produced by the LH-stimulated Leydig cells) inhibits GnRH, 
and thereby LH and FSH secretion, and inhibin (produced, under control of 
FSH, by Sertoli cells) more specifically inhibits FSH secretion (Swerdloff and 
Wang, 1998). 
16 
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Role of gonadotropins in spermatogenesis 
FSH and LH are both members of the family of large heterodimeric 
glycoproteins, which also includes thyroid-stimulating hormone (TSH) and 
human chorionic gonadotropin (hCG). Within a species, these hormones 
have an identical a-subunit that is associated with one of four different ~­
subunits. The resulting glycoprotein structures bind to specific membrane 
receptors (although LH and hCG are closely related and both bind to the LH 
receptor). The receptors specific for these hormones are also similar in 
structure: all have a large extracellular domain (encoded by 10 and 9 exons 
for the LH and the FSH receptors, respectively) that specifically binds its 
respective hormone, which involves proper positioning of the hormone in the 
'binding pocket' formed by the extracellular and transmembrane domains 
(Willey and Leidenberger, 1989; Themmen et aL, 1994). The large 
transmembrane domain traverses the membrane seven times, and is followed 
by a short intracellular C-terminal domain that together with intracellular 
loops of the transmembrane domain can interact with G proteins. The 
transmembrane and intracellular domains of the LH and FSH receptors are 
encoded by a single exon. Activation of G proteins is effectuated by a 
conformational change of the receptor as a result of ligand binding. G 
proteins, when bound to GTp, activate adenylyl cyclase as the most 
important signal transduction pathway of this type of receptor. The activated 
cyclase converts ATP into the second messenger cAMP. Release of cAMP into 
the cytoplasm is followed by binding of cAMP to the regulatory subunit of 
cAMP-dependent protein kinase, dissociation of this regulatory subunit, and 
consequent activation of the catalytic subunit of the enzyme. 
FSH 
The role of FSH in the development of the testis, and the initiation and 
maintenance of spermatogenesis, has been widely studied. The only cell type 
expressing the receptor for FSH in the male mammal, is the Sertoli cell. 
During development FSH plays an important role as a regulator of Sertoli cell 
number and, indirectly, also of Leydig cell number (Huhtaniemi etaL, 1986; 
Dungen et aL, 1990; Sharpe, 1993). Proliferation of Sertoli cells occurs 
during a relatively short time: in the rat starting during the fetal phase and 
ending around day 15 after birth, while in man proliferation may continue 
through to the very early teens (for review see Sharpe, 1994). Cessation of the 
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proliferative activity of Sertoli cells coincides with maturation of these cells. 
As the number of Sertoli cells present in the seminiferous tubuli determines 
the length of the testicular tubules and hence the maximal capacity of 
spermatogenesis in adulthood, any defect in FSH secretion or action during 
the proliferative phase of the Sertoli cells will ultimately result in lower sperm 
output. 
FSH responsiveness in immature rat Sertoli cells is quite well defined. In 
response to FSH stimnlation, Sertoli cells have been found to up regulate 
androgen receptor (AR) expression, and also show increased production and 
secretion of seminiferous tubular fluid and proteins, such as transferrin, 
androgen binding protein (ABP) , and inhibin (Blok et aL, 1989; Sharpe, 
1993). Upon maturation, there is a clear reduction in the responsiveness of 
Sertoli cells to FSH, coinciding with an increase in responsiveness to 
androgens. Indeed, there seems to be a maturation switch from FSH- to 
androgen- dependence of the Sertoli cells (Sharpe, 1994). 
In adulthood, the role ofFSH remains an issue that has yet to be fully settled. 
Male mice deficient in the FSH-~ subunit have small testes but are fertile 
(Kumar et aL, 1997). The genetic defect in these mice resulted in total 
absence of FSH activity throughout development, probably resulting in a 
deficient testis at the onset of puberty. In normally developed rodents, 
inhibition of FSH action has less far reaching implications. A number of 
studies have shown that immunization against FSH has little or no impact on 
spermatogenesis in rats (Davies et at., 1979; Dym et at., 1979), although 
careful scrutiny of the available data does show a 10% decrease in testis 
weight in these studies (Sharpe, 1994). FSH probably has a more prominent 
role in the maintenance of spermatogenesis in primates than in rodents, as 
immunization against FSH in primates results in a dramatic decrease (though 
not complete cessation) of spermatogenesis (Nieschlag et at., 1975; Wickings 
and Nieschlag, 1980; Raj et aL, 1982). This discrepancy between primates 
and rats may be explained by the following: The available evidence suggests 
that in the adult testis, FSH may have a role in regulation of the number of 
spermatogonia that enter the spermatogenic pathway. In non-human 
primates, FSH is able to increase the number of B spermatogonia, 
spermatocytes and spermatids [mediated by a relative increase in the number 
of A-pale (Ap; see later this chapter) spermatogonia (Arslan et aL, 1992)]. 
Regulation of spermatogonial numbers in the rat seems to be controlled by 
density dependent degeneration: there is a maximum number of sperma-
18 
togonia that can enter the spermatogenic pathway (i.e. can be supported by 
the Sertoli cells), and the rest degenerate (Huckins, 1978; Huckins and 
Oakberg, 1978; Rooij and Lok, 1987; De Rooij and Grootegoed, 1998). 
Thus even ifFSH would have an effect on the proliferation of spermatogonia 
in the rat, this effect would be lost by this density dependent degeneration of 
spermatogonia. In man and non-hmnan primates, however, the number of 
spermatogonia that is available to enter meoisis may not be maximal. In these 
species, there appears to be no density dependent degeneration as a 
consequence of a much lower rate of division of the undifferentiated 
spermatogonia (Clermont and Leblond, 1959; Clermont, 1972; Clermont 
and Antar, 1973; Rooij et aI., 1989). Hence, an FSH-stimulated increase in 
spermatogonial number entering the spermatogenic pathway is more readily 
discerned in primates (Sharpe, 1994). Recently, a number of men 
homozygous for an inactivating mutation in the FSH receptor have been 
studied. Although spermatogenesis was clearly negatively affected, these 
individuals did not have azoospermia, and some were fertile (Tapanainen et 
aI., 1997). The trearment of oligozoospermic males with regimens resulting 
in a higher serum FSH level, however, has given disappointing results, in 
terms of improvement of semen parameters (Baker, 1989). 
The above data indicates that, in man and rodents, FSH action is required 
for normal testis development and probably for the maintenance of optimal 
spermatogenesis in adulthood, but that qualitative spermatogenesis evolves 
and can be maintained under conditions of suboptimal, or even absent, FSH 
action. 
LH 
Within the testis, the LH receptor is found exclusively on the Leydig cells. 
Previous studies have estimated the number of Leydig cells at 18 to 34x106 
per rat testis (Mori and Christensen, 1980; Ewing and Zirkin, 1983; 
Tapanainen et aI., 1984; Kerr et al., 1987; Zirkin and Ewing, 1987; Mendis-
Handagama et aI., 1988), accounting for about 3 percent of the total testis 
volume (Ewing and Keeney, 1993). The pituitary gland secretes LH in a 
pulsatile manner inro the bloodstream, through which it reaches the Leydig 
cells within the testis. LH binds to the transmembrane receptor at the cell 
surface, resulting in stimulation of G protein and adenylyl cyclase, thereby 
increasing cAMP formation. Cyclic AMP subsequently activates protein 
19 
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kinase A, which in turn effectuates the phosphorylation of specific proteins. 
Changes observed within the Leydig cell upon stimulation with LH in vitro 
are: 1) depletion of intracellular lipid droplets that store cholesterol esters, 2) 
stimulation of cholesterol hydrolyse to produce free cholesterol esters, 3) 
changes in cytoskeletal elements, 4) transport of cholesterol to the inner 
mitochondrial membrane, site of the P450sCC enzyme, and 5) stimulation of 
RNA and protein synthesis (Dufau, 1988; Hall, 1988; Ewing and Keeney, 
1993). The conversion of cholesterol to pregnenolone has for many years 
been considered the rate-limiting step in testicular steroidogenesis. However, 
it has recently been observed that the true rate-limiting step is the transport 
of cholesterol from the outer mitochondrial membrane to the inner 
mitochondrial membrane, where the P450scc enzyme is situated (reviewed in 
Stocco, 1998). This process is tightly regulated by tropic hormone 
stimulation, and dependent on de novo protein synthesis. Many studies have 
now identified a hormone-regulated 30 kDa protein as a major modulator of 
steroidogenesis, that is instrumental in the transport of cholesterol to the 
inner mitochondrial membrane. This protein has been designated 
steroidogenic acute regulatory protein (StAR) (Stocco, 1998). 
Testosterone synthesis and secretion are the most important and best known 
functions of the Leydig cells. During fetal life, a testosterone surge is 
responsible for the differentiation of the male reproductive tract, and during 
the neonatal period a subsequent surge effectuates "imprinting" of androgen 
dependent tissues. In the pubertal period, increased testosterone production 
is responsible for the development of the secondary male sex characteristics, 
male sexual behavior, and the onset of spermatogenesis. During adult life, 
testosterone is required for maintenance of the secondary male characteristics, 
as well as for maintenance of skeletal bone density (Ewing et aL, 1980; 
Tenover, 1994). Mutations in the LH receptor have been identified, and have 
been shown to result in inactive or constitutively active receptors (reviewed in 
Themmen et al., 1997). A number of activating mutations have been 
characterized, where inappropriate G protein activation is associated with 
mutation in the second or fifth transmembrane segment. This results in 
precocious puberty in boys carrying a single allele of the mutated gene, while 
carrier girls or women have no apparent phenotype. Inactivating mutations 
may occur anywhere in the gene. The complete form of LH receptor 
insensitivity is characterized by complete male pseudohermaphroditism and 
Leydig cell hypoplasia. A milder form of this syndrome results in slightly 
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under-virilized men with a micropenis (Leydig cell hypoplasia type II). The 
latter syndrome has been associated with a mutation in the seventh 
transmembrane segment (Themmen et aI., 1997). 
Histology of the testis 
The testis is an oval shaped organ that is encapsulated by a strong fibrous 
membrane called the tunica albigunia (Kretser and Kerr, 1994 for teview). 
The testicular mesenchyme can be grossly divided into two major 
compartments: the interstitial space and the seminiferous tubules. The 
interstitial space contains Leydig cells, macrophages, blood vessels and 
lymphatic fluid. The outer wall of the seminiferous tubules is formed by 
peritubular myoid cells and endothelial cells. A basal lamina (or basement 
Epididymis ~f4f1--
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Figure 3. Artistic representation of the rat and human testis and excurrent ducts. The testis of both 
rat and human consists of a fibrous tunica albuginea, which encases a large number of seminiferous 
tubuli. The human testis is divided into lobuli, by a number of fibrous partitions within the testis. 
These partitions are absent in the rat testis. The seminiferous tubuli merge into the rete testis, from 
where the seminiferous fluid and spermatozoa are transported into the epididymis, through a 
number of ductuli efferentes. In the rat, the ductuli efferentes quiddy unite into a single highly 
contorted tubule that forms the entire epididymis, and, further distal, the vas deferens. In the 
human, a more complex tubular network is formed in the proximal epididymis, which conjoins into 
a single epididymal tubule in the distal caput. This single tubule subsequently forms the distal caput, 
corpus, and cauda epididymis, and the ductus deferens. 
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membrane) covers rhe luminal surface of rhe tubule. On the basement 
membrane are situated the germinal stem cells (spermatogonia) and the 
Sertoli cells. Cytoplasmic extensions of the Sertoli cells form a highly 
organized sttuctural matrix within which the spermatogonia develop into 
mature spermatozoa (Sertoli, 1865). Sertoli cells not only provide structural 
support, but have an important role in the support of biochemical processes 
of the germinal cells (Russell, 1993). Instrumental for this is the 'blood-testis 
barrier' or 'Sertoli cell barrier' formed by tight junctional complexes between 
adjacent Sertoli cells (Dym and Fawcett, 1970; Ross, 1970; Gilula et al., 
1976; Russell and Peterson, 1985). This barrier, impenetrable to the larger 
hydrophilic molecules, divides the tubule into a basal compartment and an 
adluminal compartment. In the basal compartment reside only the 
spermatogonia and the early preleptotene spermatocytes. The latter cells, 
which have entered the prophase of meiosis, start to traverse the barrier to 
reach the adluminal compartment (Russell, 1980; Russell, 1993). The 
following meiotic and post-meiotic steps of spermatogenesis all take place in 
the adluminal compartment. Centrally within the tubule is located the 
tubular lumen, which is filled with a seminiferous tubular fluid and 
spermatozoa. All tubuli conjoin in the rete testis, from where the tubular 
content is directed into the ductuli efferentes and epididymis. ' 
The spermatogenic cycle 
As mentioned above, Sertoli cells are the structural and functional 'nurse 
cells' of the developing germinal cells. When seminiferous tubuli are viewed 
in cross section through a microscope, one encounters a highly pleiotropic 
architecture of Sertoli cell-germinal cell complements. These variations are an 
expression of cyclic changes in phases of development, that have classically 
been divided into the spermatogenetic stages. In man, six such stages are 
identified, whereas in the rat the spermatogenic cycle is divided into fourteen 
stages (Leblond and Clermont, 1952; Clermont, 1963). A given Sertoli cell 
within a particular stage of the cycle supports a well-defined germ cell 
complement, encompassing spermatogonia through to elongating spermatids. 
The germ cell complement (as well as the structural form of the Sertoli cells) 
changes with each subsequent stage. The germ cell begins its developmental 
journey at the basement membrane of the tubule, and moves to the 
adluminal compartment. On moving 'inward', it is closely followed by a 
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Figure 4. Diagram illustrating the spermatogenic cycle in the rat and in the human. Each vertical 
column depicts a complement of germ cells associated with a Sertoli cell at a specific stage of the 
spermatogenic cycle. 
The spermatogenic cycle of the rat is subdivided into 14 stages. Abbreviations are: A= type A 
spermatogonia; In= intermediate type spermatogonia; B= type B spermatogonia; PI= ptdeptotene 
spermatocytes; L= leptotene spermatocytes; Z", zygotene spermatocytesi P= pachytene spermato-
cytes; Di", diplotene spermatocytes; 11= secondary spermatocytes; 1-19= spermatids at their 
successive steps of spermiogenesis. 
The spermatogenic cycle of the human is subdivided into 6 stages. Abbreviations arc: Ad= type A 
'dark' spermatogonia; Ap= type A 'pale' spermatogomia; B= type B spermatogonia; PI= preleptotene 
spermatocytes; L= leptotene spermatocytes; Z= zygotene spermatocytes; P= pachytene spennato-
cytes; II= secondary spermatocytes; 1-8= spermatids at their successive steps of spermiogenesis. 
(Adapted from Sharpe, 1994). 
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younger germ cell at a specific developmental distance. Thus, for example, at 
stage VII in the rat, one always finds step 7 and 19 spermatids, mid-
pachytene and preleptotene spermatocytes, and Al spermatogonia, while at 
stage XIV one invariably finds step 14 spermatids, late diplotene 
spermatocytes undergoing meiotic divisions, and A3 spermatogonia (Sharpe, 
1994 for review). 
It must be stressed that the division of the dynamic process of spermato-
genesis into stages is arbitrary, and is based for the most part on the 
development of the acrosome in spermatids (Leblond and Clermont, 1952; 
Clermont, 1963). Particularly in the rat, pronounced stage specific changes in 
Sertoli cell activities have been reported (Parvinen, 1993), indicating that, 
although the spermatogenic cycle is divided into an arbitrary number of 
stages, this subdivision is helpful to study mechanisms involved in the control 
of spermatogenesis. The fact that the human spermatogenic cycle is 
subdivided into less that half as many stages as that of the rat, reflects a less 
ordered appearance of the spermatogenic epithelium rather that a less 
intricate developmental process. 
An intriguing difference between man and almost all other mammalian 
species (with the exception of the olive baboon) is the helical organization of 
the spermatogenic stages within the seminiferous tubuli (Afzelius et al., 1982; 
Schulze and Rehder, 1984). A cross section of a human tubule will display 3 
or more different stages of the spermatogenic cycle in a mosaic fashion, 
whereas a cross section of a tubule of any other mammal will, as a result of a 
marked longitudinal organization of the cycle of the spermatogenic 
epithelium, display only one stage of the cycle, at a given timepoint. 
In recent years, many genetic and molecular aspects of spermatogenesis are 
being studied in mice, taking advantage of transgenic and knockout mouse 
models. However, spermatogenesis has been studied most extensively in the 
rat, in particular for the role of hormones and growth factors, and cellular 
interactions. Therefore the following account applies to the situation in the 
latter rodent species. 
On the basement membrane, at all stages of the spermatogenic cycle, 
undifferentiated (A) spermatogonia can be found. These are spermatogenic 
precursor cells that have the ability to proliferate through mitosis. Daughter 
cells can either remain undifferentiated spermatogonia, ensuring an adequate 
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precursor population, or they can differentiate into A1 spermatogonia. From 
there, differentiation proceeds during a series of mitotic divisions, via the A2, 
A3 and A4 to the AIn (intermediate) and B spermatogonia, increasing the 
number of spermatogonia. Having reached the B spermatogonia stage, the 
last mitosis occurs, and the spermatogenic cells enter the meiotic prophase as 
preleptotene spermatocytes (PL). The preleptotene spermatocytes start to 
pass across the Sertoli cell tight junctional barrier, to enter the adluminal area 
of the seminiferous tubuli, now separated from the rest of the body by the 
Sertoli cell barrier and completely dependent on the Sertoli cells for their 
biochemical needs. In the preleptotene phase, DNA replication occurs for the 
last time resulting in diploid (2N) cells with a 4C DNA content. Once in the 
leprotene phase, the spermatocytes have entered the lengthy prophase of the 
first meiotic division, encompassing the leptotene (pairing of the 
homologous chromosomes), zygotene (forming of the synaptonemal com-
plexes), pachytene (crossing over between paternal and maternal chromo-
somes) and diplotene (desynapsis) spermatocyte phases. Subsequently, the 
primary spermatocytes undergo the first meiotic division, resulting in haploid 
secondary spermatocytes (IN, 2C), which rapidly enter the second meiotic 
division without DNA replication. One diploid 4C-DNA spermatocyte thus 
forms four haploid lC-DNA spermatids. Development of the spermatids 
(spermiogenesis) encompasses a number of steps, 1-19 in the rat and 1-8 in 
man. Within this differentiation process, the round spermarids do not further 
divide, but start to undergo a startling morphological change. A tail develops 
from a protrusion in close proximity to the nucleus. At the other end of the 
nucleus, a granule appears which later spreads itself over one nuclear 
hemisphere (the acrosome), and subsequently nuclear elongation and 
condensation occurs. Finally, just prior to the release of the spermatids/ 
spermatozoa from the Sertoli cells (spermiation), practically all of the 
spermatid cytoplasm is removed and taken up by the Sertoli cells. The 
resulting spermatozoa are released into the lumen of the seminiferous tubuli, 
where they are carried to the epididymis with the seminiferous tubular fluid 
(for review see Sharpe, 94). In the human, the spermatogonia are subdivided 
into the Ad"k' Ap,], and B spermatogonia. The subsequent meiotic develop-
ment is quite similar to what is found in the rat, but spermiogenesis is divided 
into only 8 steps. The duration of the complete process of spermatogenesis is 
51-53 days in the rat and 64 days in the human, from the formation of 
differentiating spermatogonia to spermiation. 
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Sertoli cell-germ cell interactions 
Clearly, male germ cell differentiation is a complex process, not only 
requiring expression of many genes within the germ cells themselves, but also 
requiring supportive functions of Sertoli cells (Russell, 1993; Griswold, 
1995). The most important endocrine regulators of spermatogenesis are 
androgens and FSH. Receptors for these hormones are present inion Sertoli 
cells, but most evidence indicates that germ cells lack these receptors 
(Grootegoed etal., 1977; Bremner etat., 1994; Chapters 1 and 2). This fact 
clearly demonstrates the importance of Sertoli cells in spermatogenesis. What 
then is the tole of Sertoli cells during proliferation and differentiation of the 
germ cells? 
The structural matrix which is provided by cytoplasmic extensions of the 
Sertoli cells, together with the Sertoli cell barrier, is the cellular basis on which 
germ cell differentiation can proceed. Electron microscopical analysis, of 
sequential cross sections to reconstruct a three-dimensional model of Sertoti 
cells, has disclosed that Sertoli cells change shape during the spermatogenic 
cycle. One group of Sertoli cells (designated group A) have deep crypts that 
accommodate the germ cells. In the other group (group B), crypts are absent 
due to the apical movement of the spermatogenic cells (Russell et at., 1983; 
Weber et at., 1983; Wong and Russell, 1983; Griswold, 1995). These 
morphological changes correlate well with certain stages of the spermatogenic 
cycle, and are suggestive of a 'dual mode' of Sertoli cell function: one mode 
accommodates germ cell developmental stages including meiosis (-stages X-
IV of the spermatogenic cycle in the rat), while the other accommodates the 
spermiation stages (roughly stages V-IX in the rat). In each 'mode', the Sertoli 
cells secrete a specific set of proteins (Linder et at., 1991). 
The role of germ cells in regulation of Sertoli cell function is a subject still 
under investigation. It is clear, however, that in culture, the activity and 
morphological characteristics of Sertoli cells are dependent on association 
with germ cells (Griswold et al., 1989; Wright et at., 1989; Jegou, 1991). The 
interactions between Sertoli cells and germ cells are, for an important part, 
paracrine in nature. A large number of possible paracrine regulators have 
been identified, among which stem cell factor (SCF), Nerve growth factor 
(NGF), insulin-like growth factor I (IGF-I), epidermal growth factor (EGF), 
basic fibroblast growth factor (bFGF/FGF-4), interleukins, transforming 
growth factors ex and ~ (TGF-ex and TGF-~) and other members of the TFG-
~ family such as activin, inhibin and AMH (reviewed in: Skinner, 1991; 
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Grootegoed, 1996). The precise role of each of these factots in unknown, 
although it has been the focus of a considerable amount of research. 
One Serroli cell protein that has been extensively studied is transferrin. 
Transferrin is an iron transporting protein found in many tissues, including 
liver and brain, which is also produced and secreted by Sertoli cells. It has 
been suggested that transferrin is part of an iron shuttle system that transports 
iton across the tight junctional Sertoli cell barrier to the developing germ cells 
(Sylvester and Griswold, 1993; Griswold, 1995). Experiments involving 
transferrin deficient (HP) mice, have shown that spermatogenesis is im-
paired, and that indeed production of transferrin by Serroli cells of mice is 
required for adequate germ cell development (Bernstein, 1987; Huggenvik et 
al,1989). 
For their metabolic requirements, developing germ cells may also be highly 
dependent on Sertoli cells. It has been shown that pachytene spermatocytes 
and round spermatids from rats and hamsters require exogenous lactate or 
pyruvate for ATP production, apparently because of a relative limitation of 
the acrivity of the glycolyric enzymes glyceraldehyde 3-phosphate dehydro-
genase and phosphoglycerate kinase (Grootegoed and den Boer, 1989). The 
Sertoli cells are, however, metabolically versatile, and can produce lacrate and 
pyruvate from glucose, possibly for use by the germ cells. In vitro, 
spermatocytes and spern1atids cannot survive for more than several days 
when not associated with Sertoli cells, even in the presence of pyruvate and 
lactate, indicating that other Sertoli cell factors are required (Toebosch et al., 
1989; Rassoulzadegan etal, 1993; Kierszenbaum, 1994). 
Chromatin structure and remodelling 
The DNA of spermatogonia is associated with somatic histones, and is 
organized in a somatic fashion. Two turns of DNA (160 base pairs) wrap 
around the four core histones, H2A, H2B, H3 and H4. Together with an 
associated linker histone (HI), the DNA is further organized into solenoids 
which are, in turn, supercoiled. This construction allows the 3.3 billion base 
pair human genome to fit into a cell nucleus measuring less than 10-5 M in 
diameter. During the course of germ cell differentiation, somatic histones are 
partly replaced by testis-specific histones. In the rat, testis-specific histone 2A 
and 2B (TH2A and TH2B) are first synthesized in early primary sperma-
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Figure 5. Schematic representation of DNA packaging in somatic cells and spennatowa. In somatic 
cells, DNA is wound twice around a histone oetamer, forming a nucleosome. Nucleosomes coil 
further into solenoids. In spermatozoa, highly positively charged protamines bind to DNA 
lengthwise along the minor groove. This results in a neutral polymer, where the DNA-protamine 
com-plexes can bind together by van der Waals forces, in a linear fashion. Disulfide bonds between 
protamines further stabilize the nucleoprotamine complex. 
tocytes (peleptotene or pachytene stage) while testis-specific histone 3 (TH3) 
is present and actively synthesized already in A and B spermatogonia (Brock 
et aI., 1980; Meistrich et aI., 1985). HI t is not observed in the germinal cells 
until the pachytene spermatocyte stage (Meistrich et aI., 1985). No testis-
specific variant of H 4 has yet been reported. It is unclear why testis-specific 
histone variants have evolved, and their role remains elusive. It has been 
shown that the thermal stability of chromatin derived from the testis is 
appreciably less compared to that ofliver chromatin. The reduced stability of 
testicular chromatin may facilitate histone removal during the nuclear 
histone-to-protamine transition that occurs in spermatids (Grimes, 1986). In 
man, very little is known about the nuclear protein composition in the early 
germinal cells, although testis-specific histones have been found in whole 
testis tissue and in isolated spermatids and spermatozoa. 
In the mid spermatid stage (steps 9-12 in the rat), histones are replaced by 
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testis-specific transition proteins. Prior to this event, the nuclear chromatin 
appears to undergo decondensation and becomes vulnerable to thermal 
denaturation (Grimes, 1986). This is in part due to hyperacetylation ofH4, 
and probably a number of additional protein modifications which have not 
yet been elucidated (Grimes and Smart, 1985; Grimes, 1986). The transition 
proteins are the major DNA binding proteins found in steps 13-15 
spermatids in the rat. Subsequently, the transition proteins are replaced by 
testis-specific protamines. Protamines are relatively small, highly basic 
proteins, that are rich in arginine (40-70%), and in mammals frequently 
contain cysteine residues (18%) (Coelingh et aL, 1972; Kistler et aL, 1976). 
Protamines bind to the DNA along the minor groove. This transforms the 
polyanionic DNA into a neutral polymer, so that the DNA-protamine 
complex can bind together by Van der Waals forces in a linear fashion, at the 
molecular level (Ward, 1993). The highly condensed nucleoprotein complex 
is further stabilized by the formation of disulfide bonds between protamines 
(Grimes, 1986). This configuration results in a highly compact chromatin 
arrangement that renders the DNA unavailable for transcription, and results 
in a high resistance of the chromatin to external harmful influences. 
Furthermore, the compact arrangement allows for construction of a very 
small sperm nucleus. 
Sperm maturation 
When spermatozoa are isolated from the rete testis or the proximal region of 
the epididymis, they are found to have little or no capacity to fertilize an 
oocyte. Within the epididymis, spermatozoa undergo a number of subtle, yet 
profoundly important changes that will enable them to survive in the female 
genital tract, propel themselves toward, bind to, and fertilize an oocyte 
(Tournade, 1913; Bedford, 1967; Orgebin-Crist, 1967; Orgebin-Crist, 1969; 
Eddy and O'Brien, 1994; Yanagimachi, 1994). These changes take time, and 
while certain characteristics may develop (albeit imperfectly) spontaneously 
with the passage of time, there exists ample evidence that full maturity can 
only be attained if the spermatozoon is allowed to migrate down the tortuous 
duct of the epididymis, and is exposed to the highly regulated varying 
luminal environment. 
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Histology of the epididymis 
Structurally, the epididymis consists of one long contorted tubule that 
connects the ductuli efferentes (usually also viewed as part of the epididymis) 
to the vas deferens. Its length varies between species: in the rat it measures 
about 6 meters (Jiang et aL, 1994), with bigger mammals as a rule having an 
even longer epididymal duct [up to 50 m in large domestic animals (Bedford, 
1994)]. The length of the human epididymis is relatively short, averaging 
about 6 meters (Bedford, 1994). The rete testis drains into the ductuli 
efferentes, a collection of tubules lined with tall columnar epithelium. This 
epithelium consists of ciliated and non-ciliated cells, which on the basis of 
their appearance and possible function, is characteristic of the division of the 
efferent ductuli into initial and terminal zones (Reid and Cleland, 1957). The 
efferent ducts conjoin in the single lumen of the epididymis proper. Based on 
gross morphological characteristics, the epididymis consists of a caput, a 
corpus and a cauda. In most species, the caput is relatively modest in size and 
is joined by a slender corpus to a well-developed cauda. In man, however, the 
caput is relatively large with a surprisingly small cauda (Bedford, 1994). 
Microscopically, and on the basis of a number of functional studies, a much 
more complex series of disrinct regions can be identified. For the purpose of 
this thesis, the subdivision of the various epididymal regions will be confined 
to: an initial segmenr, a proximal caput, and a distal caput region, followed by 
the corpus and the cauda. 
---
hlitial segment 
---
Proximal capll! 
---
Distal caput 
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Corpus 
~ Cauda 
30 
Figure 6. Schematic representation of (he rat 
epididymis. For the purpuse of this thesis, 
the epididymis is subdivided i11to [he 
following segments: efferent ducts, initial 
segment, caput, corpus, cauda, and ductus 
deferens. 
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The lining of the epididymal duct is composed of a number of specific cells. 
Principal cells make up the bulk of the epithelium, accounting for 80% of the 
cells in the initial segment, where they are tall and columnar, and decline to 
67% in the cauda, where they are far less tall and more cuboidal-shaped. 
Nartow cells are found only in the initial segment and account for 3% of rhe 
cell population. Clear cells are found thtoughout the otgan, where they 
constitute about 5% of cells in the caput to about 7% in the cauda. The basal 
cells are flat and elongated, and lie close to the luminal sutface of the 
basement membrane. They account for 12% of the cells in the caput 
increasing to about 21 % in the distal portions of the epididymis (Reid and 
Cleland, 1957; Robaire and Hermo, 1988). 
Changes in sperm characteristics dnring epididymal passage 
Duting the last phase of spermiogenesis, the spermatids loose practically all of 
their cytoplasm. This results in a marked inability to perform many bio-
chemical processes. The spermatozoon is thus dependent on the epididymis 
for supporting factors needed for maturation. It has been shown that sperm 
can modifY or degrade carbohydrates and lipids to provide energy (Bedford 
and Hoskins, 1990). Sperm may need the metabolic energy mainly for their 
butst of motility after ejaculation. The capacity for motility is gradually 
acquired within the epididymis through an as yet unidentified process. When 
comparing different species, it has been found that the capacity to show 
progressive motility is attained in different parts of the epididymis: the 
marmoset sperm isolated from the distal caput displays motility, while the 
rabbit, boar and ram sperm are potentially motile from the distal corpus 
onwards. Sperm from rat, mouse, hamster and man are capable of motility 
only when they have progressed into the caudal region (Nishikawa and Wade, 
1952; Hoppe, 1975; Holtz and Smidt, 1976; Foutnier-Delpech et al., 1977; 
Moore, 1981; Moore et ai, 1983; Orgebin-Crist and Olson, 1984). 
Interestingly, it has been found that in men suffering from obsttuction of the 
epididymis, even in very proximal regions, spermarozoa from the ductuli 
effetentes can be motile and fertile (Bedford, 1994). This is in marked 
conttast to findings in a cohort of men who underwent orchiectomy, whete 
motility was found for the first time in the mid corpus (Bedford et al., 1973) 
or caudal tegions (Moore et aI., 1983). This indicates either an intrinsic 
ability to become lllotile after a certain period of time, or an interactive 
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differentiation, induced by the presence of spermatozoa, with the local 
tubular epithelium. In all studied animals, spermatozoa are immotile while 
still residing within the epididymis (Hinton et al, 1979). In the rat, this is 
presumably the result of the presence of a high molecular weight glycoprotein 
(immobilin), which is synthesized in the principal cells of the caput, and 
travels down to, and accumulates in the cauda (Usselman et al, 1985; 
Robaire and Viger, 1995). It has been suggested that immobilin inhibits 
sperm motility mechanically by creating a highly viscoelastic environment 
(Robaire and Viger, 1995). In the bovine, however, immobilin appears to be 
of little importance in inhibition of sperm motility; rather, inhibition of 
bovine sperm motility is effectuated by the relatively low pH of 5.5 (Carr and 
Acott, 1984). At an extracellular pH of7.6, bovine sperm are fully motile. 
Next to the attainment of motility, the sperm nucleus undergoes a number of 
changes, culminating in the formation of a highly compact and stable DNA-
protein complex as a result of increased disulfide bonding in between DNA-
associated protamine molecules. Caudal rat sperm are thus highly resistant to 
dissolution by sodium dodecyl sulphate (SDS) (Bedford, 1975; Bedford and 
Hoskins, 1990). Indeed, it has been suggested that the oocyte cytoplasm is 
the only known biological medium capable of overcoming the stability of the 
DNA-nucleoprotein complex (Amann et al., 1993). 
One of the most important developmental changes that occur during transit 
through the epididymis is the profound modification that is seen in the 
composition of the sperm membranes. Enzymes secreted by epithelial cells 
have been shown to modify membrane glycoproteins (Hammetstedt and 
Parks, 1987b; Jones, 1989b; Srivastava and Olson, 1991b; Tulsiani et al., 
1993b; Tulsiani et al., 1993b). A number of phospholipids located on the 
outer acrosomal membrane move through the aqueous space to the inner 
surface of the overlying plasma membrane, perhaps through activity of a 
phospholipid transfer enzyme (Amann et al., 1993). A phospholipid 'flippase' 
may serve as a catalyst for maintaining lipid balance across the sperm cell 
surface bilayer, and would thus serve as a stabilizing molecule, inhibiting 
fusion of the sperm membrane with the acrosomal membrane until the 
acrosome reaction is required (Nolan et al, 1993b; Nolan et al, 1993b). In 
addition, there is a profound change in the topical regions occupied by 
specific phospholipids as a result of modification of glyco-proteins, exchange 
of specific phospholipids, and an increase in the relative amount of 
cholesterol in the plasma membrane, resulting in decreased fluidity and a 
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lower membrane stability [as a prerequisite for the acrosome reaction (Nolan 
et ai" 1992)], An interesting phenomenon is the incor-poration into the 
sperm plasma membrane of a number of proteins that are secreted by the 
epididymal epithelium (Vreeburg et al., 1992), The precise role of each of the 
modified or acquired phospholipids in the plasma mem-brane of 
spermatozoa remains to be elucidared, However, it is clear that the ability to 
bind to and fertilize an oocyte is dependent on changes in the sperm plasma 
membrane during epididymal transit (Jones, 1989), 
Epididymal epithelial cell functions 
Functionally, the epididymis can be split into three segments: the initial 
segment where absorption of fluids and ions occurs, a middle segment where 
sperm maturation takes place, and the caudal section which is suited for 
sperm storage. 
The ductuli efferentes and the initial segment are responsible for absorption 
of most of the fluid that is expelled from the rete testis, In the efferent 
ductules, the non-ciliated cells are able to perform fluid and adsorptive 
endocytosis (Hamilton and Cooper, 1978), while the ciliated cells may have a 
function mainly in moving the spermatozoa and luminal fluid through the 
ducts, but may also assist in modifying the luminal environment by 
endocytosis (Hermo and Morales, 1984; Robaire and Henna, 1988), In the 
initial segment, it is primarily the principal cells that are actively involved in 
fluid absorption, The extraction of water from the epididymal lumen is 
passive, following active sodium absorption which is dependent on selective 
sodium channels in the apical membrane, Sodium reabsorption can be 
inhibited by the Na+ channel blocker amilioride (Wong and Yeung, 1976; 
Wong et aI., 1978) and is dependent on Na+-K+-ATPase activity in the 
basolateral membrane of the celL Next to absorption, the epididymis is 
capable of electrolyte and water transport into the lumen, Secretion is 
mediated by a Na+-K+-2Cl- symport, and a Na+-H+ exchanger and a Cl- -
HC03- exchanger located in the basolateral membrane of the epithelial cells 
(Wong, 1988; Wong, 1990), Interestingly, spermatozoa may have an 
influence on the fluid volume in their own environment; the epithelial cells 
are known to secrete angiotensin I which is converted into angiotensin II by 
angiotensin-converting enzyme located on the sperm plasma membrane, 
Angiotensin II receptors are found on the epididymal epithelial cells, which, 
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when activated, stimulate fluid secretion (Wong et aI., 1990; Wong and 
Uchendu, 1990). 
As mentioned earlier, the epididymis is highly active in synthesis and 
secretion of proteins. A large number of epididymal proteins have been 
identified, the function of which is often unknown. Some proteins, however, 
have been extensively studied, and have been assigned putative roles in 
functional maturation of spermatozoa. 
Studies by Cameo and Blaquier (Cameo and Blaquier, 1976) have elucidated 
a number of epididymal proteins (B,C,D,E) from cytosolic fractions of rat 
epididymal epithelium. Proteins B/C were later found ro be two products of 
the same gene, but with a slightly different molecular weight due to three 
additional amino acid residues at the amino terminus of protein C. Others 
have also identified proteins B/C in the epididymis of rat and mouse, and 
have introduced their own nomenclature: proteins B/C are also known as rat 
epididymal secretory protein I [ESP I] (Jones et al., 1980; Girotti et aI., 
1992), rat cauda proteins CEF-2,3 (Shabanowitz and Killian, 1987), 18 kD 
a-lactalbumin-like component (Moore et al., 1990), and mouse epididymal 
protein protein 10 (Rankin et al., 1992b). Proteins B/C are secreted only in 
the caput, bur are synthesized in both the caput and the corpus regions 
(Brooks and Higgins, 1980; Moore et aI., 1990). The synthesis of proteins 
B/C is androgen dependent, and is regulated at the level of gene 
transcription. Indeed a putative androgen response element has been 
identified upstream from this gene (Girotti et al., 1992). The exact functions 
of proteins B/C are not completely clear. It has been shown that there exists a 
similarity with the a2y"globulin superfamily of retinoic acid binding proteins 
(Brooks, 1987). Rankin et al. (Rankin et al., 1992a) have shown that the 
mouse homologue of proteins B/C (MEP 10) does indeed bind retinoic acid 
with high affinity, indicating that proteins B/C may have a role in the 
transport of retinoids within the epididymis. 
Proteins DIE are also encoded by one gene, and have been identified by a 
number of investigators: 37 kD glycoprotein (Olson and Hamilton, 1978), 
specific epididymal protein [SEP] (Kohane etal., 1980), protein IV (Jones et 
aI., 1980), acidic epididymal glycoprotein [AEG] (Lea and French, 1981), 
sialoprotein (Faye et aI., 1980), 32 kD protein (Wong and Tsang, 1982), 
proteins CEF-12,13 (Shabanowitz and Killian, 1987), and mouse epididymal 
protein 7 (Rankin et aI., 1992b). Amino acid sequence analysis shows 
similarity with metalloproteins. Interestingly, studies have shown that 
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spermatozoa may acquire proteins DIE on their plasma membrane during 
epididymal passage (Brooks and Tiver, 1983). Incubation of rat spermatozoa 
with rabbit antibodies against proteins DIE caused a latge reduction in egg 
fertilization after artificial insemination (Cameo et al., 1986). Recently 
Rochwerger et al. (1992), have shown the presence of protein DIE 
recognition sites on the egg surface, and have indicated a putative role for 
facilitating sperm-oocyte interaction. Indeed, the development of fusability 
of developing rat oocytes with spermatozoa involves the appearance of 
protein DIE-binding components on the oocyte surface (Cohen et al., 1996). 
Other epididymal proteins include clusterin, composed of a 47 kD heavy 
chain and 34 kD light chain, forming a heterodimeric glycoprotein. It is 
homologous to the testicular sulphated glycoprotein 2 produced by Sertoli 
cells. Unlike proteins BIC and DIE, it is not androgen regulated in the initial 
segment, but an increase in clusterin mRNA was found after orchidectomy in 
the corpus and cauda (Garrett et al., 1990; Cyr and Robaire, 1992). 
Spermatozoa are found to associate with clusterin in the caput, but this is 
followed by dissociation in the cauda (Hermo et al., 1991; Mattmueller and 
Hinton, 1992). 
The epididymis secretes a number of enzymes that may modify and process 
preexisting sperm plasma membrane glycoproteins. Among them are 
sialyltransferase, galactosyltransferase, N-acetylglucosidase, and fucosyl-
transferase, which are present in the caudal fluid (Hamilton, 1980a; Tulsiani 
etal., 1993a). Glycosidases, such as ~-D-galactosidase, may have a role in the 
removal of galactosyl residues from sperm surface glycoproteins during 
epididymal transit. Furthermore, a-D mannosidase [also found on sperm 
membranes and being a putative zona receptor (Cornwall et al., 1991)] is 
found in luminal fluid (Tulsiani et al., J993b). This fluid also contains 
glutathione peroxidase, a 24 kD androgen regulated secretory protein, which 
is produced in the caput epididymis and associates with spermatozoa. 
Superoxide dismutase, a powerful antioxidant enzyme, has been detected on 
the stereocilia of the epididymal principal cells (Perry et al., 1993). Further-
more) a putative sperm-protector enzyme) gamma glutamyl transpeptidase 
(GGT) plays an essential role in controlling the luminal concentration of 
glutathione, a potent scavanger of free oxygen radicals which are toxic to 
spermatozoa (Hinton etal., 1991). Other putative sperm protectors are HE4 
and cystatin-related epididymal protein (CRES), which both are similar to 
protease inhibitors found elsewhere in the body, and may serve to protect the 
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spermatozoa and!or the epididymal epithelium ftom proteolytic activity, such 
as may result from premature release of acrosomal enzymes from some 
spermatozoa (Kirchhoff et aL, 1991; Cornwall et al., 1992). 
Aim and Scope of This Thesis 
The above paragraphs indicate that male gametogenesis and sperm 
maturation are fine tuned processes, requiring a large number of regulated 
molecular interactions. The large amount of effort that has been invested into 
understanding the intricate control mechanisms of male reproduction, has 
resulted in the identification of numerous structural and regulatory 
molecules. The precise role of many of these molecules in normal male 
reproductive physiology remains to be clarified. 
Of prime importance in male reproduction is the action of androgens. In 
Chapter 2, the role of androgen in spermatogenesis and in sperm maturation 
is explored. The precise mechanism by which testosterone regulates 
spermatogenesis is largely unknown. Of major interest is the observation, 
that the restis, being the site of androgen production, is exposed to, and also 
requires a much higher level of testosterone for adequate function than do the 
other androgen dependent organs, such as the prostate and the seminal 
vesicles. 
In Chapter 3, a study is presented, where the action of testosterone, and that 
of the synthetic androgen methyltrienolone (R!SS!) is evaluated for male rat 
testis and accessory sex organs. RISSI is not metabolised and does not bind 
to androgen binding protein (ABP). This study is based on the premise, that 
the observed difference in testosterone responsiveness of the testis, cOlnpared 
to other androgen dependent organs, may be caused by a difference in 
testosterone metabolism, and! or by binding of testosterone to ABP in the 
testis, possibly making much of the testicular androgen biologically 
ineffective. In addition, the effect of androgen metabolism and binding of 
androgen to ABP on the regulation of androgen receptor immunoexpression 
in the adult rat testis is studied. 
In Chapter 4, the immunoexpression of androgen receptor and expression of 
its mRNA is studied in the rat epididymis. The epididymis is highly androgen 
dependent in quite a unique fashion, in that it is regulated not only 
testosterone by from the bloodstream, but also by luminal testosterone, 
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directly emanating from the testis through the efferent ductules. There is a 
highly compartmentalized regional variation in epididymal epithelial cell 
function. While regional differences in androgen receptor immunoexpression 
have been described for the epididymis of a number of species, little data is 
available for the rat, a model widely used for male fertility studies. Double 
staining studies were performed to ascertain whether the cell to cell variation 
in proteins B/C, a highly androgen dependent protein, correlate with a 
variation in androgen receptor immunoexpression. 
While the above reports are mainly concerned with regulation of processes in 
laboratory animals, the following Chapters describe observations from 
studies on infertile human males. Although the diagnostic arsenal within the 
andrology clinic has grown over the past number of years, many causes of 
male infertility remain to be elucidated. Knowledge of the cause of a man's 
infertility is important, not only for providing the patient with a sound 
diagnosis, but also for adequate counselling purposes if assisted reproductive 
techniques are considered. Ideally, clarification of the molecular mechanisms 
of male gametogenic impairment may open the way for a true cure. 
Additionally, with the health of the offspring in mind, it is important to 
ascertain what effects suboptimal spermatogenesis and sperm maturation 
may have on the integrity of the male gamete. In this thesis, two studies are 
presented that attempt to tackle this problem from different perspectives. 
Chapter 5 briefly introduces the reader in the genetic and a number of 
acquired conditions that are related to male infertility. Subsequently, the role 
of androgen receptor defects in male infertility is scrutinised. In Chapter 6, 
androgen receptor immunoexpression in testis biopsy samples of a number of 
infertile males is semiquantitatively assessed. A number of earlier studies have 
resulted in conflicting data regarding the prevalence of androgen receptor 
abnormalities in genital fibroblasts of infertile men. As the testis is the target 
organ for testosterone, where spermatogenesis is concerned, it is reasonable to 
speculate that putative aberrations of androgen receptor expression in the 
context of male infertility would be most apparent in that organ. 
Subsequently, a study is undertaken to assess the integrity of sperm nuclear 
condensation in sub fertile males (Chapter 7). Using an antibody targeting 
tyrosine hydroxylase, which cross reacts with testis-specific histone 2B 
(TH2B), we first evaluated the immunoexpression of this major testis-
specific histone variant in the various germinal cells within the human testis. 
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In order ro explore the relationship of sperm histone content to semen 
parameters, we then quantified sperm TH2B content in semen samples from 
men attending our andrology outpatient clinic, and correlared these results 
with the routine semen analysis data. 
In Chapter 8, the main resulrs and implicarions of the studies reported in this 
thesis are discussed. 
38 
Basic Studies on Spermatogenesis 
and Sperm Maturation 

Androgen control of spermatogenesis and 
sperm maturation 
Chapter 2 
Testicular androgens are necessary for the development and maintenance of 
male sexual characteristics, including the spermatogenic function of the testis 
and sperm maturation in the epididymis. In 1930 it was established that 
removal of the pituitary gland resulted in degeneration of spermatogenesis in 
the rat. This degeneration was prevented, however, by substitution with a 
high dose of testosterone (Smith, 1930). Since then, a considerable amount 
of research has focused on the hormonal regulation of spermatogenesis and 
sperm maturation, with particular interest in the action of androgens. 
Surprisingly, the results of this research still leave room for many questions 
and much discussion. Investigators have yet to elucidate through which 
mechanisms androgens are involved in initiation and maintenance of 
spermatogenesis. There is general agreement that the testis requires a much 
higher level of testosterone for adequate function than the other androgen 
dependent tissues; however, why this is the case, and exactly what 
concentration of testosterone is required for spermatogenesis to proceed, is 
still a matter of debate. What, then, do we know about androgens and male 
gametogenesis? 
The Androgen receptor 
Androgens exert their effect on target tissues through interaction with the 
androgen receptor (AR), a member of the superfamily of ligand-dependent 
transcription factors. Other members of this family include receptors for all 
steroid hormones, thyroid hormone, retinoids, vitamin D3, and a number of 
receptors lacking a known ligand (orphan receptors) (Tsai and O'Malley, 
1994). These receptors are similar in sttucture, and may all have been derived 
from a single archaic precursor (O'Malley, 1989; Dorit et aI., 1990; Amero et 
aI., 1992; Keese and Gibbs, 1992; Laudet et al., 1992). The sttucture is 
classically divided into four domains: 1) the N-terminal modulating domain, 
2) the DNA binding domain, 3) the hinge region, and 4) the ligand binding 
domain at the C-terminus. 
The single copy gene encoding the AR is located on the X chromosome in all 
mammalian species, in man at the Xqll-12 locus. The human AR cDNA 
sequence reveals an open reading frame of 2730 nucleotides encoding a 
protein of 910 amino acids with a calculated molecular mass of 98.5 kDa 
(Brinkmann et aI., 1989; Brown et aI., 1989; Kuiper et aI., 1989). The 
information for the protein coding region is separated over eight exons. The 
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Figure 1. The human androgne receptor is encoded by 8 exons, and has several distinct functional 
domains: the N-termina! domain, the DNA-binding domain, and the ligand binding domain. 
N-terminal modulating domain is encoded by one large exon, while the 
DNA binding domain is encoded by exons 2 and 3. The hinge region and the 
ligand binding domain are encoded by the remaining 5 exons. The N-
terminal domain of the human AR is characterized by the presence of a 
number of stretches of amino acid residue repeats (i.e. three polyglutamine 
stretches, a long polyglycine stretch, a polyproline stretch, and a polyalanine 
stretch). The functional significance of these homopolymeric stretches is 
unknown (Faber et al., 1989). The hormone binding domain comprises 
about 250 amino acid residues. Deletions in this domain result in loss of 
hormone binding. Interestingly, the complete deletion of the hormone 
binding domain results in a constitutively active receptor, indicating that the 
hormone binding domain is an inhibitor of trans regulation activity in the 
absence of hormone (Jenster et al., 1991). 
The subcellular location of the andtogen receptor is dependent on andtogen 
exposure and other factors. In cell lines where the AR is transiently 
overexpressed, cellular localization in the absence of hormone was 
predominantly cytoplasmic in COS-l cell lines, evenly distributed over 
cytoplasm and nucleus in CHO and CV-l cells lines, and predominantly 
nuclear in HeLa cells. Addition of androgen resulted in a nuclear localization 
of the AR in all cell lines (Simental et aI., 1991; Jenster et aI., 1993). In vivo 
immunohistochemical data have shown a nuclear localization of the AR even 
in androgen depleted tissues (Chang et aI., 1989; Husmann et aI., 1990; Sal' 
et aI., 1990; van del' Kwast et al., 1991), although increased cytoplasmic 
staining of AR has been observed in androgen deprived prostate tissue (Paris 
et al., 1994). 
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Upon binding of ligand (testosterone or dihydrotestostetone) to AR in 
cytoplasm or nucleus, the AR dissociates from heat-shock proteins (hsp90 
and hsp70), forms a dimer with a second activated AR molecule, and binds to 
specific enhancer sequences known as androgen response elements present in 
rhe 5' flanking regions of androgen-regulated genes (Riegman et al, 1991). 
The binding of AR dimers to the androgen response elements are thought to 
stabilize transcription factors at the promoters of target genes, rhereby 
inducing a high degree of transcriprion initiation (O'Malley and Tsai, 1992; 
Jenster, 1998). 
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Figure 2. Mechanism of androgen action in a target cdl. Testosterone (T) diffuses into the cell 
cytoplasm where it can be converted to dihydrotestosterone (DHT) by the enzyme Sa-reductase. 
Both T and DHT can bind to, and activate, the androgen receptor. Upon binding with ligand, the 
androgen receptor dissociates from heat shock proteins (hsp), and binds to DNA as a homodimer. 
TF == transcription factors; RNA pol II == RNA polymerase II. 
Expression of the androgen receptor in the testis 
The pattern of expression of the androgen receptor has been a focus of 
research for a considerable amount of time, and has been studied using 
various methods. Early biochemical studies have demonstrated AR in 
reproductive, pituitary, and brain tissues of the male rat (Liao and Fang, 
1969; Hansson et al., 1975; Kato, 1976; van Doorn et al, 1976; van Doorn 
and Bruchovsky, 1978; McGinnis et al, 1983; Handa et al, 1986; Handa et 
al., 1987; Roselli et al, 1989). Autoradiographic srudies have indicated a 
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nuclear localization of AR in a number of tissues (Sar et al., 1970; Sar and 
Stumpf, 1972). In the mid 1970's androgen receptor was demonstrared in rat 
seminiferous tubules (Mulder et al., 1974; Mulder et al., 1975). Later, 
binding studies using isola red cells indica red absence of AR in spermatocytes 
and spermatids (Grootegoed et al., 1977). The cloning of the genes encoding 
human, rat, and mouse AR subsequently provided the amino acid sequence 
of the AR, opening the way to the fabrication of antibodies to synthetic 
peptides with sequences corresponding to selected regions of the AR (Chang 
etal., 1988; Lubahnetal., 1988;Trapmanetal., 1988; Tilley etal., 1989; van 
Laar etal., 1989). A number of immunohistochemical studies have indicated 
a high level of AR expression in the testis, accessory sex organs, excretory 
ducts, and several other organs (Sar et al., 1990; Takeda et al., 1990; 
Ruizeveld de Winter et al., 1991; Kimura et al., 1992; Iwamura et al., 1994; 
Janssen et al., 1994) . The reported immunoexpression patterns of AR within 
the testis are in agreement with regard to expression of AR in the nuclei of 
Leydig cells, Sertoli cells, and peritubular myoid cells. In addition, a number 
of studies reported expression of AR in the (endothelial) cells associated with 
arterioles (Bergh and Damber, 1992; Sar et al., 1993; Bremner et al., 1994). A 
controversy has arisen, however, concerning the expression of AR in germinal 
cells. While most investigators have found no indication of androgen receptor 
in the nuclei or cytoplasm of developing germ cells, Kimura et al. (1993) and 
Vornberger et al. (1994) have reported germ cell AR immunoexpression in 
human and rat testis, respectively. When reflecting upon the presence of AR 
in male germ cells going through spermatogenesis, one should perhaps also 
consider the genetic evidence against functional importance of AR in the 
germ cells. The common male vole lacks X chromosomes in all 
spermatogonia and developing germ cells (Griswold, 1995), and it follows 
that spermatogenesis can proceed without germinal cell androgen receptors. 
In addition, breeding experiments using chimerae of Tfm (testicular 
feminization) and normal mice, resulted in Tfm offspring. This implicates 
that Tfm germ cells, lacking a functional AR, have completed spermato-
genesis, probably because they were supported by wild-type, AR posirive, 
somatic cells (Lyon et al., 1975). Lack of androgen receptors in germ cells, 
however, does not exclude the possibility of a direcr androgen action on germ 
cells not mediated via the AR. 
Close scrutiny of AR immunoexpression in Sertoli cells of the rat has 
disclosed a clear variation in staining intensity at different stages of the 
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Figure 3. Immunolocalization of androgen receptor (AR) in the testis of an adult rat. S=Sertoli cell, 
P=peritubular myoid cell, L=Leydig cell. Notice the absence of any AR immunosignal in germinal 
cells. 
spermato-genic cycle (Bremner et ai., 1994; Vornberger et ai., 1994). 
Expression was found to be relatively low at stages I-V: Subsequently, there is 
a rapid rise in the immunosignal, until staining is maximal at stage VII. 
Thereafter, the AR immunosignal decreases until it is barely detectable at 
stage IX. The peritubular myoid cells and the Leydig cells also show some 
variability in AR expression, but this is not related to the stage of the 
spermatogenic cycle in the neighboring tubule{s). It has recently been shown 
that the stage-dependent variation in AR immunoexpression in rat Sertoli 
cells is regulated at the transcriptional level, as AR mRNA in situ hybridiza-
tion studies show an expression pattern which overlaps with that of the 
protein (Shan et ai., 1995). 
Androgen receptor expression in the epididymis 
Androgens have profound effects on epididymal function. Immuno-
hisrochemical analysis of the AR in the epididymis of a number of adult 
mammalian species, revealed strong expression, most prominently in the 
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nuclei of the epithelial cells (Tekpetey et ai, 1989; Sar et ai, 1990; Takeda et 
ai, 1990; Roselli et aI., 1991; Ruizeveld de Winter et aI., 1991; Iwamura et 
a!., 1994; Janssen et al., 1994; Paris et aI., 1994). Both biochemical and 
immunohistochemical approaches have indicated region-specific variation in 
AR expression. In the human epididymis, Takeda et al. (1990) observed high 
expression in the proximal portion (caput), decreasing gradually in the corpus 
region. In the distal portion (cauda) AR immunoexpression was found to be 
higher tban in rhe corpus (Takeda et a!., 1990). A recenr report by 
Ungefroren et a!. (1997), however, describes low AR mRNA expression in the 
proximal capur, and high expression in the distal caput and proximal corpus 
of rhe human epdidymis. In rhe above study, these findings were in 
agreement with rhe pattern of immunohistochemical AR expression 
(Ungefroren and Ergun, 1997). The caput and corpus regions of the rhesus 
monkey epididymis have a more inrense AR immunosignal, compared to the 
ductuli efferentes and the cauda (Roselli et a!., 1991). In the ram, AR 
immunostaining is low in the efferent ducts but very high in the initial 
segment. Predominant AR immunoexpression was observed in the 
epithelium of the central caput, central corpus, and cauda of rhe ram 
epididymis (Tekpetey et aI., 1989). Regional variations in immunoexpression 
of AR in the epididymis were also detected in rhe rat: expression was highest 
in the caput epithelial cells, with lower levels in the corpus and cauda (Sar et 
aI., 1990). AR immunoexpression in the epididymis is regulated by rhe 
availability of androgens. Upon androgen withdrawal, the AR immunosignal 
decreases in all epididymal segments in the rar, and is rapidly resrored when 
tesrosterone is supplemented (Sar et a!., 1990; Paris et aI., 1994). The 
available evidence suggests that epididymal AR expression is dependent on a 
normal circulating androgen level, but not on testosrerone entering the 
luminal fluid from the testis, although rhis issue has not been under close 
scrutiny. At rhe level of gene rranscription, data is relatively scant. Blok et al. 
(1992a) reported a substanrial increase in AR mRNA as measured on 
Northern blot for whole epididymis,S days after rreatment with rhe Leydig 
cell roxin EDS. A pulse treatmenr with 10 mg testosterone propionate 2 
houts prior to killing, did not decrease AR mRNA level. Treatment with 
testosrerone implants (15 em) for 5 days, however, returned the mRNA level 
to control value (Blok et a!., 1992a). 
47 
Chapter 2 
Androgens: distribution and metabolism in the testis and epididymis 
Testicular androgens 
Testosterone, by far the most prominent testicular androgen, is synthesized 
by the Leydig cells upon stimulation by LH from the pituitary gland. Leydig 
cells do not store testosterone, but the testostetone diffuses rapidly into the 
interstitial compartment (De Jong et aI., 1974; Sharpe, 1994). Subsequently 
the testosterone may either diffuse into the capillary network from where it 
enters into the peripheral blood stream, or it is transported into the 
seminiferous tubules. A large effort has been made in the past decades to 
elucidate the actual level of testosterone in the testis in relation to the level of 
testosterone that is required for initiation and maintenance of sperma-
togenesis. A number of different strategies for measurement of intratesticular 
testosterone levels have yielded discordant results. Interstitial fluid has been 
collected using a number of techniques (Sharpe, 1979; Turner et al., 1984), 
giving an impression of the concentration of testosterone in the extratubular 
compartment. The obtained values vary widely between individual rats and 
studies, but fall in the range 60-400 ng/ml (Sharpe, 1994). Micropuncture 
techniques from rat testis in situ have obtained similar results (Comhaire and 
Vermeulen, 1976). Seminiferous tubular testosterone content has been 
estimated at 80-90 ng/m!. This value is similar to that found in homogenized 
rat testis (50-62 ng/m!) (Sharpe, 1994). The circulating T concentration in 
the rat is in the order of 1-3 ng/m!, about 20-fold lower than the seminiferous 
tubular testosterone content. A number of studies have measured the 
testosterone level in testicular venous blood, taken from the vessels that are 
found on the surface of the testis, containing blood that has just passed 
through the testicular interstitium. The testosterone concentration in the 
testicular venous blood appears to be in the range 25-100 ng/ml (Sharpe, 
1994). Although there is considerable overlap in the testosterone 
concentrations found in the interstitial fluid and the testicular venous blood, 
when measured in the same animal, the testosterone concentration in the 
interstitial fluid is always two- to three fold higher than that in testicular 
venous blood (Sharpe, 1994). The blood obtained from the spermatic vein 
(i.e. spermatic cord) consistently has a testosterone concentration abour 25-
50% of that found in the testicular veins (Maddocks et al., 1993; Sharpe, 
1994). Apparently, as the venous blood travels up the spermatic cord, it is 
dilured by blood from the testicular artery through the arteriovenous 
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anastomoses (Wensing and Dijkstra, 1981; Wensing et aL, 1981; Hees et aL, 
1984; Noordhuizen-Stassen et ai., 1985). The amount of shunting between 
the testicular artery and venous plexus is extremely variable, making the 
spermatic venous blood an unreliable source when one is interested in the 
testicular testosterone concentration. Peripheral venous blood does give a 
good indication of Leydig cell function, but provides no insight in the 
intratesticular testosterone concentration (Maddocks and Sharpe, 1989; 
Maddocks etaL, 1993). 
The testosterone concentration observed in the various testicular compart-
ments thus appears to disclose very different values, which indicates that 
testosterone may not diffuse freely and rapidly from one testicular com-
partment to another (Sharpe, 1994). However, at this point it is important to 
note that methodological error may play a large part in the high level of 
testosterone measured in the interstitial fluid. Normally, the newly produced 
testosterone diffuses into the interstitial fluid and then into the blood stream. 
When a testis is removed, the blood vessels are necessarily severed and the 
circulation is arrested, causing an accumulation of testosterone, still produced 
by the Leydig cells, in the interstitium. When measuring testicular 
testosterone concentration in animals with vital Leydig cells, it is important 
to prevent this accumulation by flash-freezing the testis in liquid nitrogen. 
The alternative would be to collect interstitial fluid from a testis in situ. 
Sharpe (1994) estimated the testicular testosterone concentration at 25-100 
ng/m!, in a review partially dedicated to this issue. Our own data, using f1ash-
frozen homogenized testis reveal an intratesticular concentration of 46 
ng/mg, as compared to 1.2 ng/ml in peripheral venous hlood (Chapter 3). 
Androgens in the epididymis 
The epididymis is a unique organ, in that it has a gradient of testosterone 
along its length, with a very high testosterone level in the initial segment, and 
much lower levels further distal (Vreeburg, 1975; Turner et aL, 1984). 
Testosterone enters the epididymis with the testicular fluid, and is also 
supplied via the bloodstream. Studies have shown, however, that DHT [and 
possibly also 5cx-androstan-3cx, 17~-diol (3cx-diol)], rather than testosterone, 
is vital for adequate function of the epididymis (Lubicz-Nawrocki, 1973; 
Orgebin-Crist et ai., 1976). This is indicated by an in vivo experiment where 
the effect of testosterone and DHT in the presence or absence of an inhibitor 
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of Sa-reductase in acutely castrated male mice was studied. This study 
showed that inhibition of Sa-reductase caused a decrease in number of 
motile spermatozoa, a lower percentage of oocytes fertilized, and a smaller 
number of blastocysts (Cohen et al., 1981). High-dose testosterone 
supplementation did not diminish this effect. Rapid washings of epididymal 
minces and micropucture techniques have indeed indicated a very high level 
of D HT in the caput epididymis and a somewhat lower level further distal 
(Vreeburg, 1975; Turner et aI, 1984). It can be concluded that, contrary to 
the situation in the testis, DHT is the most prominent androgen in the adult 
epididymis. 
Androgen bindingprotein and 5a-reductase in the testis 
Androgen binding protein 
Androgen binding protein (ABP) may be of some importance when 
discussing the distribution and action of testicular testosterone. ABP, the rat 
counterpart of the well known human steroid hormone binding globulin 
(SHBG), was one of the first Sertoli cell products to be identified and studied 
(Hansson et aI, 1975). ABP is secreted by Sertoli cells upon stimulation by 
FSH and testosterone, in a bi-directional manner: 20% is released into the 
bloodstream, probably from the base of the Sertoli cells and 80% is secreted 
into the seminiferous tubular fluid (Gunsalus et al., 1980). In many species 
ABP/SHBG is also synthesized in the liver. The fetal rat liver does exhibit 
ABP synthesis, but the testis is the only observed site of ABP production in 
the adult (Demyan et aI, 1989). Both liver- and testis-derived ABP are 
encoded by the same gene (Joseph et aI, 1988). Loss of germ cells results in a 
reduction of ABP that is released into the seminiferous tubules, while 
secretion of ABP at the basal side of Sertoli cells is unaltered (Gunsalus et aI, 
1985; Morris et aI, 1987). As ABP binds testosterone with moderate affinity, 
and is present at a relatively high concentration in the testis, it was thought 
that ABP may have a function in storage or buffering of testosterone in the 
testis. A number of studies attest to this, as treatment of rats with testosterone 
implants, causing a virtually complete inhibition of testicular testosterone 
production through inhibition of LH, resulted in the consistent finding that 
the testicular testosterone level was higher than the serum level (Zirkin et al., 
1989). Increasing the implant length caused a sharper increase in the 
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testicular testosterone level than the serum level (Zirkin et at., 1989). This 
finding was not dependent on the presence of gonadotropins, as similar 
results were obtained with hypophysectomized rats (Turner et aL, 1985). 
Another study, using push-pull canulae to obtain interstitial fluid, however, 
did not support these findings (Maddocks and Setchell, 1989). It was pointed 
out that the push-pull canulae method of fluid collection may dilute the 
samples, resulting in an underestimation of the testosterone concentration 
(Maddocks and Setchell, 1989; Zirkin, 1993). Whether ABP is responsible 
for the above observations is uncertain. Indeed it has been pointed out by 
Turner et aL, (1984) that, in the intact rat testis, the androgen binding 
protein concentration is far too low to account for significant retention of 
androgens. No data are available concerning the possibility that, under 
conditions of a low intratesticular androgen concentration, ABP may indeed 
be responsible for the retention of a functional amount of testosterone in the 
testis. However, a number of observations have been interpreted to indicate 
that ABP may be of some importance in spermatogenesis. First, the secretion 
of ABP into the seminiferous rubules is highly regulated. Secretion is 
maximal at stages VIII-XI in the rat, coinciding with spermiation and a short 
period thereafter (Ritzen et aL, 1982). Second, it has been observed that ABP 
associates with germ cells of rodent and monkey testis (Bardin and Petra, 
1980; Steinberger et aL, 1984; David et at., 1985). More recently it was 
reported that ABP seems to be bound specifically by rat germ cells and 
endocytosed via a receptor-mediated endocytosis pathway (Gerard et aL, 
1994). In rhe rat prostate, which also has ABP receptors at the cell surface, it 
was shown that ABP binding somehow is coupled to adenylyl cyclase, and 
that interaction of ABP with its receptor and activation of adenylyl cyclase are 
modulated by the binding of steroid to the ABP (Hryb et al., 1989; Hryb et 
at., 1990; Nakhla etaL, 1990; Rosner, 1990; Damassa etal., 1991; Rosner et 
aL, 1992). However, as will be discussed in Chapter 3 of this thesis, 
association of testosterone to ABP in the testis may be of little functional 
importance for spermatogenesis. 
Sa-reductase 
In androgen dependent tissues of the adult rat, other than the testis, 
testosterone is first converted into the more potent dihydrotestosterone 
(DHT) by the enzyme Sa-reductase. DHT has a two-fold greater affinity far 
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the androgen receptor and a dissociation rare one-fifrh that of testosterone, 
resulting in the formation of a more stable receptor-ligand complex (Grino et 
al., 1990). In the restis, however, rhe exrremely high level of testosterone may 
lead to the conclusion that testosrerone is the major androgen in the testis, 
abolishing the need for conversion to DHT There is, on the other hand, 
ample evidence that conversion of testosterone into DHT does occur in the 
testis (Matsumoto and Yamada, 1973; Rivarola et aI., 1973; Nayfeh et aI., 
1975; Rivarola et aI., 1975), in particular in the prepubertal individual (Van 
der Molen et al., 1975). In the adult human, the DHT level in spermatic 
venous blood is much higher than the DHT level in peripheral blood 
(Pazzagli et aI., 1974). In addition, immunohistochemical studies have 
localized a varying amount of Sa-reductase type 2 in the human testis 
(Eicheler et al., 1994). Studies in the adult rat have disclosed testicular 50.-
reductase activity, albeit at a low level, coinciding with a low level of 
immunostaining of Sa-reductase type 1 in the testis (Robaire and Viger, 
1993; Viger and Robaire, 1995). These reports are in agreement with earlier 
studies, which concluded that the intratesticular level ofDHT is low, but that 
DHT is not absent (Van der Molen et aI., 1975; Turner et aI., 1984). At a 
functional level, it was found that treatment of beagle dogs with finasteride (a 
potent Sa-reductase inhibitor) does not affect spermatogenesis (Juniewicz et 
aI., 1993). Treatment of rats with testosterone implants, however, disclosed a 
clear role for 5a-reductase when the intratesticular concentration is low 
(O'Donnell et al., 1996), but a functional role for Sa-reductase was no longer 
apparent when testosterone implants were larger than 6 cm. Individuals with 
a Sa-reductase type 2 deficiency are often infertile, but there is little evidence 
that this is a result of a testicular deficiency of the enzyme in adulthood. 
Clearly a Sa-reductase type 2 deficiency during development adversely affects 
testis descent, resulting in impaired spermatogenesis. In addition, this 
condition causes developmental and functional abnormalities of the highly 
DHT-dependent accessory sex organs, resulting in a rudimentary prostate 
and underdeveloped seminal vesicles with consequently highly viscous semen 
with a very small volume. Nevertheless, paternity has been reported in men 
with a Sa-reductase type 2 deficiency (Katz et al., 1997). Based upon the 
available evidence, it is not likely that conversion of testosterone to D HT is of 
major importance for the process of spermatogenesis, at least in the rat. 
Additional data on the role of Sa-reductase in the rat testis, and its possible 
requirement for spermatogenesis is further discussed in Chapters 3 and 8. 
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5a-reductase and ABP in the epididymis 
The expression of 5a-reductase in the epididymis has now been extensively 
documented. It is well known that 5a-reductase is present in a gradient along 
the length of the epididymis (Vreeburg, 1975; Turner et aI., 1984). There 
appears to be a nuclear fraction and microsomal fraction of enzyme activity 
(Robaire et al., 1981; Scheer and Robaire, 1983). The activity of the enzyme 
associated with the nuclear fraction is highest in the proximal regions of the 
epididymis, namely in the initial segment and the caput, and declines further 
distally. The microsomal fraction of 5 a-reductase activity is lower and found 
throughout the epididymis (Robaire et ai., 1981). The regulation of enzyme 
activity in the two fractions is differentially regulated, as orchiectomy and 
testosterone supplementation will restore the microsomal 5a-reductase 
activity, but not the nuclear activity. Any treatment that results in the 
cessation of flow of testicular fluid through the initial segment of the 
epididymis results in an inability to restore the normal nuclear 5a-reductase 
level, no matter how much androgen is supplemented. The appearance of the 
nuclear fraction of 5a-reductase activity does not follow the appearance and 
pattern of testosterone production by the testis during development (which is 
the case for the microsomal fraction), nor of the appearance of spermatozoa. 
Furthermore, the developmental pattern of nuclear 5a-reductase is identical 
to that of ABP. Taken together, the above-described observations have led to 
the suggestion that ABP may be of critical importance in regulation of the 
nuclear 5a-reductase activity (Robaire and Viger, 1995). In contrast, all data 
indicate that the microsomal fraction of 5a-reductase activity is solely 
regulated by the serum testosterone level. 
Mter the cloning of two cDNAs, representing two different genes, encoding 
for the two 5a-reductase isoenzymes, named type 1 and 2 based on their 
chronological order of identification (Andersson et aI., 1989; Jenkins et aI., 
1991; Labrie et al., 1992; Normington and Russell, 1992), the expression and 
regulation of expression of the mRNAs of the two isoenzymes could be 
investigated. Northern blot analysis showed that the 5a-reductase type 1 
mRNA is expressed at a high level in the initial segment of the epididymis (3-
to 7-fold higher compared to the further distal regions), and reveals a pattern 
that is identical to the pattern of expression of the nuclear 5a-reductase 
activity (Robaire et aI., 1981; Viger and Robaire, 1991; Robaire and Viger, 
1995). Orchiectomy resulted in a decrease in type 1 mRNA in all segments, 
but most dramatically in the initial segment. High-dose testosterone 
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supplementation resulted in restoration of type 1 mRNA expression 
throughout the epididymis, with exception of the initial segment. Unilateral 
orchiectomy or efferent duct ligation resulted in decrease of type 1 mRNA in 
the initial segment only. During development, changes in the type 1 mRNA 
level were observed only in the initial segment: a decrease to 50% between 
days 7 and 21 post partum, and then a 5-fold rise until day 56, after which 
the level remains constant. The observed variation in 5a-reductase type 1 
mRNA is well correlared with enzyme activity. Northern blot analysis of 5a-
reductase type 2 indicated a high level of expression in the caput epididymis, 
but not in the initial segment. During development, no increase was seen in 
type 2 mRNA expression. In fact, all epididymal regions show no change in 
type 2 mRNA from birth to adulthood (Viger and Robaire, 1994; Robaire 
and Viger, 1995). In the adult rat, unilateral castration or efferent duct 
ligation results in a marked increase in type 2 mRNA in the initial segment of 
the epididymis. Clearly the mRNAs of the 5a-reductase typel and type 2 
isoenzymes are differentially regulated, and the data suggest that it is 
primarily the type 1 mRNA expression pattern that correlates best with 
enzyme activity, while the mRNA encoding the type 2 isoenzyme appears to 
be poorly translated in the epididymis (Robaire and Viger, 1995; Viger and 
Robaire, 1996). 
Testicular effects of androgen deprivation 
The germ cell complement 
The early observation that depletion of androgens, although causing severe 
qualitative in1pairment of spermatogenesis, does not influence the duration 
of the spermatogenic cycle or the duration or number of spermatogenic stages 
(Clermont and Harvey, 1965), is at the basis of many later studies. A number 
of studies in the rat have shown that, upon withdrawal of androgens, the 
earliest morphological changes in the seminiferous epithelium are seen at 
srages VII and VIII (Russell and Clermont, 1977; Sharpe et al., 1990; Sun et 
aI, 1990; Sharpe et aI, 1992; Kerr et aI., 1993; Sinha Hikim and Swerdloff, 
1993). These changes consist of the appearance of degenerating germ cells. 
Interestingly, when time passes after androgen withdrawal, rhe number of 
degenerating germ cells at several stages following stages VI-VIII increase, 
while virtually no degenerating germ cells are seen in the stages preceding 
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stage VII. An explanation for this observation is that, as a consequence of the 
low androgen level, certain developmental events have not occurred during 
stages VII and VIII, initiating impaired germ cell development and their 
degeneration at later srages of spermatogenesis (Sharpe, 1994). The 
morphological dara thus support a stage-specific temporal window of 
androgen action during spermatogenesis, namely at stages VII and VIII in the 
rat. 
Which germ cell types are affecred most by androgen depletion, and which 
developmental processes are compromised? A srudy using intact rats treated 
with low-dose testosterone for a 13 week period, reported a decrease in the 
number of spermatogonia to 57%, in the conversion of spermatogonia to 
spermatocytes to 85%, and in the conversion of round to elongating 
spermatids to 19% (Sun et aI., 1990). Only the latter effect was largely 
prevented by high-dose, rather than low-dose, testosterone treatment (Sun et 
aI., 1990). Sustenance of spermatogenesis, particularly the conversion of 
spermatocytes to round spermatids, was less effective in hypophysectomized 
rats using the same testosterone treatments, indicating that possibly (an)other 
pituitary factor(s) may be of importance. 
Another study, using a GnRH antagonist, showed a marked and rapid (after 1 
week of treatment) reduction of preleptotene and pachytene spermatocytes 
and step 7 and step 19 spermatids at stage VII (Sinha Hikim and Swerdloff, 
1993). After 4 weeks of treatment, the conversion of Al spermatogonia to 
preleptotene spermatocytes was suppressed to 79%. This finding was 
attributed to loss of preleptotene spermatocytes, since no degenerating 
spermatogonia were encountered, and full restoration of the number of 
preleptotene spermatocytes was attained after 1 week resupplementation with 
testosterone (Sinha Hikim and Swerdloff, 1993). When GnRH antagonist 
treatment was continued during transition from preleptotene to pachytene, 
55% cell loss was encountered. The development from pachytene 
spermatocytes to step 7 (round) spermatids showed a 15% cell death. The 
step 7 spermatids failed completely to progress rhrough spermiation. Clearly, 
in rhis study, androgen deprivation results in pronounced loss of germ cells 
during the meiotic and spermiogenic stages of germ cell development. 
Quantitative results obtained using hypophysectomy were identical to those 
obtained using a GnRH antagonist (Sinha Hikim and Swerdloff, 1993). 
An important effect of testosterone on spermiogenesis was also observed in a 
study where rats were treated with low-dose testosterone and estradiol (TEst) 
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for 11 weeks to suppress spermatogenesis, after which the rats received high-
dose testosterone supplementation which resulted in a testicular testosterone 
concentration 7-12% of control (O'Donnell et a!., 1994). Round spermatid 
production at stages I-VII was suppressed to 29-35% of control in TEst 
treated rats, but remained unchanged after the high-dose testosterone 
treatment. At stage VIII, however, round spermatid production was reduced 
to 5% of control in TEst treated rats, and increased to 27% after 4 days of 
high-dose testosterone supplementation. Moreover, the conversion of round 
spermatids to elongating spermatids at stages VII and VIII was reduced to 
16% of control in TEst treated rats, but fully returned to normal after 4 days 
of high-dose testosterone supplementation. Thus, in this study, 
spermiogenesis was fully restored when the testicular testosterone concentra-
tion was only 7-12% of control. 
The above reports indicate that testosterone withdrawal acts primarily at 
stages VII and VIII of the rat spermatogenic cycle. The hourly production of 
round spermatids is impaired by androgen depletion -possibly as a result of 
germ cell depletion (degeneration or detachment from the Sertoli cells). 
Spermiogenesis (i.e. conversion of the available round spermatids) is also 
impaired, but is restored fully in situations where the testicular testosterone 
level is about 10% of normal (classically viewed as restoration of qualitatively 
normal spermatogenesis; see Sharpe, 1994). Interestingly, quantitative 
restoration of spermatogenesis, requiring the restoration of normal numbers 
of spermatogonia, spermatocytes and spermatids, appears to depend on a 
much higher level of testosterone. Additional experiments to reinitiate 
normal spermatogenesis after TEst treatment using hCG to restore Leydig 
cell function, did not succeed in restoring normal spermatogonial numbers 
despite obtaining a testicular testosterone level comparable to control 
(Meachem et a!., 1997). 
A clear dose-dependent effect of high-dose testosterone supplementation on 
the quantity of spermatozoa produced in the androgen-deprived rat, has been 
reported on numerous occasions (Sun et al., 1989; for review see Sharpe, 
1994) and has resulted in speculation on why testis tissue seems to dependent 
on such a high level of testosterone for adequate function. This issue is 
further elaborated on in Chapters 3 and 8. 
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Protein synthesis and secretion 
A number of interesting observations have been made concerning the 
regulation of protein secretion by Sertoli cells. In the normal rat, there is a 
two-fold increase in the overall level of protein secretion by the seminiferous 
epithelium at stages V-VIII, compared to the other stages (Sharpe et aL, 
1992). The secretion of a number of the major proteins is 'constitutive', that 
is, remains the same in the presence or absence of a high androgen level 
(McKinnell and Sharpe, 1995). The secretion of one Sertoli cell protein and 
six proteins found to be secreted by germ cells, however, was highly regulated 
by androgens at stages VI-VIII of the spermatogenic cycle. These results 
indicate that not the synthesis, but rather the secretion of a number of 
proteins in the testis is androgen-regulated (McKinnell and Sharpe, 1995). 
The mechanism of action of androgens on protein secretion, however, 
remains elusive. 
Gene expression 
Although testis function is clearly highly androgen dependent, the 
identification of androgen regulared genes in the testis has proven difficult. 
Only recently, a transcription factor has been identified, thar may be directly 
regulated by androgen. Using a subtraction hybridization technique, the Fem 
eDNA clone was isolated in a screen for developmentally regulated mouse 
genes (MacLeod et aL, 1990; Wayne and Wilkinson, 1998). Fem encodes a 
protein containing a homeodomain. In the adult mouse and rat, the gene is 
expressed selectively in reproductive tissues. The Pem gene has two 
promoters, a male specific (Pp) proximal promoter, that is responsible for its 
transcription in the testis and the epididymis, and a female specific (P d) distal 
promoter, that is tesponsible fot transcription in the ovaty and the placenta 
(Maiti etaL, 1996; Wayne and Wilkinson, 1998). In the male, Pem protein is 
specifically expressed in Sertoli cells and the proximal cauda of the rat 
epididymis (Lindsey and Wilkinson, 1996). As Pem is a member of a large 
family of homeodomain transcription factors, and, in the male, is regulared 
by androgen, the evidence points to a putative role for Pem in androgen-
regulared gene expression in restis and epididymis (Wayne and Wilkinson, 
1998). Identification of down-stream genes which are regulated by Pem, is a 
subject of current research. 
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Epididymal effects of androgen deprivation 
The epithelium 
It has been known for many years that removal of the testis causes extensive 
atrophy of the epididymis (Benoit, 1926). Castration experiments have 
revealed that epididymis weight cannot be restored by androgen supplemen-
tation. This appears to be due to the large weight fraction that is attributable 
to the luminal fluid and spermatozoa, making organ weight an unreliable 
parameter by which to monitor epididymal function (Karkun et aI., 1974; 
Brooks, 1979). Microscopic studies have elucidated substantial changes in 
the epididymal epithelium upon deprivation of androgens. Most of these 
changes could be reversed, however, when the normal circulating level of 
testosterone was restored (Fawcett and Hoffer, 1979), although a decrease in 
duct diameter and an increase in epithelial height are observed during long 
term interruption of the inflow of testicular fluid. Holland et al. (1992) 
noticed obvious changes in the morphology of the epithelium in the distal 
corpus region of the rat epididymis, when the efferent ducts were ligated for a 
period of 8 months. The efferent ducts and the initial segment of the 
epididymis, however, appear to be differentially regulated. A number of 
studies have clearly shown that efferent duct ligation or castration causes 
widespread regression of the epididymal epithelium, and marked inhibition 
of protein synthesis and secretion, that cannot be reversed by high-dose 
testosterone supplementation (Fawcett and Hoffer, 1979; Holland et al., 
1992). It has been postulated that other testicular factors are necessary for the 
normal function of the proximal portions of the epididymis (Fawcett and 
Hoffer, 1979). The identity of these factors is as yet unknown. However, it 
has been postulated that ABP may have a significant tole, especially in the 
transcription regulation of the Sa-reductase type 1 enzyme (Robaire and 
Viger, 1995), as previously outlined. 
In addition, it has been reported that the intermediary energy metabolism of 
the epididymal tissue is dependent on lipid oxidation in the presence of 
androgens, but changes to full carbohydrate dependence when androgens are 
withdrawn (Brooks, 1981). Furthermore, the transport of ions across the 
epididymal epithelium, and the systems responsible for the transport of 
inositol and carnitine across the membrane of the epithelial cells, are 
androgen dependent (Bohmer etal., 1977; Wong and Yeung, 1977; Brooks, 
1980; Yeung et al. , 1980; Pholpramool etal., 1982). 
58 
Androgen control o/spermatogenesis and sperm maturation 
Gene expression 
In a review by Cornwall and Hann (95), eight genes are described which are 
solely or partially regulared by androgens (genes encoding pro reins B/C, 
proteins DIE, AEPl, GPX, 5a-reductase type 1, GGT, SGP2, and NGF) 
(Cornwall and Hann, 1995). The mRNA levels of proteins B/C and DIE, 
and GPX fall dramatically following androgen withdrawal, and recover to 
normal levels following testosterone supplementation. The SGP-2 mRNA 
level increases in the corpus and cauda regions, with lirtle change in the initial 
segment and caput. Testosterone supplementarion lowers the SGP-2 mRNA 
level in both the corpus and cauda. EAPl and 5a-reducrase type 1 are both 
regulated by androgens and an as yet unidentified testicular factor. EAPl 
mRNA level is restored only to 70% of the precastrate level following high-
dose testosterone replacement. Putative androgen response elements have 
been identified upstream of the GPX (Ghyselinck et aI., 1993) and protein 
B/C (Girotti et al., 1992) genes. Studies on the effect of androgen 
supplementation on expression of GPX mRNA, indicate a role for androgens 
in stabilization of this mRNA (Ghyselinck et al., 1993; Cornwall and Hann, 
1995). 
Experimental models and pitfalls 
A logical approach to the question of how androgens support sperma-
togenesis, is the observation of molecular and cellular changes which occur 
when androgens are wirhdrawn from the testes. A number of methods have 
been devised to effectuate such a withdrawal, including: hypophysectomy; 
chemical suppression of pituitary LH and FSH secretion through treatment 
with GnRH antagonists or agonists; treatment with a low dose of testosterone 
with or without estradiol; treatment with ethane dimethane sulphonate 
(EDS), which eliminates all mature Leydig cells in the rat testis. The different 
models, although all resulting in a very low intratesticular testosterone level, 
interact at different levels within the hypothalamus-pituitary-testis axis, and 
have a variety of additional side effects: 
Hypophysectomy: Hypophysectomy results in the complete loss of all pituitary 
hormones, thus also inducing a complete absence of LH (and thereby loss of 
Leydig cell stimulation) and FSH (known to interact synergistically with 
testosterone). An advantage of this model is that the effect of testosterone can 
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be studied in the complete absence of FSH aCtiVIty. A serious drawback, 
however, is that hypophysectomy causes a number of majot changes as a 
result of the loss of the othet pituitary hormones, which clouds the obtained 
data. 
GnRH antagonists and agonists: Treatment with GnRH agonists results in a 
surge of LH and FSH, followed by a fall to undetectable levels, whereas 
GnRH antagonists evoke a direct fall in LH and FSH levels. Treatment with 
GnRH analogues, but also immunization against GnRH can be employed to 
study hormonal control of spermatogenesis. Howevet, there is a problem 
when this strategy is used in the rat, because testosterone supplementation 
results in release ofFSH through a GnRH-independent effect of testosterone 
on the pituitary (Rea etal., 1986; Bhasin etal., 1987). 
Low dose testosterone: Treatment with low dose testosterone, either by repeated 
injection of testosterone ester or by implantation of a silastic tube containing 
hormone crystals, results in suppression of serum LH, in turn resulting in a 
low intratesticular testosterone level. Testicular testosterone is suppressed to 
about 3% of the control level in the rat. When estradiol is added to this 
regimen, the intratesticular testosterone level drops even further, through a 
direct effect of estradiol on Leydig cell steroidogenesis (Tsai-Morris et al., 
1986). In this model, the secretion of other non-gonadotropin pituitary 
hotmones is unaffected. The secretion of FSH, however, is inhibited, 
resulting in a serum FSH level of about 60% of control, and this difference 
might well be of importance in situations where the testicular testosterone 
level is low. 
Ethane dimethane sulphonate (EDS): EDS is an alkylating agent that results in 
the destruction of Leydig cells in adult rats through an unknown mechanism, 
within about 36 hours after intraperitoneal injection. Testosterone 
suppression is highly effective fot a period of up to at least 2 weeks, after 
which time Leydig cells start to regenerate if serum LH levels are not 
suppressed. EDS has a destructive effect on the integrity of the epididymis 
(Cooper and Jackson, 1973), whereas spermatogenesis can be fully 
maintained when testosterone is supplemented (Sharpe etal., 1990). 
What is quite clear from close scrutiny of these models, is that it is very 
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difficult to influence the secretion of one hormone while leaving the serum 
and testicular levels of other hormones unchanged. It should be stressed that 
when studying the effects of modulation of testosterone, the FSH level must 
be well controlled. Numerous studies attest ro the fact that FSH and 
testosterone have synergistic effects in the initiation, maintenance, or 
reinitiation of spermatogenesis (Ken et aI., 1992). In studies where testiculat 
testosterone is suppressed by low dose testosterone implants or injection, the 
serum FSH level falls to about 60% of the normal value (i.e. Sun et al., 1989). 
In our opinion, 60% of normal is a significant decline which may have 
important implications. Upon increasing the supplemented dose of 
testosterone, the FSH level will rise to control levels through an as yet 
unidentified mechanism. This rise in FSH may well flatter the effect of 
testosterone supplelnentation. 
A second problem is, that it is practically impossible to completely abolish the 
secretion of testosterone by testicular Leydig cells (Sharpe, 1994). When LH 
secretion is inhibited by administration of a GnRH agonist or hypo-
physectomy, Leydig cells continue to secrete a small amount of testosterone, 
resulting in a testicular testosterone level roughly equal to the serum 
testosterone level of control rats (Sharpe, 1994). The implications of a very 
low level of testosterone in the testis are uncertain, but it has been shown that 
when EDS is administered to a hypophysectomized rat, a major additional 
loss of germ cells is observed, with a subsequent testis weight loss of 50%, 
compared to hypophysectomized controls (Ken et aI., 1992). In addition, it 
has been reported that in rats, where testicular testosterone production is 
suppressed to about 3% of control values by treatment with low dose 
testosterone and oestradiol, the observed regression in spermatogenesis was 
clearly amplified by the co-administration of flutamide, an androgen 
antagonist (Meachem et al., 1997). Similar observations were made by us, 
during a pilot study using a combination of GnRH antagonist (Org30267) 
and EDS versus each of the two treatments separately, in rats. Daily sperm 
production, as measured by the number of homogenization resistant 
spermatids and testis weight, were appreciably lower in the combined 
treatment group. 
Finally, it should be duly noted that Serroli cell function is highly regulated 
by germinal cells, and undoubtedly by a number of paracrine factors to which 
they are exposed in the testis. Anything longer than shorr-term androgen 
deptivation will cause loss of germ cells from the spermatogenic epithelium. 
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Many of the reported changes in Sertoli cell function found after androgen 
deprivation, were actually the result of the loss of a normal germ cell 
complement (McKinnell and Sharpe, 1992; Sharpe et al., 1993). Experi-
ments using in vitro Sertoli cell models (which traditionally employ pre-
pubertal Serroli cells which are differentially regulated from adult Sertoli 
cells) even in the presence of a limited germ cell complement, will not show 
normal Sertoli cell function. The above flaws in the various models that are 
routinely used in a large number of studies should be kept in mind when 
reviewing the data in the literature. 
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Abstract 
We have studied the ability of the synthetic androgen methyltrienolone 
(RI881) to maintain testis and accessoty organ weights, as compared to the 
effect of testosterone propionate (TP). In contrast to TP, RI881 is not 
metabolized and does not significantly bind to androgen binding protein 
(ABP). Thirty-six rats were treated with ethane dimethane sulphonate (EDS) 
and GnRH antagonist (Org30267) to abolish all testicular androgen produc-
tion, and recombinant human FSH (rec-hFSH, Org32489) was administered 
to ensure adequate FSH levels. Of these rats, five groups of 4 rats were treated 
daily with 0, 50, 100, 200, and 400 ~g TP s.c., and four groups of 4 rats were 
treated daily with 150, 300, 600, and 1200 ~g R1881 s.c .. One control group 
of 4 rats received vehicle injections only. EDS treatment, followed by GnRH 
antagonist and rec-hFSH treatment for 17 days, significantly reduced testis, 
prostate, and seminal vesicle weights (p<O.OOI, p<O.OI, p<O.OOI, respectively). 
Simultaneous treatment with androgens prevented this organ weight decrease, 
in a dose dependent manner. In all TP-treated animals, relative weights (% of 
control) of the accessory sex organs were significantly higher than the relative 
testis weights (p<O.OOI). However, there was no difference in relative weights 
between testis and accessOlY sex organs in the Rl881-treated animals. In 
another series of experiments, we investigated the effect of treatment with 
Finasteride, a Sa-reductase inhibitor, on testis and accessory sex organ weights 
in rats treated with EDS and TP. Treatment with EDS, TP (300 ~g/day) and 
Finasteride (40 mg/kg/day) did not alter testis weight as compared to the effect 
of treatment with EDS and TP alone. Prostate and seminal vesicles weights 
were, however, markedly reduced (significantly different from rats treated with 
EDS and TP alone; p<O.OI and p<0.05 respectively). Immunohistochemical 
analysis of androgen receptor (AR) expression in the testis revealed that 
testicular AR immunoexpression is androgen dependent, and that FSH alone is 
not able to maintain AR immunoexpression. Furthermore, the stage dependent 
pattern of AR immunoexpression in Sertoli cell nuclei, during the spermato-
genic cycle, is identical in all TP- and Rl881-treated rats. It is concluded that 
testis, prostate, and seminal vesicle are equally stimulated when the androgen 
receptor in these tissues is exposed to the same intracellular concentration of 
free androgen and that the low 5a-reductase activity in the testis plays a critical 
role in the differential response of the testis and the accessory sex organs to T. 
Furthermore, stage dependent AR immunoexpression in Sertoli cells does 
occur in the absence of testicular androgen production, and is not due to 
androgen metabolism or local differences in androgen concentration. 
64 
Male reproductive organs and adrogem 
--------------------------~ 
Introduction 
In mammals, spermatogenesis is dependent upon a number of endocrine, 
paracrine and aurocrine regulators (Sharpe, 1994). The role of testosterone 
(T), in particular the testicular concentration ofT needed for qualitatively 
and quantitatively normal spermatogenesis, has been the subject of a 
considerable amount of research (for review, see Sharpe, 1994). Various 
studies have clearly established that the physiological concentration ofT in 
the testis is more than an order of magnitude higher than that in serum 
(Comhaire and Vermeulen, 1976; Maddocks and Sharpe, 1989; Sharpe, 
1994). Furthermore, it has been shown that, while qualitatively normal 
spermatogenesis can be maintained at relatively low levels of T 
(Cunningham, R. and Huckins, 1979; Sun etaL, 1989; Santulli etaL, 1990), 
quantitatively normal spermatogenesis is dependent on a testicular level that 
far exceeds the physiological serum T concentration (Berndtson et aL, 1974; 
Blok et al., 1992; Sharpe, 1994). These data indicate that the testis is less 
responsive to circulating T than other androgen responsive organs, such as 
prostate or seminal vesicle. Several differences exist between the testis and the 
accessory sex organs that may account for this discrepancy. For example, it 
has been shown that 5a-reductase activity, which converts T into the more 
potent androgen dihydrotestosterone (0 HT), is considerably lower in testis 
compared to accessory sex organs (Van der Molen et ai., 1975; Turner et ai., 
1984). Furthermore, the testis contains a high amount of androgen binding 
protein (ABP) (French and Ritzen, 1973; Sharpe, 1988), which may 
effectively prevent a large fraction of testicular androgens from interacting 
with the androgen receptor in testicular androgen responsive cells. It is not 
known what concentration of testicular T is free and biologically active. 
The present study was undertaken to investigate whether the synthetic 
androgen methyltrienolone (RI881), which is not metabolized and which 
has very little affinity for ABP (Bonne and Raynaud, 1976; Kirchhoff et al., 
1979; Levinson and Decker, 1985; Carlson and Katzenellenbogen, 1990), 
might be equally effective in maintaining testis weight compared to 
maintenance of the accessory sex organ weights. We compared the effects of 
various doses of testosterone propionate (TP) and R1881 on the relative 
weights of testis, seminal vesicles, and prostate. Rats were first treated with 
ethane dimethane sulfonate (EDS) to eliminate mature Leydig cells, thereby 
abolishing testicular T production (Kerr et aL, 1985; Morris et aL, 1986). 
These animals also received daily injection of a GnRH antagonist (Org-
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30276; Organon, The Netherlands) to prevent regeneration and maturation 
of remaining immature Leydig cells by suppressing serum LH (Molenaar et 
aL, 1986). Previous studies in rats have shown that treatment with a GnRH 
antagonist decreases setum FSH levels significantly (Rea et aL, 1986; Bhasin 
et al., 1987). This effect, however, is partially reversed by subsequent 
treatment with testostetone, through an undefined mechanism (Rea et aL, 
1986; Bhasin et aL, 1987). To ensure that our data reflect variations in 
androgen response only, adequate FSH stimulation for each treatment group 
was obtained by twice-daily injection of recombinant human FSH (rec-
hFSH, [Org32489; Organon, The Netherlands]). 
In a subsequent series of experiments, we studied the effect of Finasteride, a 
Sa-reductase inhibitor, on the maintenance of testis and accessory sex organ 
weights in rats treated with EDS and 300 flg/day TP. In rats treated with 
EDS and such a high dose of TP, sufficient endogenous serum FSH is 
present, and setum LH is sufficiently suppressed to inhibit Leydig cell 
repopulation (unpublished results). Therefore, GnRHa treatment and rec-
hFSH supplementation was deemed not necessary in this series of experi-
ments. 
Androgen action is mediated by the androgen receptor (AR). Immuno-
histochemical studies on the cellular localization of the AR in rat testis have 
obtained conflicting results. In a study by Vornberger et al. (1994), 
immunohistochemical expression of AR was found in the nuclei of Sertoli 
cells, Leydig cells, peri tubular myoid cells, smooth muscle cells forming the 
walls of blood vessels, and in the cytoplasm of step IX elongating spermatids. 
Bremner et aL (I994) have also demonstrated AR immunoexpression in the 
nuclei of Sertoli cells, Leydig cells, peritubular myoid cells, and cells 
associated with arterioles, but not in germinal cells at any stage of their 
development, which would be in agreement with biochemical data con-
cerning the absence of androgen binding in spermatocytes and spermatids 
(Grootegoed et al., 1977). The reports by Vornberger et aL (1994) and 
Bremner et aL (I 994) describe a stage dependent immunoexpression of AR in 
the nuclei of Sertoli cells during the spermatogenic cycle, with expression 
increasing at stages II through VII and decreasing rapidly at early stage VIII 
to nearly undetectable levels at stages IX through XIV: Putative local 
differences in testosterone concentration, caused by changes in the 
production and secretion of ABP by Sertoli cells during the spermatogenic 
cycle (Ritzen et aL, 1982) might be involved in the stage dependent 
expression of AR in Sertoli cells. Therefore we also investigated rhe testicular 
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pattern and intensity of AR immunoexpression in rats treated with R188!, 
compared to rats treated with TP and control rats. 
Materials and Methods 
Animals 
Young adult male Wistar rats (body weights 300-350 g) from our own 
breeding stock were divided in groups of 4 or 5 animals, such that the mean 
body weight of each group was virtually identical. The animals were housed 
at 22 C, with a light cycle of 14 h light and 10 h dark. Water and rat diet was 
available ad libitum. 
Experimental design 
EXPERIMENT 1: One group of 4 rats was injected twice daily for 17 days with 
vehicle (control group). The remaining 36 animals received one injection of 
ethane dimethane sulphonate (EDS) [75 mg/kg body weight in D-
MSO/H20 1:3 (v/v), i.p.J on day 0, followed by daily injection of a GnRH 
antagonist (Org30276: Organon, Oss, The Netherlands) [350 J.lg/IOO g 
body weight in 0.1 ml saline, s.c.J and twice daily injection of rec-hFSH 
(Org32489; Organon, Oss, The Netherlands) [2 IU in 0.1 ml saline, s.c.,J. 
One group of 4 animals received no further treatment. The eight remaining 
groups were substituted daily with varying amounts ofTP (50, 100, 200, and 
400 J.lg/day) or RI881 (150,300,600, and 1200 J.lg/day). The androgens 
were injected s.c. in 0.1 ml of corn oil. The last injections were given in the 
evening of day 16. 1we!ve hours later, blood was collected from the retro-
orbital plexus under ether anesthesia. The animals were subsequently killed 
by cervical dislocation. One testis was removed immediately and flash frozen 
in liquid nitrogen, for determination of testicular T levels. The other testis 
was weighed and placed in Bouin' s fixative, after perforation of the tunica 
albuginea, for histological and immunohistochemical analysis. The ventral 
prostate and the seminal vesicles were dissected, the secretory fluid was 
expressed from the seminal vesicles, and the organs were weighed (the two 
seminal vesicles combined). 
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EXPERIMENT 2:Jn order to study the effect of 5a-reductase inhibition on the 
weights of the testis and accessory organs, a group of 5 tats was tteated once 
with EDS, and then daily with 300 Jlg TP and Finasteride (40 mg/kg body 
weight/day in 0.2 ml com oil, s.c.). This dose of TP (300 Jlg/day) is 
suboptimal for testis function but tesults in supra-physiological prostate and 
seminal vesicle weights. For comparison a dose response-curve was made by 
injection of 4 groups of 4 tats on day 0 with EDS (75 mg/kg body weight in 
DMSO/H20 1:3 (v/v) i.p.), followed by daily injection with 50,100,200, or 
400 Jlg TP (in 0.1 ml com oil). Treatmentlasted for 17 days, after which the 
rats were killed by cervical dislocation. The testes, the prostate and the seminal 
vesicles were removed and weighed as described above. 
Hormone assays 
Testicular and serum T levels were determined in duplicate samples by RIA 
(Verjans et aI., 1973). The sensitivity of the assay was 50 pg/ml, with intra-
assay and inter-assay coefficients of variation of 10% and 15%, respectively. 
Serum LH and FSH levels were estimated by RIA as previously described 
(Van Cappellen et al., 1995). Intra-assay variations were 4% (FSH) and 5% 
(LH). Cross reactivity of rec-hFSH with rat FSH was previously found to be 
2.6% by weight in this assay (Van Cappellen et aI., 1995). Serum rec-hFSH 
concentrations were determined using a two-site FSH time resolved fluo-
roimmunoassay (Delfina; Phatmacia, Woerden, The Netherlands) for human 
serum. Rat FSH was previously found to be undetected or below the 
detection limit of this assay (Van Cappellen et aI., 1995). The detection limit 
of the assay applied for rat serum is 0.7 pg/ml. The intra-assay variation is 
4.3%. 
Immunohistochemistry 
The primary antibody used (SP197) is a tabbit polyclonal antibody raised 
against a synthetic peptide corresponding to the first 20 N-terminal amino 
acid residues of the human, rat and mouse androgen receptor. 
Immunostaining results obtained with this antibody, in the rat testis, were 
found to be identical (results not shown) to those obtained with a number of 
other polyclonal antibodies targeting the N-terminal region of the AR (Sar et 
aI., 1990; Takeda et aI., 1990; Bremner et aI., 1994). 
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Testicular tissue was left immersed in Bouin's fixative for 2 days, afrer which 
it was stored in 70% ethanol. The tissue was embedded in paraffin, and 10 
mm sections were prepared. The sections were mounted on slides coated with 
3-aminopropyltrietoxysilane (Sigma Chemical Company, St. Louis, MO), 
and kept at 60 C overnight. The tissues were dewaxed in xylene, and 
endogenous peroxidase was blocked with a 20 min incubation in 3% HzOz 
in methanol. An antigen retrieval step was performed by heating the sections 
in 0.01 M citric acid monohydrate (Merck, Darmstadt, Germany) (pH 6.0) 
in a microwave oven at 700W (4 x 5 min). The tissues were washed in PBS 
and placed in a Sequenza immunostainer (Shandon, Zeist, The Netherlands). 
Non-specific antibody binding was blocked with normal goat serum (Dako, 
Glostrup, Denmark), diluted 1:10 in 5% (w/v) BSA in PBS (pH 7.4). The 
tissues were incubated at 4 C overnight with the primary antibody, diluted 
1 :2000 in 5% BSA (w/v) in PBS. Immunostaining was performed using 
biotinylated goat anti-rabbit immunoglobulin (Dako) for 30 min, streptavi-
din-peroxidase (Dako) for 30 min, and metal-enhanced diaminobenzidine 
(Pierce, U.S.A.) for 7 min. The sections were counterstained for 15 sec with 
Mayer's hematoxylin, and viewed with a Zeiss Axioskop 20 light microscope 
at magnifications 100x and 400x. Control sections were incubated with 
SP197 (1:2000) preincubated with an excess of peptide against which the 
antibody was raised (5 mg/ml), or pre-immune serum diluted to the same 
extent as the primary antibody. 
Statistics 
The Students t-test for unpaired samples was used when comparing the organ 
weights of a treatment group with control values. Organ weights of all rats 
treated with either TP or RISSI were compared using Wilcoxon's signed 
rank test for paired samples. 
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Results 
Hormone levels 
In rats, combined treatment with EDS, CnRH antagonist, and rec-hFSH 
(indicated with: EDSICnRHalrec-hFSH) lowered testicular T levels to 1.6 
±0.9 ng/ml (mean ±SEM) and serum T levels to under detection limits (Table 
I). Supplementation of increasing doses ofTP increased testieularT levels, up 
to a level of 11.5 ±4.4 ng/g in rats treated with 400 Ilg per day ofTP. This 
level is still significantly lower than the control level (46.5 ±9.7 ng/g; p<O.-
05). The serum T level was comparable to the control level in rats treated 
with 50-100 Ilg TP per day, but was significantly higher than the control 
level when 400 Ilg TP per day was administered (p<0.05). The testicular T 
level was 0.3 ±0.4 ng/g in rats treated with R1881. In these animals, serum T 
was invariably undetectable. 
In all EDSICnRHalrec-hFSH rats, endogenous LH and FSH levels were 
significantly reduced (p<0.05 and p<O.Ol respectively; Table 2). The serum 
LH level remained low, irrespective of subsequent treatment, while the 
Table 1. Testicular and serum testosterone levels. 
Control 
EDSIGnRHa/rec-hFSH: 
No androgen substitution 
+TP 50 flglday 
+ TI' 1 00 ~g/day 
+TP 200 ~g/day 
+ 1'P ;jO~ ~lg/day 
+R1R81 150 flg/day 
+R1881 300 ~g/day 
+R1881 GOO~g/day 
+R1881 1200 ~g/day 
ND '" not detectable. 
a Mean ± SEM 
-----
-----
Testicular 
testosterone 
ng/g 
1.6 (±0.9)' 
3.4 (± 1.5)' 
7.0 (±3.3)' 
G.5 (±4.5)' 
1 1.5 (±4.4)b 
0.3 (±0.3)' 
0.3 (±0.2)' 
1.7 (±1.7)' 
0.3 (±O.4)' 
b Significantly different from control (p<O.05) 
C Significantly different from control (p<O.O I). 
70 
Serunl 
teSLosl-erone 
ng/ml 
1.2 (±0.24) 
Nl)C 
0.9 (.0.2) 
1.6 (±U.8) 
2.5 (± 1.0) 
6.1 (±l.4)b 
NDC 
NDC 
NDC 
NDC 
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Table 2. Serum LH, FSH and rec-hFSH levels. 
LH FSH rechPSH 
ng/ml ng/ml ng/ml 
--.. 
Control 0.63 (±0.16)" 10.3 (±0.5) ND 
EDS/GnRHa/rec-hFSH, 
No androgen substitution 0.05 (±0.03)b 3.4 (±O.2)' 4.7 (±O.7) 
+TP 50 ).lghby 0.05 (±0.03)b 9.2 (±O.9) 3.7 (±1.2) 
+TP lOa ).lg/day 0.03 (±0.03)b 7.7 (±1.2) 4.7 (±0.8) 
+ TP 200 flgl Jay 0.07 (±0.03)b 10.9 (±1.7) 5.8 (±1.6) 
+ TP 400 ).lgl day 0.05 (±0.03)b 12.5 (±1.0) 5.5 (±0.9) 
+R1881 ISO ).lg/day ND' 8.4 (±O.6) 7.3 (±1.3) 
+R1881 300 ).lg/day 0.05 (±0.03)b 8.9 (±I.3) 4.2 (±0.5) 
+R1881 600 ).lg/day 0.03 (±0.03)b 10.6 (±O. 5) 4.6 (±O.3) 
+R1881 1200 ).lg/day N[)b II.G (±I.2) 5.1 (±O.6) 
ND = not detectable. 
a Mean ± SEM 
b Significantly different from control (p<0.05) 
C Significantly different from control (p<O.O 1). 
endogenous FSH level returned to control value in all rats treated with TP or 
RI88!. The rec-hFSH levels was comparable in all groups recelVlng rec-
hFSH supplementation, irrespective of the androgen level. 
Weights of testis and accessory sex organs 
For Experiment 1, organ weights are shown as percentage of control value, 
per dose ofTP (Figure Ia) or RI88I (Figure Ib). Testis, seminal vesicles, and 
prostate weights in 4 control animals were 1.433 ±0.035 g, 0.268 ±0.OI5 g, 
and 0.389 ±0.033 g (mean ±SEM), respectively. In EDS/GnRHalrec-hFSH 
rats, the weights of the testis, prostate and, seminal vesicles were significantly 
reduced, to 0.555 ±0.OI2 g (p<O.OOI), 0.090 ±0.004 g (p<O.OI), and 0.126 
±0.006 g (p<O.OOl), respectively. Increasing daily doses of TP resulted in 
more effective maintenance of testis weight, which, however, was still 
somewhat lower than control value (p<0.05) in rats treated with 400 Ilg TP 
per day. Higher daily doses of RI88I also resulted in more effective 
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Figure 1. Maintenance of tissue weights by different androgens. The weights (shown here as 
percentage of control) of testis, seminal vesicles, and prostate were measured for rats neated with 
EDS/GnRHalrec-hFSH, and with different daily doses ofTP (a) or RI8SI (b) for 17 days. Values 
are means ±SEM. Asterisk (*) denotes a value significantly lower than control. 
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maintenance of testis weight, which reached a plateau somewhat below 
control level (p<0.05) at 600-1200 Ilg R1881 per day. 
In EDS/GnRHa/rec-hFSH rats treated with 50-400 Ilg TP per day, the 
relative weights (% of control) of the accessory sex organs were significantly 
higher than that of the testis (p<O.OOI; Fig la). Prostate and seminal vesicles 
weights were fully maintained at 50-100 Ilg TP per day, a dose at which the 
mean relative testis weight was only 58%. Prostate and seminal vesicles were 
found to grow well above control values in rats treated with more than 100 
Ilg ofTP per day, reaching 151 % (p<O.OI) and 143% (p<O.OOl) of control 
weight, respectively, at 400 Ilg TP per day. 
In EDS/GnRHalrec-hFSH animals treated with R1881, no difference in 
relative testis weight compared to relative accessory sex organ weights was 
observed. At a dose of 1200 Ilg R1881 per day, however, the relative prostate 
and seminal vesicles weights increased well above 100%, whereas relative 
testis weight was maintained at 93% (Fig Ib). 
For Experiment 2, organ weights are shown in Figure 2, as percentage of 
control values per treatment group. Testis, prostate and seminal vesicles 
weights in the control animals were 1.35 ±0.06 g, 0.399 ±0.028g, and 0.237 
±0.005g (mean ± SEM), respectively. In rats treated with EDS and 100-400 
Ilgl day TP, the relative weights of the accessory sex organs were well above 
control value and significantly greater than that of the testis (p<O.OI). In rats 
treated with 300 Ilg/day TP and Finasteride, testis weight was 82% of control 
value, which is in line with the extrapolated value for rats treated with EDS 
and 300 Ilg/day TP alone (Figure 2). The relative weights of the prostate and 
the seminal vesicles were, however, dramatically reduced to 80% and 99.6% 
of control. These latter weights of the prostate and the seminal vesicles 
correspond to values found in EDS-treated rats supplemented with 50 and 
75llgTP/day, respectively. 
Immunohistochemistry 
Immunohistochemical studies of androgen receptor expression in testicular 
tissue of control rats, revealed immunoexpression of AR in nuclei of Sertoli 
cells, peritubular myoid cells, interstitial cells, and cells associated with 
arterioles (Fig. 3a). Sertoli cell AR immunoexpression is dependent on the 
stage of the spermatogenic cycle, showing faint expression at stages I-II, 
which slowly increases in intensity until expression is at its maximum at stage 
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VII. In the transition from stage VII to VIII, AR immunoexptession rapidly 
decreases, such that at stage VIII the expression is virtually undetectable. 
From stages VIII through XIII, AR immunoexpression in Sertoli cells 
remains relatively low. The petitubular myoid cells, Leydig cells and 
peri arteriolar cells did not display a stage dependent immunoexpression of 
AR. Leydig cells, however, showed a clear, apparently random, variation in 
AR imlTIUnOeXpression; such a phenomenon was much less pronounced, 
though still discernable, in peri tubular and periarteriolar cells. These results 
are in agreement with published data (Bremner et at., 1994). 
In rats treated with EDS/GnRHalrec-hFSH, spermatogenesis was severely 
disrupted, with relatively small diameter tubuli that were devoid of 
elongating and condensing spermatids. Mature Leydig cells were absent, 
while other interstitial cells, presumably macrophages and immature Leydig 
cells, were still present. In the testis of EDS/GnRHalrec-hFSH rats, AR 
immunoexpression was virtually undetectable in all cell types (Fig. 3e). In 
EDS/GnRHalrec-hFSH rats supplemented with 50 flg TP per day, sperma-
togenesis was qualitatively intact but quantitatively severely impaired, with a 
relatively small number of advanced spermatids per tubule. AR immunoex-
pression was faint, but revealed essentially the same stage dependent pattern 
in Sertoli cells, when compared to control testis tissue (data not shown). The 
peri tubular myoid cells and periarteriolar cells also displayed faint AR 
immunostaining. No AR immunoexpression was detected in the Leydig cell 
depleted interstitium. Testicular tissue from EDS/GnRHalrec-hFSH rats 
treated with 400 flg TP I day showed essentially the same pattern and extent of 
AR immunoexpression as testis from control rats (with the exception of 
Leydig cells, which arc absent due to the EDS treatment; Fig 3c). The testis 
from EDS/GnRHalrec-hFSH rats treated with 150 flg RI8811day contained 
many elongated spermatids, and also a pattern of AR immunoexpression that 
was essentially similar to control rats. Upon supplementation with a high 
dose ofR1881 (1200 flg/day) the pattern of AR immunoexpression in Sertoli 
cells was still comparable to control rats: strong expression at stage VII and 
virtually undetectable staining at stage VIII (Fig. 3d). 
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Figure 3. Immunohistochemical detection of androgen receptor in rat testis. Testes were fixed in 
Bouin's solution and embedded in paraffin, and immunostained with SP 197. 
(a) Normal rat testis with positive staining in Serroli cells (slender arrows), peri tubular myoid cells 
(thick arrows), and interstitial cells (open arrows). Note the difference in the intensity of Sefrali cdl 
AR immunoexpression at stage VII compared with the adjoining tubules. 
(b) Normal fat testis stained with SP197 pre-incubated with an excess of peptide ligand. 
(c) and (d) Testis of a fat treated with EDS/GnRHalrec-hFSH, and 400 )lgTP or 1200)lg R1881 
per day, respectively (note the similar stage dependent pattern of AR immunoexpres-sion in the 
Sertoli cdls of both specimens). 
(e) lestis of a rat treated with EDS/GnR-Halrec-hFSH, but without androgen replacement. 
Original magnification: 400x. 
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Discussion 
The present study demonstrates, that, in the presence ofFSH, a given dose of 
the synthetic androgen methyltrienolone (RJ 88 J) can maintain testis weight 
equally well as that of the prostate and the seminal vesicles (though never 
quite reaching control level, presumably because of the destruction of all 
mature Leydig cells). This finding is highly interesting, since all previous data 
have indicated that maintenance of testicular weight, upon elimination of 
testicular testosterone production, requires a circulating androgen level much 
higher than needed to maintain accessory sex organ weights (for review, see: 
Sharpe, 1994). All evidence suggests that spermatogenesis requires a relatively 
high level of testicular androgens, as compared to the circulating level of 
androgens that can evoke a normal response in other androgen dependent 
tissues (Berndtson et at., 1974; Cunningham, R. and Huckins, 1979; Sun et 
at., 1989; Santulli et at., 1990; Blok et at., 1992; Sharpe, 1994). Indeed, our 
experiments confirm that supplementation with a dose ofTP that maintains 
normal accessory organ weights, leads to a low testis weight. A relatively 
normal testis weight can only be attained by doses of TP that are almost an 
order of magnitude higher than those needed for normal accessory organ 
weights. 
It is well known that RI881 also binds to the progesterone receptor (Carlson 
and Katzenellenbogen, 1990). In order to elucidate if this binding might play 
a role in the present experiment, several EDS-treated rats were supplemented 
with either TP, or TP and progesterone, for a period of 17 days. It was found 
that the combined administration ofTP and progesterone had no additional 
stimulatory effect on testis weight or on the other androgen sensitive organs 
(data not shown). 
Presuming that all androgens exert their effect through the known nuclear 
androgen receptor, several explanations, not mutually exclusive, can be given 
for the fact that a given dose of RI881 is as effective in the testis as it is in the 
accessory sex organs, while TP supplementation results in large relative 
differences. 
The first of these explanations involves the fact that the prostate and the 
seminal vesicles have high levels of Sa-reductase, which converts T into the 
more potent 5a-dihydrotestosterone (DHT) (Buric et at., 1972). In the 
testis, the rate of conversion of T into DHT is low, though probably not 
absent (Van der Molen et at., 1975; Turnet et at., 1984). The formation of 
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DHT in the accessory sex organs undoubtedly contributes to the difference 
in relative organ weights in the TP-treated rats. It has been dearly established 
that DHT has a two-fold greater affinity for the androgen receptor and a 
dissociation rate one-fifth that of testosterone, resulting in formation of a 
more stable ligand-receptor complex (Grino et aI., 1990). This results in a 
potency which, in vitro, is approximately 10-fold greater than testosterone. 
Based upon the assumption that a difference in 5a-reductase activity between 
testis and accessory sex organs contributes to the differential response to 
testosterone, one might expect that DHT would maintain testicular weight at 
a lower dose. This, in fact, is the case (Chen et al., 1994). However, the DHT 
level needed to maintain qualitatively normal spermatogenesis is still high 
(about 50% of that of testosterone) when the hormone level is estimated in 
seminiferous tubule fluid. This might be due to rapid intracellular conversion 
of DHT to 3a-androstanediol in Sertoli cells, making DHT unavailable for 
interaction with the AR. In contrast to T and DHT, RI881 is not metaboli-
zed in androgen sensitive tissues (Bonne and Raynaud, 1976; Levinson and 
Decker, 1985). 
In the present study, the contribution of conversion of T to DHT in the 
differential response of accessory sex organs and testis to T was investigated. 
In rats depleted of Leydig cells and treated with TP, testis weight was not 
affected by the additional treatment with Finasteride, indicating that even at 
a low intratesticular T level, conversion of T to D HT does not play a 
significant role in maintaining spermatogenesis. This is in agreement with a 
number of observations that the testis has little 5a-reductase activity (Van der 
Molen et al., 1975; Turner et aI., 1984) and that Finasteride has no effect on 
spermatogenesis in beagle dogs (Juniewicz et aI., 1993). The weights of both 
the prostate and the seminal vesicles, however, were dramatically influenced 
by the concomitant treatment with Finasteride. Relative prostate weights 
were no longer significantly different from thar of testis, while the relative 
weight of the seminal vesicles, though obviously affected by Finasteride 
treatment, was still significantly higher than that of the other two organs 
(p<0.05; Wilcoxon signed rank test for matched pairs). The differential 
response of prostate and seminal vesicles to treatment with Finasteride mighr 
be due to residual 5a-reductase activity in the seminal vesicles. 
It is thus apparent that, judging by relative organ weight, the conversion ofT 
to DHT in the accessory sex organs accounts for most, if not all, of the 
differential response to T of testis compared to accessory sex organs. 
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In the rat testis, androgen binding protein (ABP) binds T with moderate 
affinity (French and Ritzen, 1973; Kirchhoff et al., 1979). The production of 
ABP by Sertoli cells is stimulated by androgens and FSH (Danza et aL, 
1990). A clear function of this protein as a modularor of androgen action in 
the testis, nor a role for ABP in spermatogenesis have been established, 
although it has been sugested that ABP binds to, and is internalized by, the 
germ cells (Gerard et al., 1994). Production and secretion of ABP into 
seminiferous tubule fluid and transport into the epididymis might diminish 
free testosterone levels in Serroli cells, such that ABP actually acts as a local 
inhibitor of androgen action. Since AR immunoexpression is androgen 
dependent, one might suggest that T is made less available to the AR in 
Sertoli cells at stages VIII-Xl, through binding to ABP, which at those stages 
is produced at the highest rate (Ritzen et aL, 1982). RI881 administration 
would not result in variable intracellular availability since this androgen is 
known to bind to ABP with very low affinity, so that a putative regulatory 
function of ABP is bypassed in this model (Kirchhoff et aL, 1979; Carlson 
and Katzenellenbogen, 1990). 
Our data confirm the findings of Bremner et aL (1994) that no AR immuno-
expression is detected in spermatogenic cells as was reported by Vornberger et 
al. (1994). In testis of EDS/GnRHalrec-hFSH rats, immunoexpression is 
essentially undetectable in all cell types, confirming that AR immuno-
expression is androgen dependent (Bremner et al., 1994), and indicating that 
FSH alone is not able to maintain AR immunoexpression. Our results 
indicate that testicular concentration of testosterone, or its metabolites, does 
not influence the temporal pattern of AR immunoexpression in Sertoli cells: 
the present immunohistochemical data show a defined pattern of stage 
dependent immunoexpression of AR in Sertoli cell nuclei during the 
spermatogenic cycle, after administration of either testosterone or R188!. In 
addition, even in the presence of a low testosterone concentration, the stage 
dependent AR staining in Sertoli cells during the spermatogenic cycle was 
invariably present. These data are consistent with the recent evidence that, in 
intact rats, the cyclic variation in AR expression in Sertoli cells is regulated at 
the level of gene transcription (Shan et aL, 1995). The loss of immuno-
detectable AR, in the absence of androgens, most likely results from decreased 
stability of the receptor (Syms et al., 1985; Zhou et al., 1995). 
In conclusion, when a sufficient level ofR1881 is given to maintain accessory 
sex organ weight, testis weight is also maintained. In addition, treatment with 
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Finasteride virtually abolishes the difference in response to testosterone 
betvofeen testis and accessory sex organs, suggesting that extra-testicular 
convetsion ofT to DHT is of critical importance in the observed difference 
in responsiveness to testosterone of testis compared to accessory sex organs. 
Furthermore, the stage dependent pattern of AR immunoexpression in 
Sertoli cells during the spermatogenic cycle is not dependent on the concen-
tration of testosterone or its metabolites, nor of binding of androgens to ABP. 
81 

Androgen receptor expression 
and androgen-dependent protein expression 
in the rat epididymis 
]. Herman van Roijen l , Maria E 00ms1 , Willy M. Baarcnds1, 
Marie-Claire Orgebin-Crist2 , J. Anton Grootegoed 1 and Jan T.M.Vreeburg l 
Department of Endocrinology and Reproduction 1, Era.\ffiUS UniversiL), RoLterdam, The Netherlands 
Center for Reproductive Biology Rcscarch 2, Vanderbilt University Nashville, Tennessee 37232 
Submittedforpubliciltion 
Chapta4 _____________ _ 
Abstract 
The epididymis is a highly specialized organ that is actively involved in the 
matutation of spermatozoa. This organ can be subdivided into a number of 
morphologically distinct regions that show well-defined differences in 
structure and cellular composition, gene expression, and protein production. 
The function of the epididymis is highly dependent on testosterone, which 
reaches the tatget cells either via the blood stream, or ditectly from the testes 
via the ductuli effetentes. Within the epididymal tatget cells, testosterone is 
metabolized into the more potent 5a-dihydtotestosterone, which then 
interacts with the androgen receptor (AR). Using an antibody tatgeting the 
fitst 20 N-terminal amino acid tesidues of the rat AR (SP 197), we studied the 
immunoexpression of AR in the different regions of the epididymis of rats, 
under various conditions. Rats were either castrated, or had their ductuli 
efferentes ligated for periods of 7 to 28 days. Casttated rats were supple-
mented with 100,25,6.25, and 1.56 ~g of testosterone propionate (TP) per 
day. In addition to AR immunoexpression, we investigated the co-immuno-
expression of the highly androgen dependent epididymal ptotein (proteins 
B/C), and androgen receptor in the above organs. 
AR immunoexpression was observed in the nuclei of principal cells, clear 
cells, and basal cells, but not in halo cells. The cells in the ductuli efferentes 
showed only light staining, while in the rest of the ptincipal cell nuclei AR 
immunostaining was intense. Interestingly, we found a marked variation in 
intensity of AR immunoexpression between morphologically indistinguish-
able principal cells within a single tubular cross section. This phenomenon 
was most pronounced in the caput. In situ hybridization experiments showed 
a regional vatiation in AR mRNA expression. The AR mRNA level in the 
principal cells of the initial segment was high, while the AR mRNA level in 
the principal cells from the caput onwards was matkedly lower. Clear 
differences in the AR mRNA level were also observed in neighbouting, 
morphologically similar principal cells. Observations on serial 8 mm sections, 
alternately immunostained for AR protein and subjected to in situ hybridiza-
tion to detect AR mRNA, suggest a correlation between AR protein and 
mRNA expression, indicating that the cell-to-cell variation in AR expression 
as observed in a single tubular cross-section may be regulated at the trans-
criptional level. In castrated rats, AR immunoexpression in the entire 
epididymis decreased to a very low level. In rats with ligated ductuli 
efferentes, the intensity of AR immunostaining was not consistently different 
from that of control rats. In castrated rats supplemented with various doses of 
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TP, a daily dose of 6.25 Ilg TP was sufficient to induce an AR immuno-
expression of normal intensity, indicating that 10% of the normal serum level 
of T is sufficient to maintain epididymal AR immunoexpression. Double 
staining experiments with SP197 and with antibodies targeting ptoteins B/C, 
showed that in cells with a low or absent AR immunoexpression a normal 
immunoexpression of proteins B/C can occur. This suggests that in these cells 
the intensity of AR immunoexpression is no measure for androgen mediated 
activity. An alternative explanation might be, that epididyal cells show a cyclic 
cellular activity, with a considerable time lag between the disappearance of 
the androgen receptor and the production of androgen dependent proteins. 
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Introduction 
When, in mammalian species, spermatozoa leave the testis, they have not yet 
acquired full maturity. A number of developmental processes, such as 
attainment of the capacity for motility, and incorporation of a number of 
vital proteins into the plasma membranes, are dependent on passage through 
the epididymis (Orgebin-Crist, 1967; Bedford, 1975; Orgebin-Crist and 
Olson, 1984; Jones, 1989; Amann et ai., 1993). Subsequently, spermatozoa 
are stored in the cauda of the epididymis, in an environment that is 
intricately controlled to optimize sperm survival. To perform this com-
plicated task, the epididymal epithelium relies on a small number of different 
cell types: the principal cell, the clear cell, the basal cell, and the halo cell 
(Reid and Cleland, 1957). The principal cells outnumber the others, and are 
clearly involved in protein synthesis and secretion into the epididymal lumen. 
The morphology of the principal cells varies along the length of the 
epididymal lumen: principal cells are distinctly tall columnar in the initial 
segment and caput, but become progressively less tall further distally, such 
that in the cauda they are more cuboidal shaped. These differences in 
morphology are associared with differences in function, as is clearly demons-
trated by regional variations in gene expression and tubular fluid composition 
(Holland and Orgebin-Crist, 1988; Holland et aI., 1992; Hinton and 
Palladino, 1995). The ductuli efferentes and the initial segment are involved 
in resorption of a large amount of fluid through active sodium absorption, 
thereby creating a high spermatocryt value (Jones and Jutd, 1987; Wong, 
1990). More distally, the epithelium of the epididymis is a major site of 
protein ptoduction and telease into the lumen (Holland and Orgebin-Crist, 
1988; Vreeburg et ai., 1990; Holland et ai., 1992; Hinton and Palladino, 
1995). In addition to regional variation in principal cell function, there is 
ample evidence that within specific areas, neighbouring ptincipal cells arc 
morphologically indistinguishable, but differ greatly in expression of specific 
ptoteins (Rankin et aI., 1992; Robaire and Viger, 1995). Very little is known 
about the factors which regulate gene expression in the epididymis on a 
regional scale, and about local variation in cell function. 
It has long been recognized that epididymal function is highly dependent on 
testicular androgens that enter the epididymis both through the ductuli 
efferentes and via the periphetal citculation (Benoit, 1926; Brooks, 1981). 
The influx of testosterone from the ductuli efferentes causes a gradient with 
vety high T levels in the initial segment and proximal caput, and a relatively 
low level in the cauda (Vreeburg, 1975; Turner et aI., 1984). Within the 
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epithelial cells, testosterone is metabolized into the more potent 5a-
dihydrotestosterone (DHT) which binds to the androgen receptor (Robaite 
and Viger, 1995). The andtogen receptor is then activated and intetacts with 
specific enhancer sequences, known as androgen response elements, thereby 
regulating the exptession of specific genes (Carson-Jurica et al., 1990). 
Although a number of studies have focused on androgen receptor expression 
in the epididymis of the ram (Tekpetey et aI., 1989), the goat (Goyal et aI., 
1998), the rhesus macaque (Roselli et al., 1991), and the human (Ungeftoren 
and Ergun, 1997), no detailed data is available on the expression and 
regulation of the AR in the epididymis of the rat. In ram, goat, rhesus 
macaque and human, differences in regional expression of the AR have been 
found; however, the implications of these findings remain unclear. 
Using a polyclonal antibody (SP 197) targeting the first 20 N-terminal amino 
acid residues of the AR (Van Roijen et aI., 1997), we performed a number of 
experiments to study the regulation of AR immunoexpression in the rat 
epididymis under a number of conditions, and searched for regional and local 
variations in AR immunoexpression. In addition, we performed in situ 
hybridization for AR mRNA, to ascertain if variations in AR immuno-
expression coincide with expression patterns of AR mRNA. Furthermote, we 
correlated the observed diffetences in AR immunoexpression with the 
immunoexpression of highly andtogen dependent proteins: proteins Band C 
(Brooks and Higgins, 1980). Proteins B/C [also known as EBP1 & EBP2 
(Ong and Chytil, 1988; Newcomer and Ong, 1990), ESP I(Girotti et aI., 
1992), and E-RABP (Newcomer, 1993; Newcomer et al., 1993)] are 
members of the lipocalin superfamily (Girotti et aI., 1992). Mouse 
epididymal protein 10 (MEP 10) is the mouse homologue of proteins B/C, 
with 86% sequence similarity (Rankin et aI., 1992b). MEP 10, recently 
renamed murine epididymal retinoic acid binding protein [mE-RABP] 
(Lareyre et al., 1998), binds active retinoids (cis and all-ttans retinoic acid, 
but not retinol) with high ligand specificity (Rankin et al., 1992a), and is 
intricately regulated by androgens (Lareyre et aI., 1998). In the present study, 
antibodies raised against MEP 10, known to specifically cross react with 
proteins B/C (Rankin et aI., 1992; Lareyre et aI., 1998), were used to study 
the differential expression of protein B/C in rat epididymis, in relation to AR 
. . ImmunoexpresslOn. 
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Materials and Methods 
Animals 
Three- to four-month-old male Wistar rats from our own breeding stock 
were selected. All animals weighed 300-350 g. Water and food was available 
ad libitum. The rats were maintained on a 12L: 12D cycle. 
Experimental design and surgical procedures 
Fourteen rats were divided into two groups of 6, and one (control) group of 2 
animals. One group was castrated, and in one group ductuli efferentes were 
ligated. Castration, and ligation of the ductuli efferentes were performed 
through the abdominal route. All surgical procedures occurred under ether 
anesthesia. Two tats per group were killed by cervical dislocation 7, 14, and 
28 days after surgery. The two control rats were sacrificed on day 28, together 
with the last group of treated animals. Epididymides were removed, cleared of 
surrounding fatty tissue, and divided into a proximal segment, which 
included the initial segment, the caput and the proximal corpus, and a distal 
segment, comprising the distal corpus and the cauda. The organs were either 
flash frozen in liquid nitrogen for evaluation on Western blot, or placed in 
Bouin's fluid for 24 hours. Subsequently, the Bouin-fixed tissues were 
thoroughly washed and stored in 70% ethanol. 
In an additional experiment, four groups of 2 rats were castrated as described 
above. After 3 weeks, they were supplemented by injection of 100 Ilg, 25 Ilg, 
6.25 Ilg, and 1.561lg TP pet day (s.c. in 0.1 ml vegetable oil) for 2 weeks. All 
animals were killed by cervical dislocation under ether anesthesia. The 
epididymides were fixed in Bouin's solution for 24 hours, for subsequent 
immunohistochemical analysis. 
Antibodies 
For detection of AR immunoexpression we used SP197, a rabbit polyclonal 
antibody raised against a synthetic peptide corresponding to the first 20 N-
terminal amino acid residues of the rat AR (Van Roijen et at., 1997). The 
antibody targeting MEPIO is a rabbit polyclonal raised against mouse 
epididymal protein 10, as described previously (Rankin et al., 1992a; Rankin 
et at., 1992a). Anti-MEP 10 antibodies are known to specifically cross react 
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with rat proteins B/C (Rankin et al., 1992b). In all sections SP197, was 
stained with metal-enhanced diaminobenzidine (DAB), staining positive 
nuclei brown, and antibodies targeting proteins B/C were stained with 
fuscine, resulting in a red colored cell cytoplasm. 
Western blot 
The proximal and distal portions of the epididymides, and seminal vesicles 
were pulverized under liquid nitrogen. The resulting powder was suspended 
in I ml high salt buffer (0.5M NaC!, 40 mM Tris, 10% (v/v) glycerol, I mM 
EDTA, pH 8.5) in the presence of inhibitors of proteolytic breakdown (0.6 
mM bacitracin and 0.6 mM PMSF). Immunoprecipitation and western blot 
were performed as previously described (Van Laar et aL, 1989). Equal 
amounts of protein were loaded on each lane. 
Immunohistochemistry 
The tissues were embedded in paraffin, and 8 mm sections were prepared. 
The sections were mounted on slides coated with 3-aminopropyltrietoxy-
silane (Sigma, St. Louis, MO, USA), and kept at 60 'c overnight. The tissues 
were dewaxed in xylene, and endogenous peroxidase was blocked with a 20 
minute incubation in 3% (v/v) H 20 2 in methanol. For SP197, an antigen 
retrieval step was performed by heating the sections in O.OIM sodium citrate 
buffer (pH 6.0) in a microwave oven at 700 W (4 x 5 minutes). No antigen 
retrieval was necessary for staining with anti-MEPIO antibodies. Non-
specific antibody binding was blocked with normal goat serum (Dako, 
Glosrrup, Denmark), diluted 1:10 in 5% (w/v) bovine serum albumin (BSA) 
in phosphate-buffered saline (PBS; pH 7.4). The tissues were placed in a 
Sequenza immunostainer (Shandon, The Netherlands), and incubated at 4C 
overnight for AR, or for 4 h at room temperature for proteins B/C, with the 
primary antibodies diluted I :4000 and I :200, respectively, in 5% (w/v) BSA 
in PBS. Immunostaining was performed using biotinylated goat anti rabbit 
immunoglobulin (Dako, The Netherlands) for 30 min, streptavidin-
peroxidase or streptavidin-alkaline phosphatase (Daleo, The Netherlands) for 
30 min, and metal-enhanced DAB or fuscine (Pierce, USA) for 7 min where 
appropriate. The sections were counterstained with Mayer's hematoxylin, 
and viewed with a Zeiss Axioscop microscope. In sections that were stained 
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with both antibodies, the procedure for proteins B/C staining was completed 
first, followed by the protocol for AR immunostaining. 
In situ hybridization 
An EcoRI fragment containing bp 2778-3329 of the mouse AR eDNA was 
cut from a vector named pmARo (Faber et aI., 1989), and cloned in 
pBlueseript KS (Stratagene, Westburg, Leusden, The Netherlands) using 
standard molecular biology techniques (Sambrook et al., 1989). This 
construct was used to generate digoxigenin-Iabeled sense and anti-sense RNA 
probes. A labeling mixture containing digoxigenin-UTP (Boehringer 
Mannheim, Almere, The Netherlands) was incubated with AR DNA 
template and T7 or T3 RNA polymerase (Stratagene) (to prepare sense or 
antisense AR RNA respectively) according to the instruerions provided by the 
manufacturer of the labeling mixture. The resulting RNA probe was dissolved 
in 20 ml sterile H 20 and analyzed using agarose-gel electrophoresis and 
ethium bromide staining for rough estimation of yield of full length 
transcripts. Diffetent dilutions of digoxigenin-Iabeled RNA were spotted on 
dot blots, to determine the relative amount of detectable probe using the 
DIG nucleic acid detection kit (Boehringer Mannheim). One in vitro 
transcription reaction (using 1 mg of template DNA) yielded enough probe 
to prepare 10 ml hybridization mixture. 
Tissue fixation, embedding and slide preparation methods were as described 
for immunohistochemistry. The in situ hybridization procedure was 
performed as described by (Millar et ai, 1993). The (pre)hybridization 
mixture contained 50% (v/v) deionized formamide, 4x SSC, Ix Denhardt's 
solution, 125 mg/ml denaturated herring sperm DNA, and 125 mg/ml yeast 
tRNA. Sections were prehybridized for 2 h at 55C in moist chambers. Mter 
removal of the prehybridization mixture (through blotting on tissue) 140 ml 
preheated (5 minutes at 85C) hybridization mixture (containing 1 ml sense 
or antisense RNA probe/500 ml hybridization mixture) was applied on each 
(prewarmed) slide containing several tissue sections. Subsequently, a coverslip 
was applied and the slides were incubated overnight at 55C in a moist 
chamber. Posthybridization washes, treatment with RNase and detection of 
digoxigenin were performed (Millar et al. 1993). The sections were counter-
stained using Mayer's hematoxylin. 
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Results 
lffestem blot 
Immunoprecipitation and Western blot resulted in detection of a single 116 
kD band in the caput and cauda epididymis and in the seminal vesicles of 
control tats (Figure 1). Castration induced a marked reduction of AR signal, 
which was apparent in both the caput and cauda epididymis of rats killed 7 
days aftet surgery. In rats with ligated ductuli efferentes we found no change 
in AR expression in the caput and cauda of the epididymis, compared to 
control (Figure 1). 
Immunolocalization of androgen receptors 
Androgen receptot immunoexpression was detected in the nuclei of principal 
cells, clear cells and basal cells, but not in halo cells. The peritubular (myoid) 
cells stained positively for AR, as did a number of intetstitial cells. In intact 
rats, there was little regional variation in the intensity of AR immuno-
exptession in the nuclei of the principal cells along the length of the 
1 2 3 4 5 6 
AR-
Figure 1. Immunodelection of androgen receptors with SP197, using SDS-PAGE and Western blot. 
Panel A, depicts the AR immunosignal in rat epididymides 14 days after various treatments. The 
AR immunosignal in rat epididymides is shown, 7 days after various treatments. Lane.~ 1 and 2 
correspond to the proximal and distal portions of control epididymis n:spectivcly. Lanes 3 and 4 
correspond to the proximal and distal portion of epididymis widl ligated ductuIi eflerentes, 
respectively. Lanes 5 and 6 correspond to the proximimal and distal portions, respectively, of 
epididymides of castrated rats. Note the weak immunoexpression of androgen receptor in the 
epididymis of castrated rats. 
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Figure 2 . Immunolocalization of androgen recepcor in rat epid idymal tissue. Bouin's fIxed rat 
epdidymis was stained wi th a polyclonal anribody specific for the androgen receptor (SP197). 
Positive (brown) staining is observed in the nuclei of principal cel ls. perirubular cells. and some 
inremi ria l cells. Halo cells (not shown on these photographs) are negative. The nudei of principal 
cells of the ducruii efferemes (A) stain much less i'lS[cnseiy (hat the nuclei of th e in itial segment (B) 
or caput ep ididymis (C). Note the dear heterogeneity in AR immunoexpression of adjacent, 
morphologicaUy identical , principal cells, particularly in the initial segment and capm regions. 
epididymis (Figure 2) . However, the epithelial cells of the ductuli efferentes 
stained weakly for AR, while, in the same section, the peri tubular cell nuclei 
were intensely stained (Figure 2). In the initial segment, the caput, and the 
cauda, AR immulloexpression is clearly much more pronounced, with clear 
staining of the nuclei of principal cells. In these segments, some cytoplasmic 
staining is also observed; however, the same cytoplasmic staining is found in 
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tissues incubated with pre-immune serum, and is thus considered non-
specific (data not shown). In castrated rats, the immunoexpression of AR in 
the nuclei of all ptincipal cells was strongly reduced. We found no clear 
difference in AR immunoexpression in the epididymis of rats that were 
castrated for periods of 7, 14 and 28 days. Ligation of the ducruli efferentes 
did not alter the immunoexpression of AR in the principal cells throughout 
the length of the ep ididymis (data not shown). 
We observed a pronounced variation o f AR immunoexpression in adjacent 
principal cells within a given cross section of a tubule (Figure 2) . Although 
this variation was observed in all segments, it is clearly most apparent in 
principal cells of the proximal part of the epididymis. In all epididymal 
segments, the heavily stained principal cells far outn umber the lightly or 
unstained cells. In the capLIt the proportion of unstained principal cel l nuclei 
seemed higher than elsewhere. 
In castrated rats supplemented with TP, a daily dose of 6.25 !lg was sufficient 
to reinduce the no rmal intensity of the nuclear AR immunoexpression in all 
epididymal epithelial cells. In these tissues, local variabili ty in AR immuno-
express ion was observed in the principal cells, compatable to intact rats. 
Figure 3. Photomicrograph of double-immunostain ing with SP197 and an antibody targeting 
proteins BIC in the epididymis of a castrated rat, treated with 1.56 jlg TP per day. Androgen 
receptor stain brown (DAB), and proteins BIC stain red (fuscine). Notice the very weak staining of 
nuclear androgen receptor in the principal cells, while an intense red colouring depicting a high level 
of proteins SIC, can be discerned in at leats two principal cells, indicating that pmteins SIC can be 
synthesized in some principal cells under the influence of low testosterone levels that are not able to 
maintain normal AR expression in the principal cells. Notice also the pseudostratified appearance of 
the epididymal epithelium; a well-known resu lt of subptimal androgen stimulation . 
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lmmunolocalization o/proteins BIC 
In the intact rat, very faint immunoexpression of proteins B/C was observed 
in the cytoplasm of the principle cells of the ductuli efferentes and initial 
segment of the epididymis. In the proximal caput, a mosaic pattern of 
expression was observed with very intense staining of cytoplasm and nucleus 
of a number of principal cells, while other principal cells were nor stained at 
all. Intensely stained principal cells were found throughout the caput, corpus, 
and cauda; however the relative number of cells with intense cytoplasmic 
proteins B/C immunostaining was highest in the caput. The extent of 
cytoplasmic staining in the principal cells was variable in that some cells 
showed light staining near the nucleus, some were intensely stained through-
out the cell, and other cells had limited staining only at the apical end of the 
cytoplasm. 
All principal cells from the distal caput onward had intense staining along 
theit apical membrane including the stereocilia. In the distal corpus and 
cauda, the cytoplasm of the clear cells was strongly immunostained. 
Castration had a dramatic effect on proteins B/C expression: in the cytoplasm 
of virtually all principal cells, proteins B/C immunoexpression was no longer 
apparent 7 days after trearment. Proteins B/C staining of the apical mem-
brane and stereocilia was appreciably decreased, but was still visible at day 14 
after castration. Ligation of the ductuli efferentes did not alter the intensity 
and pattern of proteins B/C immunoexpression. 
Proteins B/C immunoexpression was effectively reinduced in the principal 
cells of castrated rats treated with 1,56 Ilg TP per day, in a pattern and 
intensity similar to thar of intact rats. Interestingly, the dose ofTP needed to 
maintain proteins B/C expression in the rat epididymis (I,56IlgTP/day) was 
lower than that needed to maintain normal androgen receptor expression 
(6,25Ilg TP/day) (Figure 3). 
Double-staining 
Almost all proteins B/C positive principal cells stained intensely positive for 
AR. However, a few positive cells showed a very low or absent AR 
immunoexpression (Figure 4). This phenomenon was apparent throughout 
the epididymis; however, most proteins B/C positive cells with very low AR 
immunoexpression were found in the caput. 
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In situ hybridization afAR mRNA 
AR mRNA was observed in the principal cells throughout the length of the 
epididymis. A regional variation in abundance of AR mRNA was clearly 
apparent: an intense signal was observed in the initial segment. while in the 
capur. corpus and cauda. AR mRNA was less intensely expressed (Figute 5). 
Expression was most apparent in the cytoplasm, in the perinuclear region of 
the cells (Figure 6 and 7). We also observed a clear heterogeneity in AR 
mRNA expression in adjacent principal cells within the same tubular cross 
section (Figure 6). Some principal cells express high levels of AR mRNA 
while neighbouring, morphologically indistinguishable, principal cells, stain 
only very lightly. This heterogeneity in AR mRNA expression is mosr 
apparent in the initial segment and the proximal caput. 
In order to elucidate if the observed cell-to-cell variation in AR immuno-
expression may be regulated at the transciptionallevel, we obtained a series of 
8 ~m thin slices of control epididymis, and alternately performed immuno-
histochemistry and in situ hybridization. Subsequently, in areas where, in 
alternate sections, a single principal cell nucleus was suspected) the expression 
of AR mRNA and AR immunoexpression was compared. This strategy 
resulted in evidence that the local variation of AR immunoexpression in 
epididymal principal cells was regulated at the level of mRNA expression 
(Figure 7). 
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Figure 4. Phoromicrographs of immunohistochemical double-sraining studies of androgen 
rcccpror (srained brown) and proteins B/C (stained red) in rhe rar epdidymis. 8mh panels show a 
high expression of proteins B/C in principal cells with high and very low levels of nuclear AR 
immunoexpression, and viet versa. No consisrenr correlation between AR expression and proteins 
SIC expression could be discerned in the principal cells of the rat epididymis. 
, 
g.. 
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Figure S. Phorom icrograph of AR mRNA expression 
in the uIHreated rat epididymis. using in situ hybridi-
zation. Narc the intense staining in the initial segment 
of the epididymis. 
Androgen receptor expression in the rat epidiJ:ymis 
Figure 6. Photomicrograph of AR mRNA expression in a portion of a ductule from the caput of 
the rat epididymis. Using in situ hybridization, AR mRNA was visualized in control rat epididymis 
(see Materials and Methods). Notice the perinuclear staining ofAR mRNA, and the marked eel! to 
cell variation in ARm RNA expression. 
AR ARmRNA AR 
Figure 7. Serial 8 ~m sections, alternately showing AR immunoexpression and AR mRNA 
expression. k an average principal cell nucleus measures 10 )lm in diameter, slices of the same 
nucleus will inevitably appear on consecutive sections. These serial micrographs provide evidence 
that principal cells, showing low levels of AR immunostaining, also have low levels of AR mRNA 
expression, indicating that the cell-to-cell heterogeneity in AR protein expression may be regulated 
at the transcriptional level. 
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Discussion 
In the present study, we have characterized the pattern of androgen receptor 
immunoexpression in the rat epididymis, and correlated these findings with 
the pattern of AR mRNA expression and the cellular production of androgen 
dependent proteins B/C. 
Previous studies have shown nuclear AR immunoexpression in the epithelial 
cells of the rat epididymis (Sar et aI., 1990; Paris et aI., 1994). None have 
reported regional variation in AR immunoexpression in the various regions of 
this organ. In the ram, goat, rhesus macaque, and human, clear regionally 
defined variations in AR expression in the epididymis have been found 
(Tekpetey et aI., 1989; Roselli et at., 1991; Ungefroren and Ergun, 1997; 
Goyal et at., 1998). In accordance with a number of reports, we observed 
strong AR immunoexpression in the nuclei of principal cells, basal cells, 
peritubular myoid cells and a number of interstitial cells, but not in halo cells. 
We found little region-specific variation in AR immunoexpression in the 
nuclei of the principal cells, although the nuclei of the epithelial cells of the 
efferent ducts were clearly less intensely stained compared to the rest of the 
epididymis. In castrated rats, nuclear AR immunoexpression in the epithelial 
and interstitial cells is clearly rednced in all segments. When TP is 
supplemented at a dose of 6.25Ilg/day, AR immunoexpression is comparable 
to control epididymis. Epididymides of rats with ligated ductuli efferentes for 
periods of 7 to 28 days show no decrease in, or change in pattern of, AR 
immunoexpression, indicating that testicular factors other than testosterone 
do not regulate epididymal AR immunoexpression in rats. Although 
testosterone reaches the epithelial cells via the blood stream and through the 
lumen of the dnctuli efferentes, 10% of the normal setum level of 
testosterone is sufficient to maintain normal AR immunoexpression. 
A previous study snggested that androgen withdrawal by castration or 
treatment with a GnRH-antagonist results in a decrease in AR imilluno-
expression, with the remaining AR staining discernible in the nuclei of the 
principal cells (Paris et aI., 1994), indicating that the remaining AR is still in 
the tightly bound nuclear form. We confirm the marked reduction in AR 
immunoexpression in all segments of the epididymis when rats were 
castrated, but found most of the residual AR immunostaining in the 
cytoplasm of the principal cells, with only a few AR-positive nuclei in the 
proximal caput (results not shown). The regulation and distribution of AR 
immunoexpression by androgen-AR interactions in the epididymis thus seem 
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similar to those observed in the testis (Bremner et al., 1994; Van Roijen et al., 
1997), the rat prostate (Blok et al., 1992a), and the seminal vesicles (Paris et 
al., 1994). Interestingly, androgen withdrawal causes no cbange in AR 
mRNA in tbe testis (Blok et al., 1992b), and marked AR mRNA up-
regulation in tbe prostate (Quarmby et al., 1990a; Blok et al., 1992a) and 
epididymis (Blok et al., 1992a), indicating tbat AR expression is regulated at 
the level of mRNA translation and/or tbat AR degradation is enhanced in the 
absence of androgens. It has indeed been shown that binding of androgen to 
the AR results in a more stable complex with a much longer half-life than an 
unliganded AR molecule (Zhou et al., 1995). 
A surprising finding was the distinct variation of AR immunoexpression in 
the nuclei of morphologically identical adjacent principal cells tbroughout 
tbe epididymis, but especially in tbe distal caput and proximal corpus. 
Heterogeneity in AR immunoexpression bas previously been reported in tbe 
rat and buman testis (Bremner et al., 1994; Vornberger et al., 1994; Van 
Roijen et al., 1997), in human hepatocytes (Hinchliffe et al., 1996), and in 
prostate and ovarian tumor tissue (Cbadba et al., 1993; Ruizeveld de Winter 
etal.,1994). 
In the rat, spermatogenesis can be subdivided into fourteen specific srages 
(Leblond and Clermont, 1952). At stages VI and VII, AR immunoexpression 
in Sertoli cells is high, while at stages VIlI through XIV and I through V, AR 
immunoexpression is appreciably lower (Bremner et al., 1994). It is tbought 
that AR immunoexpression in the Sertoli cells is bigbest in those stages that 
are most dependent on androgens (Sharpe, 1994). Tbe stage dependent AR 
exptession is not regulated by the local level of available androgen, but by the 
level of AR mRNA expression in Sertoli cells at the respective stages (Sban et 
al., 1995; Van Roijen etal., 1997). 
We subsequently performed in situ bybridization studies to clarify the pattern 
of AR mRNA expression in tbe normal rat epididymis on a regional and local 
scale. AR mRNA levels are higbest in the initial segment, and appreciably 
lower furtber distal from the testis. The transition from high AR mRNA 
expression to low AR mRNA expression is rapid, and probably does not 
reflect a change due to local variation in the androgen level. The level of AR 
mRNA expression in adjacent, morphologically identical, principal cells can 
vary considerably. In order to assess if cells with high androgen receptor 
immunoexpression also contain a high level of AR mRNA, serial 8 mm 
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sections were alternately stained for AR protein and AR mRNA. As shown in 
Figure 7, our results indicate that indeed cells with high AR immuno-
expression show a high cellular AR mRNA content, indicating that, in 
epididymal epithelial cells, AR expression may be regulated at the transcrip-
tionallevel. 
Epididymal cell protein production is highly dependent on androgens 
(Brooks and Higgins, 1980; Holland et aI., 1992). As AR immunoexpression 
may puratively be an indication of androgen mediated cell activity, we 
attempted to correlate AR immunoexpression in principal cells with the 
expression of a highly androgen dependent gene. Proteins Band C are two 
splice variant products of a gene, expression of which is highly androgen 
dependent (Brooks et aI., 1986). Surprisingly, as shown in Figure 4, double 
staining experiments revealed that some cells had a high exptession of 
proteins B/C, but not of AR. 
Another tissue that shows a highly heterogeneous pattern of nucleat androgen 
receptor immunoexpression, is prostatic adenocarcinoma (Sadi et aI., 1991; 
Van der Kwast et aI., 1996). Because of the high inter- and intra-individual 
variation in the relative number of AR positive cells in this malignant tissue, 
many studies have been performed to elucidate if the level of AR expression 
in prostate carcinoma has prognostic significance. The results have, so far, 
been inconclusive (Sadi et aI., 1991; Prins et aI., 1998). Prostatic epithelial 
cells produce a highly androgen dependent protein, prostate-specific antigen 
(PSA). In prostate carcinoma, the immunoexpression of PSA is also hetero-
geneous. Interestingly, in a double staining study, no correlation was found in 
the cellular immunoexpression of AR and PSA (Ruizeveld de Winter et aI., 
1994). Some PSA positive cells were found to express high levels of AR, while 
others were AR negative. 
The above observations could mean that the intensity of AR immuno-
expression is not be related to androgen driven cell activity, and may thus be 
caused by other factors. It is interesting to note that the supplemental dose of 
testosterone propionate needed to maintain nonnal proteins B/C expression 
(1.56 Jlg/day) was lower than that needed to maintain normal nuclear AR 
immunoexpression (6.25 Jlg/day). One could speculate that normal trans-
cription some androgen dependent genes in the epididymis can be main-
tained by a low level of androgen receptor, not detectable by immuno-
histochemistry. Alternatively, the activity of the principal cells may not be 
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constant, but may vary in a cyclic fashion. This would result in cells that are 
'active' with a high level of AR immunoexpression and cells with low AR 
immunoexpression. To some extent this hypothesis parallels the situation in 
the testis, where Sertoli cells express high levels of AR at stages where 
androgens are thought to exert most of their effect (Sharpe, 1994). The lack 
of an obvious correlation between AR immunoexpression in principal cells 
and the expression of proteins B/C is at first sight not consistent with the 
above train of thought. However, the disappearance of the AR might precede 
the reduction in protein by an appreciable time period. 
In summary, AR immunoexpression is found in the nuclei of principal cells, 
clear cells and basal cells throughout the length of the epididymis. The 
epithelial cells of the ductuli efferentes stain weakly for AR; however, the AR 
immunoexpression in the nuclei of the epithelial cells further distal stain 
more intensely. In situ hybridization studies of AR mRNA in these tissues 
showed a regional variation in AR mRNA expression; the mRNA level was 
clearly high in the initial segment of the epididymis compared to the rest of 
the caput, corpus and cauda. A marked cell-to-cell variation in AR immuno-
expression and AR mRNA was found within a single tubular cross section. 
Double-staining experiments using antibodies targeting the AR and the 
androgen regulated epididymal proteins B/C, revealed no correlation 
between the immunoexpression of proteins B/C and the AR. The observation 
that epididymal epithelial cells expressing an androgen dependent protein 
may show no AR immunoexpression indicates that expression of proteins 
B/C may be maintained by a low level of androgen receptor, not detectable by 
immunohistochemistry. The current data are, however, also consistent with a 
putative cyclic variation in epididymal epithelial cell activiry, where the 
expression and disappearance of AR precedes the expression and dis-
appearance of proteins B/C. No information is currently available concerning 
the function of individual epididymal epithelial cells over a period of time. 
Further research is needed to fully comprehend the androgen regulation of 
epididymal epithelial cell function. 
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Introduction 
The focus of the ptevious chapters is on the normal physiology of male 
reproductive function, mainly as studied in the rat. When any part of the 
intricate chain of events leading to male reproducrive capacity breaks down, 
reproductive dysfunction or infertility may ensue. Infertility may follow from 
dysfunction of the testis, or may be the result of defective transport and/or 
maturation of the spermatozoa. Furthermore, deposition of semen into the 
vagina requires the interplay of a number of physiological processes, and 
dysfunction of anyone of these processes may result in impotence, 
premature- or anejaculation, or retrograde ejaculation. 
In a number of patients, developmental aberrations or genetic defects can be 
identified as the cause of their infertility. In others, their subfertility can be 
attributed to external influences (heat, infection, chelnicals) or disease, as in 
testicular malignancy. Often, however, no cause for a man's subfertile 
condition can be found. 
The following chapters in this thesis deal with some of the issues involved in 
disruption of human spermatogenesis, including the testicular expression 
pattern of the androgen receptor in the testis (Chapter 6), and patterns of 
expression of sperm nuclear proteins during spermatogenesis and in 
spermatozoa (Chapter 7). These studies were performed using semen samples 
and testis biopsies from male partners in infertile unions. 
In this chapter, the basis of spermatogenic disruption is briefly explored. 
Specific attention is directed towards possible genetic mechanisms behind 
testis dysfunction, as much of the present research regarding male infertility is 
focussed on this area. 
Male factor infertility: the magnitude of the problem 
World-wide, 60-80 million couples are unable to conceive a child (Diczfalusy 
and Crosignani, 1996). Although infertility poses no direct threat to physical 
health, it can be disastrous for the psychological and social well-being of those 
involved. It was traditionally the women who were singled out as the cause of 
a barren marriage, but it is now clear that male factor infertility plays a major 
role. In a joint analysis by the World Health Organisation (WHO) and the 
World Bank, it is estimated that, globally, reproductive ill health accounts for 
12 % of the overall burden of disease in the male (Diczfalusy and Crosignani, 
1996). Among subfertile couples, defined as not having conceived after 1 year 
of unprotected coitus, about 50% of the male partners have subnormal 
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semen parameters according to WHO criteria (The ESHRE Capri Worbhop 
Group, 1994). The increasing awareness of the role of male reproductive 
(dys)function in infertile couples, has resuIted in a large number of clinical 
and more fundamental studies to elucidate the mechanisms of male repro-
ductive disease. 
In a latge cohort of subfertile couples, semen abnormalities or other 
reproductive dysfunctions could be identified in 51.6% of the male partners 
(Farley and Belsey, 1988). In 51.2% of these men, no cause for their 
subfertility could be identified (idiopathic male infertility). A later study 
performed in a European center with a special interest in male reproductive 
endocrinology revealed 31.7% idiopathic male infertility (Behre etal, 1994). 
Although the population of the two studies are probably quite different, it is 
evident that in a large percentage of sub fertile males the underlying pathology 
cannot be identified. At our Andrology Clinic, we found that about 25-30% 
of subfertile men present with unexplained semen abnormalities (Pierik et al., 
submitted for publication). Nevertheless, in males where a clear underlying 
anomaly is found, the influence of this condition upon reproductive function 
is not always clear. Varicocele, a condition where the venous pampiniform 
plexus, carrying blood from the testis, is dilated with dysfunctional valves, 
causing backflow of blood from the body to the testis, resulting in a higher 
scrotal temperature (Lerchl et al, 1993; Wright et al, 1997), is found in 
approximately 30% of sub fertile men (Aaf)es and van der Vijver, 1985; Marks 
et al, 1986; Pierik et al, unpublished resuIts). Varicocele is also found in 
about 15-20% offertile men (Nieschlag et al, 1997). One must be weary of 
identifYing a diagnosed varicocele as the cause of a manls infertile condition 
(Hargreave, 1993). 
Chromosomal abnormalities in sub fertile males 
Male infertility may result from chromosomal abnormalities or (multi) gene 
defects. The genetic analysis of infertile men has, until relatively recently, 
mostly been restricted to karyotyping of lymphocytes or spermatozoa 
(Zuffardi and Tiepolo, 1982a; Bourouillou etal, 1985a; Martin etal., 1988a; 
Martin et al, 1991a; Vogt, 1995a). These studies have shown a clearly 
increased incidence of chronlosome aneuploidy and chromosome structure 
anomalies in sub fertile men, especially in men with severe oligoasthenoterato-
zoospermia. Autosomal translocations are found 10 times more frequently in 
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infertile men compared to fertile men, with concomitantly an incteased tisk 
of spontaneous abortion of ptegnancies fathered by these men (Vogt, 1995a). 
Similarly the frequency of pericentric chromosome inversions of 
chromosomes 1,2,5,6,9 and lOis also increased. The transfer of so-called 
Robertsonian translocations may increase the risk of mental retardation in the 
offspring (Lange et aI., 1990a; Vogt, 1995a). A recent review article pooling 
and comparing the results of 7 of the latgest and most relevant studies, 
comprising a total of7,876 infertile men, versus the data for 94,465 newborn 
infants, revealed a 5.1 % incidence of chromosomal abnormalities in infertile 
men: 3.8% involved sex chromosomes (see below) and 1.3% the autosomes. 
In newborn infants, the frequency of chromosome abnormality was 0.38%: 
0.14% involved sex chtomosomes and 0.25% autosome anomalies (Van 
Assche et aI., 1996). The comparison of a number of studies using diffetent 
cut-off values for inclusion of oligozoospermic males, indicates that an 
increase in the severity of spermatogenic dysfunction is concomitant with an 
increase in chromosome abnormalities. Three studies using 20x106 
spermatozoa pet ml as the cut-off value, obtained and average of 2.4% 
chromosomal abnormalities, compared to 6.6% for two other studies using a 
cut-off value of lOx] 06 sperm per ml (Van Assche et aI., 1996). A further 
increase in chromosomal abnotmality is observed in azoospermic individuals. 
In six studies of azoospermic men, an average of 13.7% chromosomal 
abnormalities was found (Van Assche et aL, 1996). The ratio between auto-
some and sex chromosome aberrations is different in azoospermic and 
oligozoospermic men: in the azoospermic men, sex chromosome abnormali-
ties predominate with an incidence of 12.6%, while in the oligozoospermic 
group autosome anomalies are most frequent with an incidence of 3% (Van 
Assche et aI., 1996). Thus, early observations indicating an invetse correlation 
between the incidence of chromosomal abnormalities and sperm count 
(Kjessler, 1966) are confirmed by many recent findings. 
Sex chromosome aneuploidies are a relatively frequent finding in infertile 
men. Most ftequent among these, is Klinefeltet's syndrome which has an 
incidence of about 11500 in the male population and 7-13/100 in 
azoospermic males. Ninety percent of men with Klinefeltet's syndrome have 
a 47,xxy karyotype, with the other patients having eithet a larger number of 
X chromosomes or some form of mosaicism (mostly 46XY/47,XXY). 
Practically all patients with Klinefelter's syndrome are infertile, with 
azoospermia and small firm testes. These testes show sclerosis and hyalini-
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zanon of the seminiferous tubules with absence of spermatogenesis (Vogt, 
1997a). 
Somewhat more rare is the occurrence of men with a 47,xyy karyotype 
(11750). These men are not always infertile. In pachytene spermatocytes of 
patients with a 47,XYY karyotype, an increased rate of YY bivalents are 
observed. This suggests disturbance of the XY sex body formation during the 
male meiotic prophase, and possibly explains the infertility in most of these 
men (Mak and Jarvi, 1996a; Vogt, 1997a). 
A very rare chromosomal aberration is the 45,xO male where the distal part 
of the long arm of the Y chromosome is lost, while the rest (including the 
SRYlocus) is translocated to an autosome, usually the short arm of one of the 
chromosomes 13, 15 or 22 (Vogt, 1997a). 
A group of microdeletions of the long arm of the Y chromosome, with 
subsequent azoospermia or severe oligozoospermia, has led to a search for loci 
that contain genes that are essential for spermatogenesis. On Yq 11 a region is 
now known to contain at least three loci that are involved in spermatogenesis, 
AZFa, AZFb and AZFc (AZF referring to azoospermia factor). Men with a 
deletion of AZFa have a Sertoli-cell-only syndrome; tubules contain only 
Sertoli cells, and no germinal cells at any stage of development can be found. 
Testis histology of men with an AZFb deletion is different, with a 
spermatogenic arrest at the spermatocyte stage, at the prophase of meiosis. In 
histological sections of testes from men with a deletion of AZFc, a pleitropic 
effect is found, with some tubules containing only Sertoli cells while other 
tubules contain germinal cells reaching various stages of development 
including (small numbers of) mature spermatozoa. The latter suggests a 
defect in post-meiotic maturation with variable penetrance (Vogt, 1997a). 
Genes located within the AZF regions will be discussed below. 
Genetic defects causing infertility as one of a number of pleitropic effects 
Although relatively rare in the andrology clinic, a large number of genetically 
determined clinical syndromes result in male infertility through a number of 
very different mechanisms. Generally, the syndromes can be grouped into: a) 
those causing spermatogenic defects, and b) those that have normal 
spermatogenesis, but result in anatomical or functional defects causing a 
disability to deliver sperm to the female genital tract (Mak and Jarvi, 1996a; 
Vogt, 1997 a). In Table 1, a summary of the known syndromes resulting from 
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a genetic defect and causing male infertility is displayed along with the 
Mendelian Inheritance in Man (MIM) reference number, obtained at 
http://www3.ucbi.ulm.nih.gov/Omim/.Itis nor our intent to extensively 
review all the mentioned aberrations; however, in prelude to Chapter 6, 
genetic defects resulting in impaired androgen receptor function will briefly 
be discussed. 
Androgen receptor dejects 
Initially recognised in 1937 by Petterson and Bonnier, dysfunction of the 
androgen receptor in a 46,XY individual results in the development of an 
external female phenotype with gynecomastia, but absent axilarry and pubic 
hair, and an internal phenotype with undescended testes, absence of uterus 
and ovaries, and a blind ending vagina. This condition was referred to as 
testicular feminization (Tfm) but is now more commonly known as complete 
androgen insensitivity syndrome (CAIS). As the gene coding for the 
androgen receptor resides on the X chromosome, the disorder is inherited in 
an X-linked recessive fashion. The frequency of occurrence of complete or 
incomplete AlS is about 1160,000 male births (Griffin and Wilson, 1989). 
Mutations resulting in either complete or partial androgen resistance 
syndromes have been identified in all exons (Brinkmann et aI., 1995; 
Brinkmann et aI., 1996). Mutations in exon 1, usually result in premature 
stop codons causing a highly truncated non functioning androgen receptor, 
and hence in complete androgen resistance. To date, only three missense 
mutations have been identified in exon 1 resulting in either a reduced 
translational efficiency or a slightly increased hormone dissociation rate 
(Choong et al., 1996; Gottlieb et aI., 1997). Many mutarions leading to a 
variety of phenotypes have been found in the hormone binding domain, the 
hinge region and the DNA-binding domain of the androgen receptor. 
Androgen resistance can be complete, with an invariable female psychosexual 
identity. Partial androgen resistance is associated with an extremely variable 
phenotype, including a predominant female external phenotype or individuals 
with ambiguous genitalia. 
A mild form of androgen receptor dysfunction, known as Reifenstein 
syndrome, displays a predominantly male phenotype with penoscrotal 
hypospadias, cryptorchidism and gynecomastia. The psychosexual identity of 
the latter patients vary, but is usually male. 
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Interestingly, some AR mutations do not result in a specific phenotype, since 
two individuals with the same mutation in the androgen receptor gene may 
well differ considerably in the degree of masculinization (Batch et al., 1993; 
Imasaki et al., 1994; Evans et al., 1997). No clear explanation has as yet been 
offered for rhis phenomenon, although receptor activity is probably 
influenced by orher factors such as androgen levels and co-factor expression. 
Furthermore the length of the polymorphic polyglutamine stretch in the 
NH2 terminal domain of the AR may also have a modulatory function on 
receptor activity (Jenster et aI., 1994). 
In addition to the -mild- Reifenstein syndrome, evidence exists that an even 
milder form of androgen resistance may exist in the form of infertile, 
otherwise fully androgenized, males. In 1979 Aimann et al. presented three 
unrelated infertile men with high serum LH and testosterone levels (Aiman et 
al., 1979). In all three men, genital skin fibroblasts contained a diminished 
amount of androgen receptor, indicating a mild form of androgen 
insensitivity syndrome. Subsequently, a quantitative analysis of androgen 
receptor from the scrotal skin of a number of infertile men with oligo-
zoospermia and azoospermia was compared to fertile controls (Aiman and 
Griffin, 1982). Using the lowest value found in normospermic males as a cut-
off, the above investigators found a staggering 40% incidence of androgen 
receptor deficiency in idiopathic azoospermic or oligozoospermic males. A 
later study (Morrow et aI., 1987) indicated a 19% incidence of androgen 
receptor defects in fully androgenized men with idiopathic oligozoospermia, 
largely corroborating the findings of Aimann and Griffin (1982). In a small 
group of infertile men, however, Eil et al. (1985) found no indication for a 
quantitative androgen receptor anomaly using pubic skin fibroblasts (Eil et 
aI., 1985). Bouchard et at. (1986) also found no evidence for a quantitative 
androgen receptor defect in genital skin fibroblasts of a group of 24 men with 
severe oligozoospermia (Bouchard et aI., 1986). The above-mentioned studies 
are clearly contradictory, and a serious flaw appears to be the lack of study 
pertaining to the molecular basis of the putative androgen receptor 
impairment. Molecular techniques were utilized in a report by Akin et al. 
(1991) who found one patient in a group of seven infertile males with a 
deletion of exon 4 (Akin et al., 1991). It is questionable, however, whether 
this relatively large deletion would result in such a mild phenotype, as much 
smaller deletions in exon 4 have resulted in complete ot partial androgen 
resistance. Yong et at. (1994) identified a mutation in exon 5 of the androgen 
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receptor of a man with oligozoospermia (Yong et a!., 1994). Whether the 
mutations found in these selected individuals are indeed cause of infertility 
remains to be elucidated. Interestingly, Tut et al. (1997) found a strong 
association between the risk of impaired spermatogenesis and the length of 
the polyglutamine stretch-encoding sequence in exon 1 of the androgen 
receptor (Tur et al., 1997). Men with 28 or more glutamine residues had 
more than a 4-fold increased risk of spermatogenic failure, while men with 23 
glutamine residues or less had a relative risk of 0.5 for hypospermatogenesis. 
In addition, the more severe the oligozoospermia, the higher the proportion 
of patients with a long polygluramine stretch (Tut et a!., 1997). 
Several of the reports described above, clearly indicate that a quantitative or 
qualitative defect in the androgen receptor may play a role in the 
pathogenesis of infertility in otherwise fully androgenized males. Much 
remains unclear, however. It may well be that a mild defect in the androgen 
receptor results in spermatogenic failure, because spermatogenesis requires a 
high testicular testosterone level, and Sa-reductase is largely absent in the 
testis (see Chapter 3). Also, one may postulate the existence of testis-specific 
co-factors which fail to function properly in case of certain AR mutations. 
Although the testis is the relevant target organ, in case of infertility related to 
subtle dysfunction of the androgen receptor, all of the above reports have 
studied either genital skin or pubic skin fibroblasts. In Chapter 6, we have 
studied the expression of androgen receptor in the testis of infertile men using 
immunohistochemistry. An immunohistochemical investigation of the 
androgen receptor will generate quantitative rather than functional data. 
However, expression of the androgen receptor may in many instances be 
dependent on its function. Based on rat studies (Chapter 2), it can be 
postulated that an androgen receptor defect, particularly in the hormone-
binding region, however subtle, might result in decreased stability of the 
receptor protein. In the studies described by Aimann and Griffin (1982) and 
Morrow et a!. (1987), clear quantitative differences in androgen receptor 
expression in fibroblasts were noted in fertile men, as compared to a number 
of infertile men. Possibly such a difference would more pronounced when 
testis tissue is investigated. 
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Defects in 11 spermatogenesis genes n 
As explained in Chapter 1, spermatogenesis is a unIque process, encom-
passing mitotic divisions, meiotic prophase and divisions, and spermio-
genesis. This series of events, as well as many of the proteins and enzymes 
required for rhis process, are regulated by a number of genes expressed only in 
the tesris. Muration or deletion of anyone of rhese genes may result in 
decreased fertility without any other phenotypic manifestation. At the 
present time, a considerable number of these genes have been found, but 
many more remain to be identified. In addition, with the exception of genes 
within the AZFa/bl c loci, none are known to contribute significantly to the 
male infertility case-load. There is a large effort to elucidate the genetic 
control of spermatogenesis, with particular consideration for testis-specific 
genes. Most of the knowledge so far has been attained with the use of mouse 
models, which involve knockout of both alleles of one or more genes. 
Endeavouts to find mutations in the homologous human genes in the 
infertile male population, however, have been tediously unfruitful. Evidently, 
human male infertility may involve multigene defects. 
Testis-specific genes 
Spermatogenesis is highly dependent on the presence of a Y chromosome, 
and regions have now been identified that contain genes that are essential for 
male fertility. First and foremost, the SRY gene is located on the short arm of 
the Y chromosome very near the pseudo-autosomal region, and the timely 
expression of this gene in the early embryo is essential for testis determination 
and subsequent development of the male phenotype (Gubbay et aL, 1990; 
Sinclair et aL, 1990; Koopman et al., 1991). The three regions identified on 
Yq 11 (AZFa/b/c; see above) contain a number of genes that appear to playa 
vital role in spermatogenesis (Vogt et aL, 1996a; Vogt, 1997a). AZFa contains 
the Drosophila fot focets-related Y gene (DFFRy) which has an X chromo-
somal homologue (DFFRX) (Jones et aL, 1996). DFFRX encodes a 
deubiquinitination enzyme, which releases the ubiquitin peptide chain from 
ubiquitinated proteins. The precise role of DFFRYin spermatogenesis has yet 
to be established. AZFb contains the multicopy gene REM, encoding a 
protein with a ribonucleic acid binding motif (Vogt et aL, 1996). RBM is 
expressed in the nuclei of pre-meiotic germ cells, and the encoded protein is 
probably involved in metabolism of newly synthesised RNA at that stage of 
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spermatogenesis (Najmabadi et at., 1996a; Elliot et al., 1997a; Vogt, 1997a). 
No mutations in REM genes have yet been found in relation to male 
infertility, and the AZFb region may contain other genes, which also playa 
tole in spermatogenesis. AZFc contains genes of the DAZ (deleted in 
azoospermia) family (Vogt et al., 1996). Like REM, DAZ is a multicopy gene 
encoding RNA binding protein, and its protein ptoduct has been found in 
late spermatids and in sperm tails (Vogt et al., 1996; Habermann et al., 
1998). The function of DAZ, however, is not known. Some men with 
deletions in the AZFc region can produce mature spermatozoa and procreate 
(Terada and Hatakeyama, 1991b; Vogt, 1997b). In the mouse, the DAZ-
related autosomal gene Dazla is essential for both male and female 
gametogenesis (Ruggiu et at., 1997). 
During the meiotic prophase, the X and Y chromosomes condense and 
become transcriptionally inactive, forming the so-called sex body (Monesi, 
1965). Although most, if not all, of the Y-chromosomal genes are reactivated 
in spermatids, this is not the case for many X-chromosomal genes (Eddy et 
al., 1993; Hendriksen et at. , 1995; Grootegoed, 1996). Interestingly, enzymes 
encoded by a number of genes on the X chromosome lPgk-l (phospho-
glycerate kinase) and Pdha-l (Ela-subunit of pyruvate dehydrogenase)] and 
taking part in the energy-yielding machinery of somatic cell types, appear to 
be replaced during spermatogenesis by specific isoenzymes encoded by 
autosomal genes (Kramer, 1981; Takakubo and Dahl, 1992; Hendriksen et 
al., 1997). These autosomal genes (Pgk-2 and Pdha-2) are intronless 
retroposons which have originated from reverse transcribed mRNA, and 
which are functional both in mouse and human (Boer et at., 1987; McCarrey 
and Thomas, 1987; Dahl et at., 1990). For the mouse, a similar switch from 
G6pd-1 to G6pd-2 (glucose 6-phosphate dehydrogenase 1 and 2, 
respectively) has been reported (Hendriksen et at., 1997). A number of other 
genes (glyceraldehyde 3-phosphate dehydrogenase, lactate dehydrogenase 
subunits and, cytochrome c), situated on autosomes, are also silenced during 
the meiotic prophase and their gene products are substituted for by germ cell-
specific activation of alternate autosomal genes (see Grootegoed, 1996; Eddy, 
1998). A mutation in any of the genes encoding for these testis-specific 
isoenzymes may result in male infertility without any other phenotypic 
abnormality, but no such muration has yet been found in the human infertile 
male population. 
Interaction ofligand-activated gonadotropin receptors with G protein, which 
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modulates adenylyl cyclase activity, results in an increase in the intracellular 
level of cAMP. Regulation of transcription of certain genes is under the 
influence of cAMP, through the binding of activated cAMP-response element 
(CRE)-binding proteins with CRE-elements associated with promoter 
regions of these genes (Monaco and Sassone-Corsi, 1998). A number of 
CRE-binding proteins have been identified, including transcription activa-
tors (CREB, CREM, and ATF-I) and transcription repressors [i.e. inter-
leukin-I ~-converting enzyme repressor (ICER)]. In the adult testis, a high 
level of CREM, (a testis-specific CREM splice variant) has been identified 
(Monaco and Sassone-Corsi, 1998). Western blot and immunohistochemical 
studies have located the expression of the CREM, protein specifically in 
round spermatids (stages VII-VIII in the mouse and stages I-III in man), 
although CREM transcripts are identifiable as early as the pachytene 
spermatocyte stage, implicating a translational control mechanism (Monaco 
and Sassone-Corsi, 1998; Weinbauer et aL, 1998). The importance of 
CREM, in spermatogenesis is illustrated by a knockout mouse model, where 
female mice homozygous for the inactivated gene are phenotyically normal, 
but heterozygous males have a clear deficiency in spermatogenesis. Male 
knockout mice are infertile showing developmental arrest of spermatogenesis 
at the early spermatid stage, without any other somatic phenotypic 
abnormality (Blendy et al., 1996; Nante! et aL, 1996). The relevance of 
CREM in human spermatogenesis is suggested by studies showing reduced 
immunoexpression of CREM protein in round spermatids of male infertility 
patients with round spermatid maturation arrest (Weinbauer et aL, 1998). 
Among the post-meiotic germ cell-specific processes, is the condensation of 
rhe sperm nucleus. This condensation involves the removal of nuclear 
histones, which are first replaced by transition proteins and later by prota-
mines, resulting in a highly compacr nucleoprotein complex (see Chapter I). 
This histone-to-protamine transition requires considerable protein synthetic 
capabilities along with prodigiously efficient processing and breakdown of 
proteins. The molecular ll1echanisms for removal of hisrones and transition 
proteins are largely unknown. Undoubtedly the signal to remove and degrade 
the histones and later the transition proteins is preceded by some form of 
posttranslational modification, such as the known hyper-acetylation of H4 
(Meistrich et aL, 1992). One other form of modification that may be 
involved in the removal and degradation of spermatid nuclear proteins is 
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Clinical syndrome 
Alpha thalassemia (ATRX) 
AMH resistance I 
A1'v1H resistance II 
Androgen resistance syndromes 
Barde(t-Biedl Syndrome 
Campomelic dysplasia 
Cystic fibrosis 
Congenital absence of the vas deferens 
Corticol steroid deficiency 
Dystrophia myoconica 
Dose sensitive sex (DSS) 
BPES syndrome 
Fanconi syndrome A (FACA) 
Fanconi syndrome B (FACB) 
Fanconi syndrome C (FACC) 
Fanconi syndrome D (FACD) 
Fanconi syndrome E (FACE) 
FSH receptor dysfunction 
Fragile X syndrome 
Garlin syndrome 
Hanhart syndrome 
Hutchinson-Gilford-Progeria syndrome 
Kallman I 
Kartagener syndrome 
Male pseudohermaphroditism 
Leopard syndrome 
LH recepcor dysfunction 
Nonnc-Milroy-Meige syndrome 
Noonan syndrome 
Opitz syndrome 
Prader-Willi syndrome 
Prune belly syndrome 
Rieger syndrome Type 2 
Robinow syndrome 
Rothmund-Thomson syndrome 
Russell-Silver syndrome 
Sex reversal (Y-linked) 
Stein-Leventhal syndrome 
Werner syndrome 
Wilms tumors 
Young syndrome 
~----­
* Mendelian Inheritance in Man 
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MIM* 
Chromosomal Position Ref. Number 
Xq13 301040 
19pI3.3-pH2 261550 
12ql3 261550 
Xq12 300068 
16q21 209900 
17 q24.3-q25.1 211790 
7q31.2 219700 
7q31.2 277180 
9q33 184757 
17q 13.2-q 13.3 160900 
Xp21 300200 
3q22-q23 110100 
16q24.3 227650 
9q22.3 227646 
3p 
600901 
136435 
Xq27.3 309550 
119500 
262600 
176670 
Xp22.3 308700 
244400 
2p23 264600 
151100 
152790 
153000 
12q22 163950 
22ql1.2 145410 
15qll 176270 
100100 
13q14 601499 
180700 
8 268400 
17q25 180860 
Ypl1.2 480000 
184700 
8pI2-pl1.2 308700 
IIp 194080 
279000 
Spermatogenic disO/ders 
ubiquitination. Ubiquitin is a highly conserved 76 amino acid protein that 
can be covalently attached to ptoteins through a process tequiting a number 
of steps and enzymes, including ubiquitin-activating (El) enzymes (such as 
Ubelx and Ubely), ubiquitin-conjugating (E2) enzymes (such as mHR6A), 
and ligating (E3) enzymes (5cheffner et al., 1995). Ubiquitination of proteins 
is involved in protein (re)folding, in protein degradation, and in the 
endocytotic pathway of integral membrane proteins. Poly-ubiquitinared 
proteins are degraded by 265 proteasomes (Varshavsky, 1997). Most likely, 
protein ubiquitination is of much importance for protein degradation in 
. . 
spennlOgeneSlS. 
The testis clearly is a specialised organ, also when it comes to the ubiquitin 
pathway of protein metabolism. A number of ubiquitin-conjugating enzymes 
have increased, or even exclusive, expression in the testis. These include 
HR6A and HR6B, E2
,7kb, hUBC9, and UbcH-ben (see Baarends et a!., 
1998). In addition, microdeletion of a region of the Y chromosome (AZFa) 
involving DFFRY, a gene encoding putative deubiquitination enzyme, results 
in male infertility (Jones et a!., 1996; Vogt, 1997). 
The importance of ubiquitination of testicular proteins in spermatogenesis 
was recently illustrated using a knockout mouse model in which the 
ubiquitin-conjugating enzyme mHR6B was inactivated (Roest et al., 1996; 
Grootegoed et a!., 1998). The mHR6B gene is one of the mouse homologs of 
RAD6, found in S. cerevisiae (budding yeast) where its gene product is 
involved in a number of processes including postreplication DNA repair and 
sporulation (Lawrence, 1994). RAD6 null mutants exhibit cell cycle 
perturbance, temperature-sensitive growth, inability ro sporulate, and 
increased retrotransposition (Lawrence, 1994). RAD6 has been shown to 
mono- and polyubiquitinate histone 2A and histone 2B in vitro (Jentsch et 
a!., 1987). The yeast RAD6 and mammalian HR6B proteins are highly 
conserved, sharing about 70% amino acid sequence identity. One hundred 
percent homology is observed between mouse mHR6B and the human 
homologue hHR6B, suggesting a highly conserved and evolutionary 
important functional activity (Koken et a!., 1991; Koken et a!., 1996). The 
male mice that were homozygous for the inactivated mHR6B gene had a 
normal phenotype, with apparently no increased sensitivity to mutagens 
(possibly because of a functional redundancy of mHR6B and mHR6A 
proteins). However, the mHR6B knockout males appeared to be infertile. 
Upon closer scrutiny, spermatogenesis appeated to progress normally during 
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the beginning of the first wave of germ cell development, until the germ cells 
arrived at the post-meiotic stages when the spermatid nuclei should start to 
condense. At that point, a profound derailment of spermatogenesis starts to 
occur, with variable loss of the germinal epithelial architecture. Although all 
mHR6B knockour males were found to be infertile, the epididymides of most 
of these mice contained a small number of morphologically abnormal sperm. 
Two-dimensional Western blot analysis has shown that mouse elongating 
spermatids and spermatozoa containing a relatively low mHR6A protein level 
relative to that of mHR6B. This has not been found in any other mouse 
tissue. As a result, knockout of mHR6B will result in a more than 50% 
reduction of total mHR6A+mHR6B protein, in spermatids. 
Screening of men with unexplained infertility for hHR6B murations at our 
Andrology Clinic,thus far yielded no abnormalities (Roest et aL unpublished 
results). 
It is well known that about 15% of the basic nuclear protein in human sperm 
are his tones (Tanphaichitr et ai., 1978), possibly indicating an inherent 
ilnperfection of histone-to-protamine transition during human spermato-
genesis. We have tried to identifjr human testis-specific histone 2B, using a 
monoclonal antibody raised against tyrosine hydroxylase, which was 
previously shown to crossreact with rat TH2B (Unni et ai., 1995). 
Subsequently, TH2B content in the spermatozoa of a number of infertile 
men was estimated, to elucidate if indeed the amount of residual histone in 
spermatozoa might represent a measure of some form of spermatogenic 
derailment (Chapter 7). 
Non-genetic causes of male infertility 
Endocrine disruption/stress 
The hypothalamus-pituitary-testis axis is of paramount importance for the 
development, initiation and maintenance of spermatogenesis (see Chapter 2). 
The hormones that are secreted by the fetal testis (anti-Mullerian hormone 
and testosterone) regulate the development of the male excretory ducts, the 
involution of the female duct system, and are probably important factors in 
testis descent. Furthermore, testosterone and its reduced metabolite 
dihydrotestosterone are essential for the differentiation of the male external 
genitalia and other sex characteristics (Hunter, 1995). Any external hormonal 
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influence that disrupts this homeostasis will inevitably affect the male 
reproductive system. Over the last number of years, a great deal of concern 
has been raised with respect to the possible decline of human sperm cOUnts 
and dysregulation of reproductive organ development and function (Carlsen 
et aI., 1992; Auger et aI., 1995). Although the debate whether the analysis is 
accurate is far from over, in particular for sperm counts, theories have 
emerged that may explain the possible dysregulation of sex differentiation 
and reproductive function (Sharpe and Skakkebaek, 1993). Of primary 
importance in these theories is the almost ubiquitous presence of estrogenic 
compounds in the environment. Whether the source is in plants 
(phytoestrogens), in dairy milk, or from estrogenic chemicals, estrogenic 
compounds may have a profound effect on the male fetus. Exogenous 
estrogenic compounds can be more active than endogenous estrogens, due to 
low metabolism and low protein binding. The fetal pituitary is highly 
sensitive to oestrogen, and stimulation will cause a decline in LH and FSH 
secretion. The decline in FSH may exert a negative effect on Sertoli cell 
development and the secretion of anti-Mullerian hormone, while the lower 
level of LH will result in lower testosterone secretion (Sharpe and 
Skakkebaek, 1993). Both these influences may cause impaited development 
of the testes and accessory sex organs. A lower fetal testosterone level may also 
be of importance in the pathogenesis of hypospadia. Indeed, male children 
who were exposed in utero to the synthetic oestrogen diethylstilbestrol (DES) 
appeared to have a higher incidence of cryptorchidism and hypospadias, and 
also decreased semen volume and sperm counts (Stillman, 1982), although 
this is not supported by all publications (Wilcox et ai., 1995). In addition, a 
higher maternal oestrogen level appeared to be linked to the incidence of 
cryptorchidism (Depue, 1984). 
In adult life, men may come into contact with a number of chemicals that 
have a hormonal or anti-hormonal action, such as p,p cODE, a metabolite of 
DDT, which is a potent androgen receptor antagonist (Kelce et aI., 1995). 
The most frequent source of exogenous hormone action in young adult 
males, however, is the use of anabolic steroids to enhance physical appearance 
and performance. Anabolic steroids are potent inhibitors of pituitary LH and 
FSH secretion, resulting in a dramatic fall in testicular testosterone 
production and inhibition of Sertoli cell function. Spermatogenesis is, as a 
result, negatively affected (Lloyd et aI., 1996). Cessation of the use of 
anabolic steroids will result in spontaneous restoration of fertiliry (Lloyd et 
ai., 1996; Gazvani etal., 1997). 
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Stress as a result of overtraining in men supptesses the hypothalamus-
pituitary-gonadal axis, causing a drop in serum testosterone level, and a 
decrease in sperm concentration, together with an increment of serum 
cortisol and prolactin (Doh Ie et ai, 1998; Weber, 1998). In addition to 
physical stress, psychological stress as a result of psychiatric disorders, death 
sentence or combat stress have also been shown to be detrimental to male 
reproductive function (Amelar et ai., 1977; Moghissi and Wallach, 1983). It 
has been shown that during exposure to stressful conditions, an overactivity 
of the hypothalamic pituitary adrenal axis results in an increase in cortico-
tropin-releasing factor (CRF) , pro-opiomelanocortin (POMC) , adreno-
corticotropin (ACTH) and ~-endorphin. Stress-induced hypogonadism may 
result from suppression of gonadotropin-releasing hormone (GnRH) by 
increased release of POMe, which in turn may result from a higher CRF 
level (Rivier and Rivest, 1991). The role of prolacrin in stress-induced 
hypogonadism is unclear, although prolactin has been shown to be a potent 
upregulator of CRF secretion (Weber and Calogero, 1991; Calogero et ai, 
1993). 
Non-hormonal toxins 
As our knowledge of male teproductive dysfunction broadens, so does the list 
of chemicals that are known to be detrimental to male reproductive health 
(Chatterjee and Ralph, 1998). Environmental agents include a long list of 
pesticides, herbicides, rodenticides, fungicides, fumigants and sterilants. 
Food contaminants, industrial chemicals, and other factors including tobacco 
smoke, alcohol, and radiation, have been implicated. Furthermore, a large 
numbet of antineoplastic agents are also highly toxic to the male germinal 
epithelium. A number of drugs that primarily act on the nervous system such 
as anaesthetic gases, anti Parkinson drugs, appetite suppressants, opioids, 
neuroleptics, tranquillizers and anti-adrenergic drugs have been shown to 
cause damage to male reproductive capacity. Othet drugs, including 
antibiotics, diuretics, and gout-suppressants, are also included in the list. It is 
not our intention to provide a cOlnprehensive overview of allinale gonado-
toxic agents in this thesis; the reader is refetred to reviews on the subject 
(Schrader, 1992; Brinkworth and Handelsman, 1997; Chatterjee and Ralph, 
1998). Wbether the use certain medications or exposure to gonadotoxic 
chemicals actually contributes significantly to the male infertility case-load, is 
presently not certain. 
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Trauma to the testis and inftction 
Disruption of the anatomic and histological integrity of the male 
reproductive system, is a situation that is often encountered in the andrology 
clinic. Torsion of the testis results in an acute hypoxic state of the testis, that 
will cause irreversible damage to the seminiferous epithelium within hours of 
onset, if not immediately surgically corrected (Turner and Brown, 1993; 
Carroll et a/., 1997; Rajfer, 1998). Invasion of micro-organisms into the testis 
not only causes an acute inflammatory reaction which by itself is detrimental 
to spermatogenesis, but may eventually result in distuption of the integrity of 
the testicular structure. In particular, disruption of the Sertoli cell barrier 
within the seminiferous tubuli (as caused by trauma or inflammation due to 
the mumps), but also damage of the excretory ducts (as in vasectomy and 
vasectomy reversal), by any traumatic cause, will bring the immune system of 
the male in contact with germ cell antigens. Many antigens of meiotic and 
post-meiotic germ cells are not found on any somatic cell type or on pre-
meiotic germ cells. Because these antigens are first expressed during puberty, 
the immune system recognises developing germ cells as foreign. Exposure of 
germ cell antigens to the immune system may thus cause an immune 
response, and, subsequently, the production of anti-sperm antibodies. The 
association of anti-spetm antibodies with the sperm membrane may result in 
impaired cervical mucus penetration, premature acrosome reaction, 
impairment of zona binding, or fertilisation failure. (Turek and Lipshultz, 
1994; Sigman and Howards, 1998). An inflammatory reaction within any 
part of the male reproductive tract will also result in local accumularion of a 
large number of white blood cells. In particular the polymorphic neutrophils 
generate large amounts of reactive oxygen species (ROS) that are detrimental 
to the integrity of spermatozoa (Wang et al., 1997). Spermatozoa are very 
poorly equipped to withstand damage caused by ROS. Sperm membranes 
contain a high level of polyunsaturated fatty acids which are extremely 
susceptible to peroxidation, and spermatozoa have a very limited capacity to 
repair damage caused by ROS (Sharma and Agarwal, 1996). Although in 
healthy males the luminal fluid in the epididymis serves to protect the 
spermatozoa against ROS damage, inflammation of the male accessory sex 
organs, and infiltration of the seminal fluids with leukocytes will cause 
extensive damage to the spermatozoa and to their DNA content, by ROS 
action. 
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Heat 
The scrotal position of the testis, as opposed to an intra-abdominal position, 
results in a testicular (and epididymal) temperature that is about two 
centigrade below body temperature (Mieusset and Bujan, 1995). The testis is 
extremely temperature sensitive, and a slight elevation of testis temperature 
will result in massive derailment of spermatogenesis. In addition to the testis, 
the epididymis also apparently is dependent on slightly lower-than-body 
temperatures for adequate function (Bedford, 1978; Bedford and 
Yanagimachi, 1991). Any condition that causes an increase in testis tem-
perature will result in a deterioration of spermatogenesis and male fertility, as 
is elegantly illustrated by experiments requiting men to wear special retainers 
which held their testes in an inguinal position for varying amounts of time 
(Mieusset and Bujan, 1994). In addition, it has been shown that tight fitting 
underweat can negatively affect sperm counts. Clearly, scrotal temperature is 
one of the confounding factors in the discussion on declining semen 
patameters during the last 50 yeats. 
The incidence of varicocele is telatively high in the male sub fertile popula-
tion, and may be an important (co)factor in causing maie subfertility (Aafjes 
and van der Vijver, 1985; Marks et al., 1986). Although other theories exist as 
to the influence the presence of a varicocele may have on testis function, it 
has been shown that varicocele tesults in a higher scrotal temperature, 
particularly in standing position when the cooling effect of the scrotum is 
greatest (Lerchl et aI., 1993; Hargreave, 1997). Men with a varicocele may 
have progressively deteriorating testis function, that may only be partially 
restorable upon ligation of the spermatic vein (Hatgteave, 1997). Although it 
has now been shown that spermatic vein ligation will tesult in improved 
semen parameters (Pierik et aL, 1998), it remains to be elucidated whether 
this procedure will actually improve male fertility. 
A non-scrotal position of the testis, as in cryptorchidism or retentio-testis, 
will cettainly result in a higher testis tempetature and poor spermatogenesis. 
Men with bilateral cryptorchidism who bave undetgone bilateral orchidopexy 
in early childhood have a high incidence of infertility, indicating that high 
testis temperature in childhood affects later fertility, and/or that an inherent 
defect in the fetal testis caused both maldescent and a spetmatogenic defect, 
through unrelated mechanisms (Rajfer, 1998). 
Fever as a tesult of any ailment has been shown to have a rapid and 
devastating effect on spermatogenesis, to the point of azoospermia (Mac-
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Leod, 1951; Burch and Havlovec, 1991). Because the effect offever on sperm 
counts can be observed only days after its onset, it is highly likely that fever is 
equally detrimental to the epididymis as it is to the testis. 
In the following chapters, two facets of human infertility are studied. First, to 
ascertain the involvement of deregulated AR expression in male infertility, the 
immunoexpression of androgen receptor in the testes of subfertile males is 
explored. Subsequently, the effect of spermatogenic impairment upon sperm 
nuclear histone composition is studied, using an antibody targeting testis-
specific histone 2B in the human testis. 
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Chapter 2 
Abstract 
The localization and intensity of androgen receptor immunostaining was 
studied in the testes of thirty-seven subfertile men with oligozoospermia and 
normal serum gonadotropin levels, using a polyclonal antibody raised against 
a synthetic peptide corresponding to the first 20 N-terminal amino acid 
residues of the androgen receptor (AR). Furthermore, we investigated 
whether or not the immunoexpression of the AR in human Sertoli cells, in 
histologically normal testis tissue, is dependent on the stage of the spermato-
genic cycle, as has been found in the rat. In the human testis, AR immunoex-
pression was observed in Sertoli cells, peritubular myoid cells, Leydig cells, 
and periarteriolar cells, but not in germinal cells. We found no evidence for a 
stage dependent immunoexpression of AR in Sertoli cells. The intensity of 
AR immunoexpression varied substantially between biopsy specimens of 
different patients. There was, however, no correlation of the intensity of AR 
immunoexpression in either Sertoli cells or peri tubular myoid cells with 
spermatogenic adequacy as measured by the method of Johnsen. When, in 
this study, the intensity of peritubular myoid cell staining was used as a 
standard to evaluate the intensity of Sertoli cell staining, also no correlation 
was detected. Furthermore, serum gonadotropin levels were not correlated 
with AR immunoexpression levels in Sertoli cells and peri tubular myoid cells. 
These results indicate that immunodetectability of the AR is not related to 
the condition of the spermatogenic epithelium in patients with oligozoo-
spermia. Inappropriate expression of the AR is neither a cause, nor a 
consequence of idiopathic infertility in the present group of patients. 
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Introduction 
Male factor subfertility is a frequent clinical problem (Greenhall and Vessy, 
1990). A number of conditions affect spermatogenesis, such as a hisrory of 
cryptorchidism, an infection, the presence of a varicocele, an abnormal 
karyotype, pituitary lesions, systemic disorders, and iatrogenic damage to the 
testes (World Health Organization, 1987). Also, subfertility in the presence 
of normal spermatogenesis can be found, in case of an obstruction, or an 
immunological condition, sexual inadequacy, or retrograde ejaculation. There 
remains, however, a large number of males in whom no cause for their subfer-
tility is apparent (idiopathic infertility). One group of patients with 
idiopathic male infertility may have defective spermatogenesis caused by 
inadequate androgen receptor (AR) function; it has been suggested that 
functional impairment of the AR due to certain mutations might be 
associated with spermatogenic defects in normally virilized males (Aiman et 
aI., 1979; Aiman and Griffin, 1982; Akin et al., 1991), although this remains 
a point of discussion (Bouchard et aI., 1986). Some forms of insufficient 
androgen action may become apparent only in the testes. 
Recently, well-characterized antisera targeting the AR have become available. 
Studies in rats have demonstrated that the immunodetectability of the AR in 
the testis decreases under conditions oflow androgenic stimulation (Bremner 
et al., 1994). We argued that if idiopathic male infertility is associated with an 
impaired androgenic stimulation of the Sertoli cells, low levels of AR 
immunoexpression would be observed herein. 
Previous studies have specifically located the human testicular AR in the 
nuclei of Sertoli cells, peritubular myoid cells, Leydig cells, and fibroblasts 
(Takeda et al., ] 990; Ruizeveld de Winter et aI., 1991; Iwamura et al., 1994). 
One report described AR immunoexpression also in germ cells (Kimura et aI., 
1992). In rat Sertoli cells, AR immunoexpression is dependent on the stage of 
the spermatogenic cycle (Bremner et aI., 1994; Vornberger et aI., 1994). 
However, no report on a possible cyclic pattern of Sertoli cell AR 
immunoexpression in the human testis is presently available. 
This study was designed to retrospectively investigate the intensity of AR 
immunoexpression in Sertoli cells and peri tubular myoid cells in relation to 
the quality of spermatogenesis, in biopsy specimens of subfertile males. 
Attention was paid to AR immunoexpression in Sertoli cells in histologically 
normal testis tissue, to ascertain whether or not AR immunoexpression varies 
with the stages of the spermatogenic cycle. 
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Materials and Methods 
Biopsy specimens 
Thirty-seven recent testicular biopsy specimens were collected in the period 
1989-1993, from men who visited our andrology outpatient clinic because of 
male factor subfertility. All men had an uneventful history, a normal physical 
exam (including ultrasonography for varicocele), repeated oligozoospermia 
«20xlOG sperm/mI), and normal serum FSH, LH, and testosterone levels. 
Biopsy specimens were scored using the method described by Johnsen (1970) 
as modified by Aafjes et al (1978). Tubular cross sections were given score 
numbers from 1 to 10 depending on the most advanced stage of 
spermatogenesis observed. Per tubule, a score of 10 was given for complete 
and abundant spermatogenesis; 8 for when all stages of spermatogenesis were 
present, but fewer than 5 condensed spermatids were seen; 7 for no 
condensed, but many round spermatids present; 6 for no condensed 
spermatids, and less than five round spermatids present; 5 for no spermatids, 
but many spermatocytes present; 4 for no spermatids and fewer than five 
spermatocytes present; 3 for when only spermatogonia were present; 2 for 
Sertoli cells only; and 1 for no cells in tubular section. The mean score, of 100 
tubules, was calculated for each sample. Immunohistochemical analysis of 
these biopsies was performed in 1994. 
Immunohistochemistry 
All biopsy specimens were fixed in Bouin's solution, dehydrated in ethanol, 
cleared in xylene, embedded in paraffin and stored at room temperature. 
Since, during routine processing, biopsy material is immersed in Bouin's fix-
ative for periods ranging from one to three days, immunohistochemical 
analyses of AR was performed on a fresh biopsy sample that was divided into 
three pieces, immersed in Bouin's solution for 24, 48 and 72, hours and 
subsequently routinely processed to assess if prolonged immersion in Bouin's 
fluid has a significant effect on AR immunoexpression. 
The primary antibody (SPI97) is a rabbit polyclonal raised against a synthetic 
peptide corresponding to the first 20 N-terminal amino acid residues of the 
human androgen receptor. Its use as a valid immunological probe for human 
AR has recently been established. 
Five ~m thick sections were mounted on 3-aminopropyltriethoxisilane 
(Sigma, St Louis, MO) -treated slides, deparaffinized and rehydrated. 
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Endogenous peroxidase was blocked by a 20 min incubation in 3% (v/v) 
H 20 2 in methanol. An antigen tetrieval step was performed by heating the 
sections, immersed in O.OIM citric acid monohydrate (Merck, Germany) at 
pH 6.0, for 3 x 5 min in a 700W microwave oven. The material was left to 
cool down to room temperature, after which the slides were washed in 
phosphate-buffered saline (PBS) and placed in a Sequenza immunostainer 
(Shandon, The Netherlands). Non-specific antibody binding was blocked by 
a 15 min incubation with normal goat setum (Dako, The Netherlands) 
diluted 1: 10 in 5% (w/v) bovine setum albumin (BSA). The ptimary 
antibody (SPI97), diluted 1 :4000 in 5% (w/v) BSA, was applied for 
overnight incubation at 4C. Sections were rinsed with PBS, and were 
subsequently incubated with biotinylated goat anti-rabbit antibody (Daleo, 
The Netherlands) diluted 1 :400 in PBS, for 30 min, streptavidin-biotin-
peroxidase complex (Daleo, The Netherlands) for 30 min, and 3,3'-
diaminobenzidine tetrahydrochloride (Flub, Getmany) for 7 min, at room 
temperature. Between incubations, sections were rinsed three times with PBS. 
Counterstaining was performed with Mayer's hematoxylin (15 sec). All slides 
were evaluated with a Zeiss Axiosleop 20 light microscope. Controls included 
incubarion with no primary antibody (5% (w/v) BSA in PBS) or with pre-
Immune serum. 
Estimation of intensity ofimmunostaining 
AR immunoexpression in Serroli cells and peri tubular myoid cells was 
evaluated using two methods. First a general score was given for AR 
immunoexpression in Serroli cells and peritubular myoid cells in the sample 
as a whole. A score of 0, 1 ,2, or 3 was assigned for absent, low, medium, or 
high expression, respectively. Subsequently, maximal intensity of AR 
immunoexpression in Sertoli cell and peritubular myoid cell nuclei was 
evaluated semiquantitatively in ten tubules per biopsy. A false impression of 
AR immunostaining in parrs of the testes might be obtained, if its intensity is 
influenced by the stage of the spermatogenic cyle. A, a single cross section of a 
human tubule teveals 3 or 4 stages of the spermatogenic cycle (Schulze and 
Rehder, 1984), scoring the maximal intensity of AR expression per tubule 
might provide a more reliable measure than scoring the mean intensity. Per 
tubule, expression was scored as 0,1,2, or 3 for: no visible AR expression, faint 
AR expression, moderate AR expression, and strong AR expression, 
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respectively. The score per sample was calculated as the sum of the scores of 
ten tubules for each cell type. 
In analyzing our results, we chose two approaches: one was to specifically 
compare AR immunoexpression from patients with Johnsen scores of 8.0 and 
higher with those from patients with lower scores. Biopsy scores of 8.0 or 
higher correlate with a relatively high pregnancy rate, whereas scores below 
8.0 correlate with a very poor rate of pregnancy (Aafjes et aL, 1978). In 
addition, we searched for correlations between AR immunoexpression in 
Sertoli cells and peritubular myoid cells with the respective Johnsen scores 
and a number of clinically relevant parameters. 
Statistics 
All statistical calculations were performed using SPSS software (version 6.0 
for Windows). The relationship between the quality of spermatogenesis and 
intensity of AR immunoexpression was evaluated according to Spearman's 
rank correlation. The significance of differences between groups was 
determined by Wilcoxon's signed rank test. 
Results 
Immersion of the biopsy sample in Bouin's solution for a period of 24 to 72 
hours did not affect the intensity of AR immunoexpression in the testis. In 
testis with a biopsy score of 8.0 or higher, AR immunoexpression was specifi-
cally found in the nuclei of Sertoli cells, peri tubular myoid cells, Leydig cells, 
and cells associated with arterioles (Figure I). We found, however, no AR 
immunostaining in any type of germinal cell. A similar localization of AR was 
found in tissues with severely impaired or absent spermatogenesis (Figure 2). 
Some variation in the intensity of the immunostaining of AR in Sertoli cells 
was observed. This variaton was, however, not associated with the stage of the 
spermatogenic cycle. In histologically normal testis tissue, all 6 stages, as iden-
tified by Clermont (1963), were found, on average, to express the AR in equal 
abundance (Figure I). Some random variation in AR immunoexpression was 
also found in Leydig cells and, to a lesser extent, in peritubular myoid cells. 
In our group of patients, thirteen patients (35%) had a Johnsen score below 
8.0, and 24 patients (65%) scored an 8.0 or higher. As shown in Table I, LH, 
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FSH, and testosterone levels were not significantly different between the two 
groups. A comparison between the biopsy scores and the intensity of AR 
immunostaining in Serroli cells, as estimared by the general and the 
semiquantitarive analysis, revealed no difference (Table 2). The intensity of 
immunoexpression of AR in peritubular myoid cells is also similar in the two 
groups, using both scoring merhods. No correlation between the intensity of 
AR immunoexpression in Serroli cells or peri tubular myoid cells and the 
Johnsen score, and a number of clinically relevant parameters, was found 
(Table 3). There is clearly a very heterogeneous picture, with AR immu-
noexpression in Serroli cells varying widely in biopsies with both high and 
low Johnsen scores (Figure 3). It is imporrant to note that we found a 
significant correlation between the intensities of AR immunoexpression in 
peri tubular myoid cells and Serroli cells. Eventhough all sections were iden-
tically processed during a single experiment, a certain amount of variation in 
accessability of the tissue to antibodies may have occurred. Because our 
interest involving AR expression in the idiopathic subfertile male involves 
especially rhe AR in Serroli cells, we used the peritubular myoid cell AR 
immunoexpression as a srandard againsr which Serroli cell AR immuno-
expression was measured. This was done by subtracting rhe peritubular myoid 
Figure 1. Testis section showing normal spermatogenesis. The stages of the cycle of the seminiFerous 
epithelium are indicated by roman numerals. Sertoli cell nuclei, heavily stained with SP197 (*) 
were encountered in all epithelial stages. (bar corresponds to 25 )..lm). 
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Figure 2. Immunohistochemical staining of the androgen receptor with SP197 of human testicular 
biopsy material (A,C,E). (B) is a section from the same biopsy sample as (A), but incubated with 
SP197 pre-adsorbed with an excess of peptide against which the antibody was raised. The figure 
shows three different biopsies with a Johnsen score of 8.7 (A,B), 3,7 (C), or 2.7 (D). Note similar 
staining of Sertoli cell nuclei (slender arrows) and peritubular myoid cell nuclei (broad arrows) in 
all specimens. Bar = 50 Mm. 
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Table 1. Serum FSH, LH and testosterone levels in 37 patients who underwent testicular biopsy 
(mean±SD). 
Johnsen score <8.0 2:S.0 Significance 
(n=13) (n=24) 
FSH 4.8 (±1.4) 4.4 (±1.4) p=O.50 
LH 3.9 (±1.7) 3.0 (±1.2) p=O.07 
Testosterone 18.0 (±6.3) 18.7 (±4.5) p=.G7 
Table 2. Comparison of Johnsen score to intensity of androgen receptor immunoexpression in 
adequete and inadequate spermatogenesis (mean±SD). 
?--~----~--------------------
Johnsen score <8.0 2:8.0 Significance 
(n=13) (n=24) 
Intensity of AR immunoexpression in: 
General impr: 
Sertoli cells 2.8 (±O.S) 2.S (±U.8) p=0.94 
Peritubular myoid cells 2.8 (±0.7) 2.9 (±U.8) p=O.70 
Semi Quant: 
Sertoli cells 15.9 (±7.3) 13.3 (±5.6) p=0.24 
Peri tubular myuoid cells 15.2 (±4.9) 15.3 (±3.8) p=0.95 
cell score from the Sertoli cell score, and correlating the results with the 
respective Johnsen scores. We again found no correlation between these 
values (r=-0.24; p=0.16). 
Discussion 
Our results indicate that, in a population of patients with oligozoospermia 
and normal serum gonadotropin levels, inappropriate AR expression in 
Sertoli cells does not seem ro be an important causative factor for, or 
accompanying phenomenon of, male infertility. The variation in immunoex-
pression of AR in Sertoli cells is large, in both the histologically normal group 
(where subfertility is probably caused by an obstructive disorder) and in the 
hypospermatogenic group. In accordance with a previous report (Janssen et 
al., 1994), the storage time of the sample did not influence the intensity of 
AR immunoexpression. Neither was there a change in AR immunoexpression 
with a number of clinically relevant parameters, including the Johnsen score. 
The wide variation in the intensity of AR immunoexpression might be the 
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Table 3. Correlations of intensity of Senoli cell and peritubular myoid cell A.R immunoexpression 
with a number of clinical parameters (correlation coefficient; significance). 
Year of biopsy 
Patient age 
Serum FSH 
Serum LH 
Serum testosterone 
Johsen score 
n=37 
Year of biopsy 
Patient age 
Serum FSH 
SerumLH 
Serum testosterone 
Johsen score 
General impression 
Serroti cells Perimbular myoid cells 
----
-0.1029; p=0.54 
-0.0966; p=0.65 
0.2386; 1'=0.15 
-0.0227; p=0.89 
0.1021; 1'=0.54 
-0.0717; p=0.67 
-0.190 I; p=0.25 
-0.0577; 1'=0.73 
0.2366; p=0.15 
-0.0551; p=0.74 
-0.0436; p=0.70 
-0.0888; p=0.60 
Semiquantitative method 
Sertoli cells peritubular myoid cells 
---------~ 
-0.1070; p=0.52 
-0.2702; 1'=0.10 
0.1936; p=0.24 
0.2865; 1'=0.07 
0.2108; p=0.20 
-0.2248; 1'=0.\8 
-0.190\; 1'=0.70 
-0.0577; 1'=0.68 
0.2366; 1'=0.19 
0.0551; p=O.l1 
-0.0436; 1'=0.44 
-0.0888; p=O.92 
-----
Figure 3. Correlation between biopsy score and Serroti cell AR immunoexpression in 37 sub fertile 
males. The data were analysed by the semiquantitative method (see Materials and Methods). 
Correlation coefficient: -0.2248; p=0.18. 
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result of a difference in accessability of tbe tissue to antibody. On the other 
hand, this variation could be real, and might reflect a natural variation in AR 
immunoexpression in different men, not associated with fertility or hormonal 
status. In this respect, our results are in agreement with the findings of Wilson 
et aL (J 992), who found large variations in andtogen receptor expression in 
cultured foreskin fibroblasts of normal men. Local variations in AR immuno-
expression might be caused by damage to the cell nuclei during slicing of the 
sample on the microtome. 
This study was done in a well selected group of patients, with oligozoo-
spermia and serum gonadotropin levels within the normal range. Idiopathic 
male infertility also encompasses a large number of patients with elevated 
serum FSH levels (World Health Organization, 1987). Thus, our results 
should not be applied indiscriminantly upon other groups of patients. As 
idiopathic male infertility is probably a heterogeneous collection of hypo-
spermatogenic disorders, the possiblility that inappropriate AR expression is 
indeed a causative factor in some cases of male infertility, cannot be excluded. 
Androgen receptor expression in Sertoli cells might be under the influence of 
a complicated regulatory mechanism in which hormones such as FSH may 
possibly play an important role (Verhoeven and Cailleau, 1988b; Blok et at., 
1989b; Blok et aL, 1992b). The role of FSH in human spermatogenesis is, 
apart from the fact that it is essential (Sharpe, 1994), not well understood. In 
the premature rat FSH plays a key role, with testosterone, in the initiation of 
spermatogenesis (Gondos and Berndtson, 1993). In vitro and in vivo, 
evidence points to a possible role for FSH as a stimulator of the expression of 
androgen receptor mRNA and protein in prepubertal Sertoli cells (Verhoeven 
and Cailleau, 1988b; Blok et al., 1989b; Blok et aL, 1992b). Although the 
importance ofFSH seems to diminish in the adult rat (Sharpe, 1994), a role 
in maintaining spennatogenesis cannot be excluded, in particular in primates 
including the human. In the adult non-human primate Macaca foscicularis, 
FSH still stimulates spermatogonial proliferation (van Alphen et al., 1988). 
We confirm the absence of AR immmunoexpression in human germinal cells 
at any stage of their development as reported by a number of authors (Takeda 
et at., 1990; Ruizeveld de Winter et at., 1991; Iwamura et aL, 1994), and thus 
do not support the findings of Kiwamura et at. (1992). 
In the rat, the question of whether there is AR immunoexpression in germinal 
cells is also, as yet, unresolved (Bremner etal., 1994; Vornberger etal., 1994). 
Using the immunohistochemical protocol described above, we have obtained 
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results similar to those reported by Bremner et al. (1994) in the rat testis 
(results not shown), i.e. no AR immunostaining in getminal cells. Vornberger 
et al. (1994) found AR immunostaining in the cytoplasm of step IX 
elongating spermatids. The immunohistochemistry protocol used in that 
study, however, differs considerably from that employed by Bremner et al. 
(I 994) and ourselves. In addition, although the antibody used by Vornberger 
et al. (1994) also targets the N-terminus of the AR, there might be a 
difference in epitope specificity. 
In the rat, immunohistochemical data have clearly revealed that AR expressi-
on in Sertoli cell nuclei is dependent on the stage of the spermatogenic cycle, 
while expression of AR in the nuclei of Leydig cells and peritubular myoid 
cells shows no such pattern (Bremner et aI., 1994; Vornberger et aI., 1994). 
There have been several publications reporting AR immunoexpression in the 
human testis (Takeda et aI., 1990; Ruizeveld de Winter et al, 1991; Kimura 
et aI., 1992; Iwamura et aI., 1994), but none of these sought to identifY 
specific variations of AR immunoexpression in the 6 stages of the human 
spermatogenic cycle (Clermont, 1963). Our results clearly show that a stage 
dependent variation in human Serto!i cell AR immunoexpression was not 
detectable in the histologically normal testis. The mechanism involved in the 
stage dependent immunoexpression of the androgen receptor in rat Serroli 
cells is not clear. Expression appears to be highest at stages thought to be 
especially dependent on testosterone (Bremner et aI., 1994; Sharpe, 1994). 
AR function might be modulated through the direct interaction of Sertoli 
cells with specific germinal cell types. It has been shown, however, that 
pachytene spermatocytes, and round and elongating spermatids are not 
instrumental in this phenomenon, demonstrating that the presence of earlier 
germinal cell types might be sufficient to induce a cyclic pattern of AR 
immunostaining (Bremner et al., 1994). Why such a phenomenon is not 
demonstrable in man is not known, though a possible clue may be found in 
the different architecture of the spermatogenic epithelium. In the rat, the 
stages of the spermatogenic cycle are arranged sequentially along the length of 
the tubule, such that a cross section reveals a single stage of development 
(Leblond and Clermont, 1952). In man, the arrangement may be either in a 
helical fashion, revealing three or four distinct stages in a single cross section 
(Schulze and Rehder, 1984) or not exist at all (Johnson, 1994). In this 
respect, a human Sertoli cell might be exposed to a more heterogeneous 
environment, obscuring possible stage specific modulatory effects on AR 
136 
Androgen receptor immunoexpression in the teste;; ofmbftrtile men 
immunoexpression. Also, the subdivision of the human spermatogenic cycle 
in only 6 stages (Clermont, 1963) compared to 14 in the rat (Leblond and 
Clermont, 1952), may be too imprecise to allow detection of certain testos-
terone-dependent developmental steps. 
In conclusion, in men with oligozoospermia and normal gonadotropin levels, 
the quality of spermatogenesis was not related to the intensity of AR 
immunoexpression in Sertoli cells or peri tubular myoid cells. Moreover, in 
men with normal spermatogenesis, expression of the AR in Sertoli cells is not 
dependent on the stages of the spermatogenic cycle. 
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Abstract 
During mammalian spermatogenesis, the chromatin of the spermatogenic 
cells is profoundly reorganized. Somatic histones are partly replaced by testis-
specific histones. These histones are then replaced by transition proteins and 
finally by protamines. This series of nucleoprotein rearrangements results in a 
highly condensed sperm cell nucleus. In contrast to spermatozoa from other 
species, human spern1atozoa still contain a significant amount of histones, 
including testis-specific histone 2B (TH2B). In the present study it is shown 
that an antibody targeting tyrosine hydroxylase, previously found to cross-
react with rat TH2B, also specifically immunoreacts with human TH2B on 
Western blot, in immunohistochemistry of human testis tissue, and in 
immunocytochemistry of decondensed human spermatozoa. In human testis 
tissue, TH2B imillunostaining is first apparent in spermatogonia, shows 
marked variation especially at the pachytene spermatocyte stage, and then 
reaches an intense signal in round spermatids. Shortly before spermatid 
elongation, a portion of the spermatid nucleus, corresponding to the 
acrosomal region, loses its immunoreactivity. During condensation of the 
spermatid nucleus, the immunodetectability of TH2B disappears gradually, 
from the anterior region of the nucleus onwards. At the final stages of 
spermiogenesis, the immunostaining is completely absent. Imillunocyto-
chemical staining of spermatozoa revealed no TH2B immunosignal, but 
immunostaining was observed when spermatozoa obtained from semen were 
decondensed to make nuclear proteins accessible to the antibody. There was, 
however, a striking intercellular variability in the intensity of staining of 
spermatozoa within an ejaculate. In a population of 35 men attending our 
Andrology Clinic, we observed inter-individual differences in total sperm-
TH2B content, which showed a significant, although not very pronounced, 
negative correlation with normal morphology (p=0.05). 
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Introduction 
Spermatogenesis is a complex process, by which diploid stem cells divide, 
differentiate and mature into haploid, highly specialized spermatozoa. 
Among the many changes, one of the intriguing developmental characteris-
tics of spermatogenic cells is the replacement of somatic his tones, first partly 
by restis-specific histones, then by transition proteins which are finally 
replaced by protamines (Meistrich et al., 1978; Balhorn, 1982; Meistrich and 
Brock, 1987; Balhorn, 1989). This results in a compact nucleoprotamine 
complex thar is highly disrinct from rhe somaric nucleohistone complex, with 
inter- and intra-protamine disulfide bridges resulting in a highly compact and 
stable supramolecular structure that fits into a small sperm nucleus and also 
may render the chromatin relatively resistent to harmful external influences 
(Marushige and Marushige, 1975; Hunter et al., 1976; Ward, 1993). In rat 
and mouse spermatogenesis, the histones are completely replaced by prota-
mines, so rhat mature spermatozoa are devoid of his tones (Grimes, 1986). In 
human spermatozoa, however, abour 15% of the basic nuclear proteins are 
histones (Tanphaichirr etaL, 1978). 
It is as yet unclear whether the remaining his tones in hUInan spermatozoa 
have a specific role. It has been suggested that the sperm DNA that is 
complexed as nucleohistone may have a role in the designation of initiation 
sites for nuclear decondensation, or that the nucleohistone complement may 
contain genes poised for early expression after fertilization (Gatewood et al., 
1987). In contrast to this possibly beneficial effect of sperm nuclear histones, 
a number of studies have presented evidence that spermatozoa of infertile 
males contain mote histones than that of fertile males, indicating that 
insufficient removal of his tones might be involved in infertility (Chevaillier et 
aL, 1987; Hofmann and Hilscher, 1991; Foresta et al., 1992). Among the 
his tones present in human spermatozoa, TH2B is a major variant 
(Tanphaichitr etal., 1978). 
Recently, an antibody targeting tyrosine hydroxylase (TH) was found to 
cross-react with rat testis specific histone 2B (TH2B) (Unni et aL, 1995). 
Since the primary structure ofTH2B is highly homologous between man and 
rat (Wattanaseree and Svasti, 1983), we evaluated whether the anti-TH 
antibody would also specifically bind to human TH2B. After having 
established that this indeed is the case, we characterized the immuno-
expression pattern ofTH2B in human testis tissue and in human spermato-
zoa, and investigated the TH2B content of spermatozoa in a number of males 
visiting our infertility clinic. 
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Materials and Methods 
Preparation of acid extractable proteins 
Testes and epididymides from adult Wistar rats were used. After 
hornogenisation of rat testis tissue, the homogenate was centrifuged at 
10,000g fot 10 min. The pellet was stored at -2SC Rat spermatozoa were 
obtained from caput and cauda epididymis. Epididymal tissue was minced 
and shaken in phosphate-buffered saline (PBS) to permit dispersal ofluminal 
contents. After sedimentation of the tissue pieces, the supernatant was layered 
over a discontinuous Percoll gradient consisting of 10%, 40% and 65% 
Percoll (v/v in PBS). The gradient was spun at SOOgfor 45 min. Spermatozoa 
were recovered at the interphase between the 40% and 65% Percol!. 
Human semen was layered on top of 40% Percoll and centrifuged at 500g for 
20 min. Spermatozoa were collected from the bottom of the tube, washed 
and stored at -25C 
Human peripheral blood mononuclear cells were isolated from heparinized 
blood of a healthy adult volunteer. A leukocyte-enriched cell suspension was 
obtained by lysis and removal of red blood cells. Ten ml of whole blood was 
added to 30 mllysis buffer (containing 155 mM NH4Ci, 10 mM KHC03, 
and 0.1 mM NA2EDTA, at pH 7.4) at 4C, and was shaken vigorously. The 
mixture was left on ice for IS min during which it was periodically shaken. 
The non-lysed cells were pelletted by centrifugation at 4000 r.p.m. at 4C 
The supernatant was removed and the pellet was resuspended in 10 ml lysis 
buffer at 4C After vigorous shaking, the remaining cells were pelleted by 
centrifugation at 4000 r.p.m. and the supernatant was removed. The pellet 
was frozen in liquid nitrogen for storage until use. 
The basic nuclear proteins of spermatozoa and white blood cells were 
extracted as described previously (Platz et aL, 1977). In short, the sample was 
suspended in 1 ml of cold distilled water. Subsequently 0.33 ml of 1 N Hel 
was added, followed by 1 ml of 0.25 N HC!. The sample was left to stand on 
ice for 20 minutes during which the mixture was ftequently shaken. The 
suspension was centtifuged at 12,OOOg for 10 min. The spernatant was 
removed and proteins were precipitated by adding an equal volume of 
trichloroacetic acid (TCA). The precipitate was recovered by centrifugation 
(12,000gfor 10 min) and washed with acidified acetone (200 ml of acetone + 
0.1 ml of 12 N HCl). Mter subsequent washing in acetone, the sample was 
dried under vacuum. 
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Preparation of human sperm proteins 
Semen samples were obtained from patients attending the Andrology 
outpatient clinic of the University Hospital Dijkzigt, Rotterdam. Thirty five 
consecutive semen samples, with more than IxI06 sperm/ml and a volume of 
at least 1 ml, were included. All semen samples were first routinely analyzed 
using the WHO methodology (WHO, 1992). Subsequently, 1 to 2 ml of 
each sample was layered on top of 2 ml 60% Percoll (v/v in PBS) and 
centrifuged at 500g for 20 min. The pellet was washed twice in 1 ml PBS. 
The final pellet was resuspended in 1 ml PBS and the sperm concentration 
was determined in an improved Neubauer counting chamber. A portion 
containing 0.5xI06 spermatozoa was centrifuged in a microfuge (IO,OOOg) 
for 10 min and the pellet was stored at -SOC until analysis. 
Since the basic nuclear proteins could be efficiently extracted by the Laemmli 
buffer without previous acid extraction (data not shown), the acid extraction 
was omitted. The sperm pellets were suspended in 25 ml double strength 
Laemmli electrophoresis lysis buffer (Laemmli, 1970), containing 0.125 M 
Tris-HCL pH 6.S, 2% SDS (w/v), 20% glycerol (v/v), and 130 mM dithio-
threitol (DTT). From one semen sam pIe with a high sperm concentration 
(I70xI06 sperm/ml), pellets of 0.5xI06 Percoll purified spermatozoa were 
stored, and used as a standard by running one sample per gel alongside the 
other semen samples. 
Each sample was boiled for 3 min in the sample buffer, and was run on SDS-
PAGE (Laemmli, 1970) using 15% polyacrylamide gels. The separated 
proteins were transferred to a nitrocellulose membrane and immunostained 
as described below. The intensity of the signal was quantified with a Hewlett 
Packard ScanJet IIcx and analyzed using DeskScan II version 2.0 for 
Windows software. 
Sperm decondensation 
Semen samples used for immunocytochemistry were also obtained from the 
Andrology outpatient clinic. After routine analysis, spermatozoa present in 1 
ml of semen were washed twice in 4 ml Ham's medium after which the 
remaining pellet was resuspended in PBS to obtain a concentration of 50-
1 OOx 1 06 spermatozoa per m!. Smears of spermatozoa were fixed in methanol 
for 5 min and subsequently incubated for 20 min in TRIS-HCI pH 7.2, 
containing 0.3 mM DTT and 0.1 % SDS. The smears were washed in TRIS-
HCI and fixed again with methanol for 5 min. 
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Testis biopsy samples 
Samples were obtained from normogonadotropic patients undergoing testis 
biopsy for evaluation of azoospermia. The tissue was immediarely immersed 
in Bouin's fixative and left for 24 hours, afrer which the samples were 
thoroughly washed in 70% erhanol. The sections were dehydrared in ethanol, 
cleared in xylene and embedded in paraffin, and stored ar room temperature. 
Electrophoresis and Western blot 
The anti-TH antibody (mouse monoclonal anti-tyrosine hydroxylase IgG; 
Boehringer Mannheim GmbH, Germany) is known ro specifically cross-react 
with rar TH2B, because of sequence homology ar rhe N-rermini ofTH and 
rar TH2B (Unni et al., 1995). In order to assess wherher anti-TH anribody 
could recognize human TH2B, we performed two types of gel electro-
phoreses. First, basic nuclear proteins of human leucocytes, human sperm, rat 
restis, and rat caput and cauda epididymal sperm were extracted by boiling 
for 3 min in double strengrh Laemmli buffer. The samples were run on a 15% 
polyacrylamide sodium dodecyl sulphate (SDS) gel (Laemmli, 1970). Mter 
electrophoresis, proteins were transferred to a nitrocellulose membrane. Non-
specific antibody binding was blocked by incubating the membrane in 5% 
(w/v) BSA in PBS-Tween 0.1% (v/v) for 1 hour. After washing 4x in PBS-
Tween, the membrane was incubated wirh the primary antibody (anti-TH) 
diluted 1:1600 in 5% BSA (w/v) in PBS-Tween 0.1% (v/v) for 1 hour. The 
membrane was then again washed 4x in PBS-Tween and subsequently 
incubated with biorinylated goat anti-mouse antibodies (Dako, Glostrup, 
Denmark) diluted 1:2000 in 5% BSA (w/v) in PBS-Tween 0.1% (v/v) for 
1 hour. The membrane was again washed 4x in PBS-Tween and incubated for 
1 min with chemiluminescent reagent (Pierce, Rockford, IL, USA). Excess 
reagent was removed with blotting paper. The specifically bound antibody 
was visualized using Hyperfilm ™ ii-max paper (Amersham, CEA AB, 
Sweden). The above samples were also run on a 15% polyacrylamide-acid-
urea-Triton (AUT) gel to provide further evidence that the observed 
immunoreactive band is indeed a histone (Wattanaseree and Svasti, 1983). 
Samples were dissolved in 0.4% (v/v) Triton X-lOO, 1% (v/v) mercapto-
ethanol and 0.9 M acetic acid. The AUT gels contained 0.4% (v/v) Triton X-
100, 1.5 M urea and 0.9 M aceric acid, while rhe electrode buffer contained 
0.4% (v/v) Triton X-lOO, 0.1 % (v/v) mercaptoethanol and 0.9 M aceric acid. 
Gels were prerun for 4 hours ar 130 Volt until a consistent current was 
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obtained, and run for 30 hours. The sepatated proteins were transferred on a 
nitrocellulose membrane in 50 mM acetic acid. Immunodetection ofTH2B 
was petformed as described above. 
Immunohistochemistry and immunocytochemistry 
Immunolocalization of TH2B was performed using the mouse anti-TH 
antibody. Five micron thick sections were mounted on slides treated with 3-
aminopropyltrietoxysilane (Sigma Chemical Company, St Louis, Missouri), 
deparaffinized and rehydtated. Endogenous peroxidase was blocked by a 20 
min incubation in 3% (v/v) H Z02 in methanol. Non-specific antibody 
binding was blocked with normal goat serum (Dako, Glosn'up, Denmark), 
diluted 1: lOin 5% (w/v) BSA in PBS (pH 7.4). The tissues were then placed 
in a Sequenza immunostainer (Shandon Scientific Ltd., Runcorn, England) 
and incubated at 4C overnight with the primary antibody (anti-TH), diluted 
1: 100 in 5% (w/v) BSA in PBS. Immunostaining was performed using 
biotinylated goat anti-mouse immunoglobulin (Dako) for 30 min, 
streptavidin-peroxidase (Dako) for 30 min, and metal enhanced diamino-
benzidine (Pierce) for 7 min. The sections were counterstained for 15 sec 
with Mayer's hematoxylin, and viewed with a Zeiss axioscop 20 light 
microscope at magnifications of 100x and 400x. Control sections were 
incubated with 5% BSA (w/v) in PBS without the primary antibody and 
subsequently processed as described above. 
Immunocytochemistry was performed as described above, excluding the 
deparaffinization step. 
Statistics 
All statistical calculations were performed using SPSS software (version 6.0 
for Windows). The relationship between semen parameters and sperm 
histone content was calculated according to Spearman's rank correlation. 
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Identification ofTH2B in human spermatozoa 
In order to elucidate if anti-TH could be used to identifY human TH2B, acid 
extractable proteins from human spermatozoa, human white blood cells, rat 
restis tissue and rat epididymal sperm were separated by 50S-PAGE, blotted 
and immunostained with anti-TH. As can be seen in Figure 1 a, an 
immunoreactive protein of 17 kOa was present in human spermatozoa (lane 
B) but not in human leukocytes (lane A). The other signal in the lane 
corresponding to rhe human leukocytes, is non-specific (see figure legend). In 
Figure 1 b, it is apparent that the anti-TH antibody reacts specifically with a 
17 kOa protein that is present in rat testis tissue (lane A) but that is nor found 
in rat caput and cauda epididymal spermatozoa (lanes B and C). Lane D 
(a) A B 
17 kDa-
(b) A B c o 
17 kDa-
~-
Figure. 1. Immunodctection of proteins, using an antibody targeting tyrosine hydroxylase (TH) on 
SDS-PAGE and Western blot. (a) shows a dear 17-kDa band in lane (B) corresponding to human 
spermatozoa. This band is not present in lane (A) corresponding to human leukocytes, known to 
concain somatic type H2B but not TH2B. In lane (A) a non-specific band appears, that is also seen 
in negative comrols where no anti-TH is added, indicating non-specific binding of the second 
antibody (biotinylated goat anti-mouse Immunoglobulin-G) to a human leukocyte protein (not 
shown). (b) shows a dear 17-kDa band in lanes (A) and (D) corresponding to rat testis tissue and 
human spermatozoa, respectively. lanes (B) and (C), corresponding to rat caput and caudal 
epididymal spermatozoa, respectively, do not show a detectable immunoreactive signal. 
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corresponds to human spermatozoa, which produce a signal of identical 
electrophoretic mobility as that of rat testis tissue. Acid extractable proteins 
of rat testis, human spermatozoa and human leukocytes were further 
analysed by acid-urea-Triton (AUT) electrophoresis followed by immuno-
blotting. It appeared that the anti-TH antibody recognized a protein band 
co-migrating with a H2B marker (standard samples of H2A and H2B were 
obtained from Boehringer Mannheim) in the extracts from human 
spermatozoa and rat testis, while no leukocyte protein was recognized (Figure 
2). The TH-reactive band in rat testis extract migrated slighly slower than the 
TH-reactive band in human sperm extract. 
1 
H2A-
H2B -
2 3 
Figure 2. Detection of proteins that immunoreact 
with antibodies targeting tyrosine hydroxylase 
(TH), arrer acid-urea gel electrophoresis and 
Western blotting. The standard calf thymus H2A 
and H2B were obtained from Boehringer 
Mannheim. AliquOls of 3 !-1g of standard H2A and 
H2B were loaded on the polyaClylamide acid-urea-
Thton gels and run alongside the samples con-
taining human spermatozoa, human leuko-cytes 
and rat testis tissue. A dear band, represen-ring 
TH2B is seen in lanes I and 3 corresponding to rat 
testis tissue and human spermatozoa respectively, 
but is absent in lane 2 corresponding to human 
leukocytes. Both immunoreactive bands co-
migrate with the standard H2B, although the 
immunoreactive rat testis protein migrates slightly 
slower that the immunoreactive human sperm 
protein, indicating that the observed protein is 
indeed a histone of the 2B type. 
Immunohistochemical localization ofTH2B in the human testis 
Immunohistochemical studies using anti-TH antibodies on human testis 
tissue displaying normal spermatogenesis, demonstrated strong immuno-
reactivity in the nuclei of spermatogenic cells (Figure 3). The nuclei of the 
somatic cells of the testis (Sertoli cells, peri tubular myoid cells, interstitial 
cells, endothelial cells) remained invariably negative. A clear signal was 
apparent in the spermatogonia lining the basement membrane of the 
seminiferous tubules. Primary spermatocytes, especially the pachytene 
spermatocytes, showed a marked variation in nuclear immunodetectability of 
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Figure 3. TmmunohistochemiL1l1 localization ofTH2B in human testis tissue, stained with anti-TH 
antibody. The histological sections were counrerstained with Mayer's hematoxylin. Tmmunostaining 
is loca.lized in the nuclei of spermatogoni a, primary and secondary spcrmatocytcs, and round and 
elongating spennatids. Sertoli cells (curved arrows in panels C and E), peri tubular myoid cells. 
interstitial celis, and cells associated with arterioles were not stained. Panel B, C. and D show human 
testis tissue at a higher magnification . Note the variation in pachytene spermatocyte immunosraining. 
especially in panel D (large arrowheads). There is also a change in TH2B immunostaining in 
elongating spermatids; panel B shows a decrease in TH2B immwlDstaining at the acrosomal region of 
the round spermatid nucleus (small arrowheads), and panel C shows a small region of 
immunodetectable TH2B at the posterior region of rhe spermatid nucleus (small arrowheads), 
whereas in panel D no immunodetectable TH2B is seen in the elongated spermatid nuclei (small 
arrowhead). Panel E shows a derail of a testis biopsy sample from an infertile patient showing only 
Sertoli cells (curved arrow) and spermatogonia in the tubular lumen; nOte the presence ofTH2B 
immunoreactivity in all spermatogonia. Panel A, originalmagnificarion x200; panels B,C,D, original 
magnification xIOOO; panel E, original magnification x400. 
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TH2B (Figure 3D). The early round spermatids displayed a uniformly 
intense immunosignal. During early spermiogenesis, a region corresponding 
to the acrosomal cap of the round spermatid nucleus, displayed reduced 
TH2B immunostaining as compared to the rest of the nucleus (Figure 3B). 
During spermatid elongation, this region of reduced immunostaining 
increased, concomitant with expansion of the acrosome. In the final stages of 
spermatid nuclear condensation, a small region of immunodetectable TH2B 
could be discerned in the posterior region of the spermatid nucleus (Figure 
3C), after which TH2B became immunologically completely undetectable 
(Figure 3D). 
In human testis tissue from an infertile male, where only Serroli cells and 
spermatogonia were present in the seminiferous tubules, again the nuclei of 
spermatogonia, but not Sertoli cell nuclei, stained positive (Figure 3E). All 
other somatic cell nuclei did not immunoreact. 
Immunocytochemical localization ofTH2B in human spermatozoa 
Immunostaining ofTH2B was absent in all morphologically normal and in 
most abnormal spermatozoa in human semen samples. However, some of the 
abnormal spermatozoa and most of the round cells stained intensely (results 
not shown). When the spermatozoa were subjected to decondensation 
treatment, a larger number of spermatozoa stained positive (Figure 4). 
Figure 4. Immunocytochemical localization of TH2B in human spermatozoa. The spermatozoa 
were treated (see Materials and Methods) to induce decondensation. There is a dear signal in some, 
but not all, of the decondensed sperm nuclei. All non-decondensed sperm nuclei remain negative. 
Original magnification xl 000. 
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However, the spennatozoa that remained in the condensed form remained 
negative. Among the spermatozoa rhat became decondensed, the intensity 
and pattern of immunostaining showed variation, which was, however, not 
correlated with the size of the decondensed sperm nucleus. After deconden-
sation, the original morphology of the spermatozoa was lost, making it 
impossible to ascertain which spermatozoa might have been morphologically 
abnormal prior to decondensation. Therefore it was not possible to detect a 
putative correlation between sperm morphology and sperm TH2B immuno-
staining at the single cell level. 
TH2B level in semen samples 
The amount ofTH2B present in a fixed (0.5x106) number of spermatozoa of 
35 males visiting our Andrology Outpatient Clinic was determined by 
measuring the intensity of the TH2B immunosignal on Western blot. Figure 
5 shows the TH2B immunoblots for several of these patients. There clearly 
was a large inter-individual variation in sperm-TH2B content. It should be 
noted that this data represents the total amount of TH2B per 0.5x106 
spermatozoa, and do not give information about the variation of TH2B 
content among individual spermatozoa. Quantitative analysis of the TH2B 
level in sperm samples confirmed the qualitative observations (Figure 6). In 
order to assess if the variation in total sperm-TH2B content might be 
associated with semen sample characteristics, the TH2B concentration was 
1 2 3 4 5 6 7 
17 kDa-
Figure 5. Immunodetection ofTH2B in spermatozoa from human infertility patients. Protein was 
extracted from O.SxI Q(i spermatozoa from seven different patients attending our Andrology Clinic, 
separated on 5DS-PAGE and transferred on a nitrocellulose membrane. Note the diversity of signal 
intensity between the different lanes. The gel shown in this figure was exposed slightly longer (han 
normal in order to highlight the patient-to-patient variation in sperm TH2B content. A less 
exposed version was used for the actual measurements (Figure 6) but was less suitable for 
photography. 
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Figure 6. Variation of total sperm TH2B content in 35 infertile males. The total TH2B content of 
O.5xl06 spermatozoa isolated from a single ejaculate from each of the subfertile males was 
estimated. All values are relative to the average amount of TH2B in a standard sperm sample 
obtained from an ejaculate with a high number of spermatozoa. Samples were first washed in 
PercoIl600/0. Proteins were separated on SDS-PAGE, blotted and immunostained. The intensity of 
the resulting signal was quantified (see Materials and Methods). 
compared with the results of the corresponding semen analyses. As is shown 
in Table 1, there is no correlation between total sperm TH2B content and 
sperm concentration of the initial sample (r=-0.210, P=0.9J) or sperm 
motility (r=-0.138, P=0.43). In this group of patients, total sperm TH2B 
content showed a marginally significant correlation with morphology 
(r=0.328, P=O.OS): a higher TH2B concentration was found in ejaculates 
with more abnormal spermatozoa. In only six samples more than lxl06 
round cells per ml were present, thus this factor was not included in the 
statistical calculations. 
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Table 1. Results of routine semen analysis (mean±SEM) and correlation with sperm testis-specific 
histone 2B (TH2B) content in 0.5xl0G spermatozoa of 35 subfertile men. The sperm TI--I2B 
content' of patients were compared with the TH2B coment of a standard sperm sample. 
----'----
Total sperm count (xIOG) 
Concentration (xl OG) 
Motiliryb (%) 
Motphologyc (%) 
Histone comentd 
98.8 (±15.1) 
27.4 (±3.1) 
38.1 (±3.2) 
19.9 (±2.1) 
1.3 (±0.06) 
Corrclariona with 
histone content 
-0.144 
-0.021 
-0.138 
-0.328 
a Spearman; b Grades a+b (\VI--IO); cWHO criteria; d Arbitrary units 
Discussion 
p-value 
0.41 
0.91 
0.43 
0.05 
In this study we have shown that the anti-TH antibody, known to cross-reacr 
with rat TH2B, can also be used to detect human TH2B in testis tissue and in 
spermatozoa. A clear and prominent 17 kDa band was detected on immuno-
blots of acid-soluble proteins extracted from rat testis tissue and human 
spermatozoa, but not from human leukocytes and rat epididymal spermato-
zoa. Tyrosine hydroxylase, a 57 kDa protein (Mayerhofer and Russell, 1990), 
was not encountered in any of the extracts. Additional evidence that the 
protein recognized by the anti-TH antibody is indeed a histone of the 2B 
type and not H2A or a totally unrelated protein of 17 kDa was obtained by 
electrophoresis on AUT-gels. The mobility of the immunoreactive protein 
was almost similar to rat TH2B and the bovine H2B standard. 
In histological sections of human testis, only the nuclei of spermatogenic cells 
showed immunostaining: spermatogonia, spermatocytes, and round sperma-
tids reacted positively with varying intensity. The immuno-detectability of 
TH2B in elongating spermatids was confined to the post -acrosomal region of 
the nucleus, whereas the nuclei of fully condensed spermatids did not stain. 
All somatic cell nuclei (Sertoli cells, Leydig cells, peritubular myoid cells, and 
endothelial cells of arterioles) were clearly negative. The absence of 
immunodetectability ofTH2B in the anterior part of the nuclei of elongating 
spermatids and in spermatozoa is due to the highly condensed condition of 
the nuclei and not to the absence of TH2B, as Western blotting and 
immunostaining of acid-extractable proteins from human spermatozoa 
revealed a positive signal corresponding to TH2B. 
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Previous studies have shown that about 15% of human sperm nuclear 
proteins are histones (Tanphaichirr et aI., 1978), including TH2B 
(Wattanaseree and Svasti, 1983; Gusse et al., 1986; Gatewood et al., 1990; 
Prigent et aI., 1996). Using immunocytochemistry, we could not detect 
TH2B in untteated human and rat spermatozoa. Protein separation on 505-
PAGE followed by immunoblotting, however, confirmed the presence of 
TH2B in human spermatozoa, and also showed that TH2B is absent in rat 
spermatozoa. It appears that immunocytochemical detection of TH2B in 
morphologically normal mature human sperm cells is hampered by 
inaccessibility of the epitope to the antibody. When the human spermatozoa 
were decondensed, immunocytochemistry showed the presence of TH2B, 
albeit with a remarkably diverse pattern of staining. Whether the observed 
intercellular variation in TH2B immunostaining indeed reflects a difference 
in sperm TH2B content is a point of concern. During the course of this 
study, it became clear that a too vigorous decondensation of spennatozoa 
resulted in loss of immunostaining ftom all spermatozoa (results not shown). 
Presumably all TH2B is then removed from the nucleus. The heterogeneous 
staining pattern of the decondensed spermatozoa can probably not be 
attributed to loss of TH2B from some cells because many well decondensed 
and large nuclei stain intensely while other nuclei, also decondensed but 
smaller, stain lightly or not at all. Conversely, one might argue that the 
smaller nuclei contain TH2B that is still masked; however, there was no 
correlation between the size of the decondensed spermatozoa and the signal 
intensity. Therefore the observed heterogeneity in immunostaining probably 
is a true reflection of an intercellular variation in sperm TH2B content. 
Very little is known about regulation of expression of the testis-specific 
his tones in the human testis. A recent report indicates that during 
spermiogenesis, the immunodetectability of his tones H2B and H3 is 
constant in the nuclei of early round spermatids, and then increases in 
intermediate spermatids (step 3-4). The histone H3 immunosignal decreases 
at the end of the elongation phase (step 5), while the H2B labelling decreases 
in marure spermatids (step 6) (Prigent etal., 1996). Previous studies in the rat 
have shown that a number of his tones (Hla, H2AX, TH3) are expressed early 
during the mitotic stages of spermatogenesis, while others (TH2A, TH2B, 
HIt) are first expressed at a later time when the spermatogenic cells have 
entered the meiotic phase (Meistrich et aI., 1985; Meistrich and Brock, 
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1987). In the rat, TH2B is first synthesized in the preleptotene or leptotene 
spermatocytes, and its synthesis continues until the mid or late pachytene 
stage. TH2B is the major form of H2B in rat round and elongating 
spermatids, although somatic H2B is still present (Brock et aI., 1980; 
Meistrich et al., 1985; Unni et aI., 1995). Our studies show a strong TH2B 
immunosignal in spermatogonia in human testis tissue, indicating that, 
contrary to the situation in the rat, first expression of TH2B in the human 
testis occurs at the early mitotic stages of spermatogenesis. 
A number of investigators have shown that ejaculates of subfertile men 
and/or ejaculates containing a large number of morphologically abnormal 
cells, contain a relatively large amount of histones (Terquem and Dadoune, 
1983; Chevaillier etal., 1987; Foresta etal., 1992). Most studies have used 
indirect methods to detect the persistence of histones in spermatozoa, such as 
staining with toluidene blue to test the availability of DNA phosphates 
(Andreetta et aI., 1995), aniline blue to stain all remaining histones (Terquem 
and Dadoune, 1983), differential nuclear chromatin decondensation using 
detergents (Calvin and Bedford, 1971a; Bedford et aI., 1973a), acridine 
orange to test for single stranded DNA (Evenson et aI., 1980; Tejada et aI., 
1984), and chromomycin A3 to test for guanosine rich sequences of DNA 
(Bianchi et aI., 1996). We are now in a position to determine the presence of 
a single histone variant in human sperm, and to correlate its persistence to 
routine semen analysis parameters. In our patient population, we found no 
correlation between total sperm TH2B content and total number of sperm 
per ejaculate, sperm concentration, and sperm motility. There was a 
marginally significant negative correlation between total sperm histone 
content and sperm morphology (p=0.05). Although fertile men produce a 
substantial amount of morphologically abnormal spermatozoa, abnormalities 
of sperm morphology are encountered more often in subfertile men (Bosofte 
et al., 1985; Kruger etal., 1988). Sperm morphogenesis is a complex process, 
which includes the successful compaction of the DNA. An association 
between defects in DNA packaging and sperm morphology abnormalities 
have previously been reported (Gledhill, 1970; Bedford et al., 1973; 
Dadoune and A1fonsi, 1986). Recently it was observed that knock out of the 
gene encoding ubiquitin-conjugating enzyme HR6B in the mouse is 
associated with morphological abnormalities of spermatozoa (Roest et ai., 
1996). These morphological abnormalities may result from impaired 
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chromatic reorganization during spermatogenesis, which may require 
ubiquititation of histones. Disruption of the normal dense chromatin 
structure of spermatozoa in transgenic mice expressing a gene construct that 
encodes galline, the avian homologue of protamine, under the control of a 
protamine-l promotet, causes spetm abnormalities and infertility (Rhim et 
aI., 1995). This is probably explained by impaired DNA compaction in 
chromatin containing both protamine and galline. Both mouse models 
demonstrate that a disturbance in chromatin temodelling can lead to marked 
motphological abnormalities of spermatozoa and to infertility. 
The ptesence of his tones in human spetm is also regarded as a consequence of 
a derailment in the process of chromatin remodeling during spermatid 
condensation, and is considered an ominous sign with respect to fertility 
(Terquem and Dadoune, 1983; Chevaillier et at., 1987; Foresta et aI., 1992). 
Our results and those of others (Gatewood et at., 1990), however, show that 
in virtually all human ejaculates, spermatozoa can be shown to contain 
histones. It should be kept in mind that, in somatic cells, histones not only 
playa structural role in otganizing nucleat DNA; evidence is accumulating 
that histones may playa crucial role in regulation of transcription (Ura et at., 
1997). Histones in spermatozoa are possibly interacting with a specific part of 
the genome (Gatewood et aI., 1987), and there are indications for early post 
conception paternal-specific expression of several genes (Sawicki et aI., 1981). 
From this, it is tempting to suggest that sperm his tones might be involved in 
marking the genes that are poised for early expression after fertilization. In 
addition to the role of nuclear proteins, mRNA's found in human ejaculated 
spermatozoa have been the focus of a considerable amount of speculation. A 
number of recent studies have demonstrated the presence of mRNA coding 
for c-myc, b-actin, b l-integrin, protamine 1, protamine 2 and transition 
protein 2 in mature human spermatozoa (Kramer and Krawetz, 1997). 
Whether the highly condensed chromatin within the head of the 
spermatozoa is actually (partially) transcriptionally active, or whether the 
observed mRNA's are stable and dormant remnants of past haploid synthetic 
and equilibrative activity in earlier stages of germ cell differentiation (Miller, 
1997), persisting because of lack of degradative mechanisms within the 
spermatozoa, remains to be elucidated. 
In conclusion, we have shown that an antibody targeting tyrosine hydroxylase 
can be used to specifically identity TH2B in human spermatozoa and testis 
tissue. Our results indicate that TH2B is first expressed at an early mitotic 
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stage of human spermatogenesis, and is present throughout spermatogenesis 
and in mature spermatozoa. There appears to be a marked variation of total 
sperm TH2B content among sub fertile males, that may correlate, to some 
extent, with abnormalities of sperm morphology. Finally, the present results 
indicate sperm-to-sperm variation in TH2B immunoexpression within a 
single ejaculate. The significance of this observation, and the fertilizing 
potential of human spermatozoa containing varying amounts of TH2B, are 
subject of present research. 
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Introduction 
Over the years, a great wealth of knowledge has accumulated in the field of 
male reproduction, for human and other mammalian species. Experiments 
on animal models have played a crucial role in the attempt to understand the 
more basic and intricate mechanisms of regulation of spermatogenesis and 
sperm maturation. Human testes and epididymides are both organs that are 
not eagerly offered for experimentation. It has primarily been the study of the 
male rodent reproductive system, that has led to our present understanding of 
the workings of the hypothalamus-pituitary-testis axis, and, more recently, of 
many of the molecular and genetic regulators of male reproductive function. 
In the quest for an even more intricate insight in this process, however, 
investigators have removed cells and tissues from the animal or human body 
for study in a 'test tube environment'. Although these studies have provided 
us with a great deal of information, it is questionable whether the obtained 
data indeed reflects cell function under physiological conditions. It is well 
known rhat cells taken out of their physical and physiological milieu are 
different, with respect to morphology and reaction to hormonal or other 
stimuli (Sharpe, 1993; Sharpe, 1994). When studying testicular cells, the 
drawbacks of this methodology may be even more compelling. The function 
of the testicular cells, and indeed the testis as a whole, is dependent on 
feedback systems that involve essentially an intact and healthy organism 
(Sharpe, 1994; Grootegoed, 1996). Many of the Serroli cell functions are 
highly dependent on their association with germinal cells, and require not 
only the pituitary endocrine regulators, bur are also highly sensitive to factors 
secreted by other testicular cells [peritubular myoid cells, Leydig cells and 
germinal cells (Griswold, 1995)]. Similarly, the principal cells of rhe 
epididymis probably require a number of testicular factors, in addition to a 
well functioning mesenchymal layer ar their basal side, for normal function 
(Garrett et at., 1990; Sujarir et ai., 1990; Holland et ai., 1992; Turner et ai., 
1995). Ir is desirable, therefore, to study the processes involved in 
spermatogenesis and sperm maturation, where possible, in a whole organism. 
This is especially true for the study of hormonal control mechanisms and 
hormone metabolism. 
158 
Discussion 
Animal model; physiological aspects 
The animal studies described in this thesis have explored mechanisms of 
androgen action in spermatogenesis and regulation of expression of the 
androgen receptor in the rat testis and epididymis (Chapters 3 and 4). As our 
experiments were mainly concerned with the function and expression of the 
androgen receptor, and androgen metabolism, in whole organs, we were able 
to conduct our research in intact animals. In manipulating anyone factor 
within the highly tuned hypothalamus-pituitary-testis feedback system, 
changes may result in that system which are not only caused by the primary 
influence, but also by secondary adaptations of that system. Specifically, 
injecting varying doses of testosterone in a rat, to study its effect on spermato-
genesis, will not only result in a varying concentration of serum testosterone, 
but will also cause a fall in serum FSH level (Sun et al., 1989). Because FSH is 
known to influence spermatogenesis, this factor must be controlled. Treating 
rats with a GnRH antagonist will result in suppression of serum LH and FSH 
to very low levels without affecting other pituitary hormones (Chapter 3; Rea 
et al., 1986). The advantage is that, even in rats treated with very low 
testosterone doses, LH will remain fully suppressed so that the testicular 
testosterone level can be better controlled. Unfortunately, in the GnRH 
antagonist-treated rat, a rise in serum testosterone will result in an increase in 
serum FSH due to a direct effect of tesrosterone on the pituitary (Rea et al., 
1986; Bhasin et ai, 1987). Thus, in order to control for a varying FSH level 
in each treatment group, recombinant human FSH must be supplemented in 
all rats. Although the serum LH level falls below the detection limit in rats 
treated with a GnRH antagonist (Chapter 3), mature Leydig cells will 
continue to secrete a small amount of testosterone in the absence of LH 
(Sharpe, 1994). This amount is negligible in rats treated with a high level of 
androgen. However, it has been shown that residual testosterone secretion by 
non-stimulated Leydig cells does have some stimulatory effect on 
spermatogenesis (El Shennawy etal., 1998; Russell etal., 1998). To eliminate 
all mature Leydig cells, rats can be treated with ethane dimethane sulphonate 
(EDS) (Kerr et al., 1985; Morris et al., 1986). The advantage of LH 
suppression by a GnRH antagonist in this situation is that the maturation of 
immature Leydig cells is prevented, resulting, theoretically, in prolonged 
maximal androgen blockade in the rat testis. Combining the above 
treatments will result in an animal model, albeit rather complicated, allowing 
one to study specifically the effect of exogenous androgens on spermato-
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genesis in a situation where all mature Leydig cells are destroyed and the 
influence of LH on development of a new population of mature Leydig cells 
is negligible, wbile serum FSH is controlled. 
Although the notion that all factors except the factor under scrutiny must 
remain constant within an experiment to enable one to draw reliable 
conclusions seems self evident, virtually all of tbe previous studies regarding 
the effects of androgens on spermatogenesis fail on this point (see Chapter 2). 
This renders the data difficult to interpret, and precludes reliable answers to 
some of the nagging questions relating to androgens and spermatogenesis. 
Androgen action in spermatogenesis 
How much testosterone is needed for normal spermatogenesis? 
The importance of androgens for spermatogenesis has been well recognised 
for many years. Androgens are, however, important for the adequate function 
of a number of other tissues in the male body as well. Due to local pro-
duction, the levels of testosterone found in the testis are far higher than the 
levels found in the peripheral blood of all studied mammals (Chapters 2 and 
3; Sharpe, 1994). Although there is ample discussion about the exact levels of 
testosterone in the rat testis, and about in which testicular compartment 
testosterone should be measured, it is accepted that levels are between 25-100 
nglml (see Chapter 2; Sharpe, 1994). Our own studies have revealed a value 
of about 46.5 nglml of testosterone in whole, flash frozen, adult rat testis, 
confirming earlier reports. 
Testicula1" testostaone level1"equi1"ed for qualitative" normal spermatogenesis 
It has become quite clear that the very high levels of testosterone found in the 
testis are far higher than what is needed for qualitatively normal 
spermatogenesis, which is attained at relatively low testicular testosterone 
levels. In a study by Sun et al. (1989), qualitatively normal spermatogenesis in 
rats was maintained at a testicular interstitial fluid testosterone level of about 
7 nglml over a period of 13 weeks. A more recent study in intact rats treated 
with low dose testosterone and estradiol indicated that the testicular 
testosterone level needed for qualitatively normal spermatogenesis may be at 
about 7-12% of control (O'Donnell et aI., 1994). In hypophysectomised rats, 
however, tbe interstitial fluid testosterone level needed for qualitatively 
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normal spermatogenesis was clearly more than 10 ng/ml (Sinha Hilum and 
Swerdloff, 1993). Many other studies have shown that the ability of 
testosterone to maintain spermatogenesis is impaired in hypophysectomized 
rats compared to intact animals (see Sharpe, 1994 for review). As is discussed 
in Chapter 2, the absence of FSH in hypophysectomized rats may contribute 
to the need for a higher level of testostetone, although it is likely that other 
factors are also involved. 
Although qualitative maintenance of spermatogenesis can be attained at a 
relatively low testicular testosterone level, the level needed is still considerably 
higher than that normally found in serum (1.2 ng/ ml in our study; see 
Chapter 3). At this point, it should be stressed once again that testosterone 
suppletion at a very low dose, be it in an intact animal, an animal co-treated 
with estradiol, or in particular in a hypophysectomised anima!, results in a 
significant £all in the serum FSH level (there is no FSH at all in 
hypophysectomised rats). It is conceivable that in the presence of a normal 
FSH level, the testicular testosterone level needed for qualitatively normal 
spermatogenesis would have been even lower. A strong synergistic effect of 
testosterone and FSH has been described on a number of occasions, especially 
at low testosterone levels (Kerr et aI, 1992). At what dose of testosterone 
qualitatively normal spermatogenesis can be maintained at a physiologic 
serum FSH level is currently unknown. In our study, EDS/GnRHalrecFSH 
treatment without androgen supplementation resulted in a testicular 
testosterone level of about 1.6 ng/m!, which is comparable to the control 
serum testosterone level. In the animals treated with this regimen, no 
condensing spermatids could be detected, indicating that the normal 
circulating level of testosterone cannot maintain qualitatively normal 
spermatogenesis even in the presence ofFSH (Fig 1, Chapter 3). A testicular 
testosterone level of 3.4 ng/ ml (7% of control) was sufficient to maintain 
qualitatively normal spermatogenesis in our model, albeit quantitatively 
markedly reduced, as measured by identification of homogenisation resistant 
spermatids (unpublished results). 
Testicular testosterone level required fin' quantitatively normal spermatogenesis 
Maintenance of quantitatively normal spermatogenesis (i.e. production of a 
normal amount of mature spermatozoa) requires a relatively high testicular 
testosterone level. The exact testosterone level needed to maintain normal 
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spermatogenesis, is not exactly known, due to differences in study design and 
varying methods of estimating spermatogenic activity (see Sharpe, 1994). On 
the basis of the available evidence, most investigators accept a value of 20 
ng/ml for the tat. An important factot that may be overlooked in some 
instances, is that spermatogenic efficacy seelns to dilninish over time, even in 
animals treated with extremely high doses of testosterone (i.e. Sun et aL 
1989). In view of this, Sharpe (1994), in his extensive treatise on the subject, 
indicated that the testicular level of testosterone needed for long term 
quantitative spermatogenesis might be as high as 40 ng/ m!. Our results 
indicate that quantitative spermatogenesis, as Ineasured by testis weight, 
nevet quite teaches 100% in both the testosterone propionate-(TP) and 
Rl881-tteated groups (Chapter 3). It must be remembered that these testes 
are devoid of mature Leydig cells, which may account for the fact that testis 
weight in the supplemented rats can never quite teach the controlleve!' 
However, again it has become clear that the testicular testosterone level that is 
needed fot normal spermatogenesis is far higher than the normal serum 
testosterone level which is adequate for maintenance of the function of other 
androgen dependent organs such as the prostate and seminal vesicles. 
Why does the testis need a high level of testosterone for adequate 
spermatogenesis? 
Testosterone acts on androgen dependent tissues through the androgen 
receptor: a ligand dependent transcription factor that, upon activation, can 
bind to consensus DNA sequences and regulate gene transcription 
(Brinkmann et aL, 1989; Chapter 2). The levels of testosterone normally 
found in the testis ate about five-fold of that needed to occupy 100% of all 
testicular androgen receptors (Blok et al., 1992). Although it is highly likely 
that this high level of testosterone may not be necessaty fot normal 
spermatogenesis, the lowest level that is required is still more than a 
magnitude highet than that found in serum. The mechanisms underlying this 
phenomenon have temained enigmatic, although a number of explanations 
have been forwarded (see Sharpe, 1994 for review). 
The difference in testosterone dependency of the testis compared to other 
androgen dependent organs may have a metabolic basis. In a number of 
highly androgen dependent organs in the male, such as the prostate and 
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seminal vesicles, the primary ligand for the androgen receptor is not 
tesrosterone, but its 5a-reduced metabolite dihydrotestosterone (DHT) 
(Wilson, 1972). In activating the androgen receptor, DHT is about an order 
of magnitude more potent than testosterone (Grino et aL, 1990). The activity 
of 5a-reductase in these organs thus, in effect, results in a ten-fold 
amplification of the androgen signal. As testosterone levels within the testis 
are in excess of ten-fold of that found in serum, it has been proposed that no 
role exists for 5a-reductase in this organ. Indeed expression of 5a-reductase 
is very low in adult testis. 
Furthermore, it is concievable that a substantial portion of the testicular 
testosterone is made unavailable to the testicular testosterone-reponsive cells, 
through binding to extracellular testicular proteins. A candidate protein in 
this respect, is androgen binding protein (ABP), which is present at a high 
level within the testis. It is known that the majority of ABP is secreted, by 
Sertoli cells, into the seminiferous tubular lumen, carrying a substantial 
amount of biologically unavailable testosterone out of the testis into the 
epididymis (Gunsalus etal., 1980). 
Finally, it cannot be excluded that androgens act on Sertoli cells and perhaps 
other testicular cells, through an as yet unknown plasma membrane receptor 
mediated pathway. In recent years, many steroid hormones have been shown 
to exert rapid actions at the level of the cell plasma membrane, through an 
unknown mechanism which does not involve the respective nuclear receptor. 
Androgens have been shown to induce a rapid increase in intracellular 
calcium in cardiac myocyres (Koenig et aL, 1989), mouse kidney cells 
(Koenig et at, 1982), and human prostate cancer cells (Steinsapir et aL, 
1991). Gorczynska and Handelsman (1995) published a report describing a 
rapid increase in Sertoli cell cytosolic calcium as a result of androgen 
stimulation. This rise in cytosolic calcium results from the induction of a 
transmembrane influx of extracellular calcium. Both testosterone and its 
reduced metabolite dihydrotestosterone resulted in this effect, while pre-
cursors of restosterone and estradiol had no effect. In addition, conjugation 
of testosterone to bovine serum albumin (BSA), which limits uptake of 
testosterone in the cell, did not prevent the calcium influx, indicating that the 
process is mediated via a membrane bound mechanism (Gorczynska and 
Handelsman, 1995). The above effects could be abolished using a selective 
anti-androgen, indicating that the mechanism might involve a putative 
membrane receptor with a binding domain that is somewhat similar to that 
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of the nucleat androgen receptor. Although the receptor itself has not been 
identified, the specificity of the androgen mediated activity as well as the 
ability of anti-androgens to reverse these effects, point to an androgen 
binding moiety that closely tesembles that of the classic intracellular teceptor. 
Whether other testicular cell types, specifically the germinal cells, display 
membrane associated andtogen regulated activity, or whether this 
phenomenon is involved in the necessity for a high intratesticular androgen 
level, is presently not clear. It is important to note, however, that all known 
androgen effects require the presence of an intact classical androgen receptor, 
as can be observed in 46,xy individuals with complete androgen resistance, 
caused by AR mutations. 
Is there a role for 5a-reductase in normal adult testis function? 
Although it has been shown on a number of occasions that indeed 5a-
reductase expression and activity in the adult testis are extremely low (Van der 
Molen et at, 1975; Turner et at, 1984), a number of observations have raised 
doubts as to whether testosterone metabolism can fully explain the 
discrepancy in testosterone dependence between testis and other androgen 
dependent organs. First, if the ten-fold amplification of the androgen signal, 
by T to DHT conversion, as occurs in other androgen dependent organs, is 
absent in the testis, one would expect that a testicular testosterone 
concentration ten-fold higher than that found in peripheral blood should be 
sufficient for normal spermatogenesis. Many studies have attested to the fact 
that this may not be the case (see Sharpe, 1994). Second, a number of studies 
have shown some, albeit low, 5a-reductase expression and activity in adult 
human and rat testis, indicating that a low rate of conversion of testosterone 
to DHT in the testis cannot be excluded (Van der Molen et al., 1975; Turner 
et at, 1984). Third, men with a genetic defect resulting in a 5a-reductase 
type 2 deficiency have impaired spermatogenesis. It has been implied, 
therefore, that the testis expresses a low activity of 5a-reductase, and that its 
activity seems to be essential for spermatogenesis even at the physiologic high 
levels of testosterone in the testis. 
The study described in Chapter 3, however, provides compelling evidence 
that indeed a relative lack of 5 a-reductase activity in the testis is responsible, 
at least in part, for the discrepancy in testosterone dependence of the testis 
compared to the prostate and seminal vesicles. Supplementation with various 
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doses of R1881 (methyltrienolone), a synthetic androgen that is not 
metabolised and does not bind to ABp, in rats pre-treated with EDS/ 
GnRHalrecFSH, resulted in an equal response of the testis, the prostate and 
seminal vesicles. This indicates that the testis is not less sensitive to androgen 
compared to the other organs, in a situation where metabolism and binding 
of the androgen are eliminated. A second experiment, where testosterone was 
supplemented in EDS-treated rats co-treated with fina-steride (a potent Sa-
reductase inhibitor), resulted in a practically identical response of the testis, 
the prostate and the seminal vesicles, judged by changes in organ weight. 
The testis apparently contains a low activiry of Sa-reductase, but its 
functional importance may be very limited. Inhibition of Sa-reductase 
activiry in beagle dogs has no discernable effect on spermatogenesis 
(Juniewicz et aL, 1993). At a low testicular testosterone level, however, inhibi-
tion of Sa-reductase does appear to have a negative effect on post-meiotic 
development of spermatids in the rat (O'Donnell et aL, 1996). When 
testosterone supplementation is increased to a higher dose, however, 5a-
reductase inhibition no longer has any discernable effect on any spermato-
genic process. This data indicates a very limited role for Sa-reductase in the 
testis, which becomes apparent only when the testicular testosterone level is 
very low. 
Men with a Sa-reductase deficiency have impaired spermatogenesis, mainly 
as a result of maldescent of the testis into the scrotum. There is no indication 
that the enzyme deficiency itself is directly related to impairment of 
spermatogenesis. 
Androgens in the search for a male contraceptive 
The observed necessiry for a relatively high testicular testosterone level for 
normal spermatogenesis, has been put to good use in the search for a male 
contraceptive pill. Since the early 70's, it was realised that administration of 
exogenous testosterone, inhibiting pituitary gonadotropin secretion, induced 
a strong decrease in serum FSH level, and inhibition of testicular testosterone 
production as a result of a low serum LH level (Wu, 1996). Early studies 
using either androgen alone or in cOlnbination with progestogens resulted in 
azoospermia in 40-80% of Caucasian men (Wu, 1997). Between 1987 and 
1994, two important WHO contraceptive efficacy srudies, using a weekly 
regimen of 200 mg testosterone enanthate i.m. inducing a two-fold increase 
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in the serum testosterone level, res lilted in a pregnancy rate of 0.8 per 100 
person years, for couples in which the men were suppressed to azoospermia 
(Pearl rare of 0.8%) (WHO Task Force on Methods for the Regulation of 
Male Fertility, 1990; WHO Task Force on Methods for the Regulation of 
Male Fertility, 1996). In the second stlldy, 98% of all treated men wete 
sllppressed to azoospermia or deep oligozoospermia «3 million sperm per 
m!) (WHO Task Force on Methods for the Regulation of Male Fertility, 
1996). Previolls in vitro stlldies had indicated that the fertilizing capacity of 
residllal sperm of severely oligozoospermic men due to androgen treatment 
was impaired (Wll, 1997). The Pearl rate for individuals reaching azoo-
spermia or oligozoospermia of <3 million sperm pet ml was 1.4. (this is 
comparable to the first year failure tate of female oral contraceptives) (Wu, 
1997). The above Pearl rates Sllggest an efficacious contraceptive effect in 
men in whom semen parameters have been redllced to less than 3 million 
sperm per ml. However, all pregnancies occurred in men in whom 
azoospermia was not attained, bur who had <3 million sperm per ml in their 
semen. It is possible that the failure rate in the latter grollp is deemed highet 
than acceptable. 
Unfortllnately these regimens had a number of problems, including a twice 
normal senU11 testosterone level resulting in acne and a decrease in HDL-
cholesterol. The increased circulating testosterone level also raises concerns 
about prostatic disease, cardiovasclllar disease, and behavioural disturbances. 
In addition, the need for a weekly injection is unpleasant, and resulted in 
treatl11ent discontinuation. 
As a reslllt of the fact that only 50 to 70% of Caucasian men (as opposed to 
>90% of Asian men; see below) will attain azoospermia with androgen alone, 
with the above-mentioned side effects, a number of other tegimens have been 
forwarded. Progestogens have been lltilised, as they are potent inhibitors of 
gonadotropin secretion (Goldzieher and Castracane, 1984). In addition, 
progestogens appear to possess 5a-redllctase inhibitory activity, which, in 
light of data discussed below, would make this substance ideal for lISe in 
combination with an androgen (Mauvais-Jarvis et ai., 1974). A number of 
trials using various combinations of androgens and progestogens arc ongoing 
(Wu, 1997). Anti-androgens and androgen combinations and the use of 
androgen esters with improved phannacokinetic properties are also currently 
being stlldied for use in male contraception (Wu, 1997). 
Interestingly, the influence of testicular 5a-reductase on androgen action in 
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human spermatogenesis may be of some importance in the observed failure of 
testosterone enanthate to induce azoospermia. In one of the studies on this 
topic, of 33 men who were treated with testosterone enanthate (200 mg i.m. 
weekly), only 18 men achieved azoospermia (Anderson and Wu, 1996). The 
rest maintained a low level of spetmatogenesis with 2.0 +/- 0.6 million sperm 
per ml of ejaculated semen. The setum level of DHT in the oligozoospermic 
men had increased while the D HT level in azoospetmic men had not 
changed (Anderson and Wu, 1996). Similarly, in the same cohort of men, 
incomplete suppression of spermatogenesis was associated with a rise in 
seminal DHT, while for men who responded with azoospermia, no rise in 
seminal D HT could be detected (Anderson et al., 1997). Although the 
seminal DHT level is probably the result of an increased production ofDHT 
in the accessory sex organs (epididymis, seminal vesicles, and prostate), and 
provides no information about inter-individual differences in testicular 5a-
reductase activity, the authots conclude that this difference in androgenic 
milieu might underlie the difference in response to testosterone enanthate 
treatment. Studies involving treatment of Asian men with androgens alone or 
progestin/androgen combinations, have indicated a consistently higher rate 
of suppression to azoospermia (about 90% of men) than that found in 
Caucasian men (about 75%) (fot review see Wu, 1997). The mechanisms 
behind this observation are presently not clear. One could speculate that 
Asian men have lowet Sa-reductase activity, as is possibly indicated by the 
less beard growth and a lower incidence of male pattern baldness in Asian 
men, compared to Caucasian men. This would concur with the obsetvation 
that 5a-reductase activity in the testis has an influence on spermatogenis in 
situations of low testicular androgen concentration (O'Donnell et a/., 1996). 
Recent investigations using GnRH agonists and antagonists to suppress 
gonadotropin release have generated hopeful results (Behre and Nieschlag, 
1997). GnRH antagonist treatment in monkeys fails to reduce the testicular 
testostetone level below 30% of normal atter 15 weeks of treatment, even 
though the setum LH level is suppressed (Weinbauer et al., 1988). In a later 
study, only a small proportion of men treated with a GnRH antagonist were 
rendered azoospermic (Behre and Nieschlag, 1997). Combination of GnRH 
antagonist and testosterone treatment induced azoospermia in 88% of men 
(Behre and Nieschlag, 1997). Why addition of androgen to GnRH 
antagonist treatment should further reduce sperm production remains 
elusive. 
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It would seem that, for successful hormonal induction of azoospermia in 
healthy men, a combination of maximal blockade of androgen production 
(including Sa-reductase inhibition) in the testis with maximal repression of 
serum FSH, combined with adequate androgen stimulation of periphetal 
tissues, would be a prerequisite. This is a difficult combination to achieve, 
and with the necessity fot easy and cheap administration modalities, 
introduction of a hormonal male contraceptive will require much innovative 
research. 
Heterogeneity of androgen receptor expression 
Inter-individual variation in androgen receptor expression 
Early reporrs have illustrated the presence or absence of the nuclear androgen 
receptor within a number of human and animal tissues. With the advent of 
the realization that some diseases such as Reifenstein's syndrome (see Chapter 
5) can be the result of an abnormal expression of the androgen receptor, 
quantitative analysis of androgen receptor expression in cohorts of men were 
initiated. Subsequently a number of authors have reported a large variation in 
androgen receptor expression in cultured foreskin fibroblasts of normal men 
(Ei! et al., 1985; Morrow et al., 1987; Wilson et at., 1992). Our own data on 
the expression of androgen receptor in the testes of subfertile men with 
morphologically normal spermatogenesis, where infertility is probably the 
result of an obstruction of the epididymis or vas deferens, confirm these 
findings (Chapter 6). In some men, androgen immunoexpression was very 
low in both Serroli cells and peritubular myoid cells, whereas in other men 
both cell types displayed strong immunoexpression. Although some studies 
have suggested a lower androgen expression pattern in non testicular tissue to 
be associated with androgen resistance and subsequently subfertility (Morrow 
et at., 1987; Akin et at., 1991), our findings and those of others (Eil et at., 
1985; Bouchard et at., 1986) do not implicate that the level of androgen 
receptor expression is the cause of spermatogenic failure in a significant 
percentage of infertile men. The foundation for, and implications of, the 
apparently large variation in androgen receptor expression in apparently 
normal men remains to be elucidated. 
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Cellular variation in androgen receptor expression 
Cells within a tissue that display identical morphology are generally 
considered to perform identical functions. Although there may be some 
periodic cell-to-cell vatiation in function because of mitotic activity, generally 
the basic assumption would be that identical cells show comparable activities. 
Observations concerning the pattern of exptession of androgen receptor and 
the expression of androgen dependent proteins in both testis and epididymis 
tissue, now point to a functional variation between individual Sertoli cells 
and epididymal epithelial cells, which is quite unexpected, at least for the 
epididymal cells. 
The testis 
In 1994, two reports were published indicating that androgen receptor 
immunoexpression is variable in Sertoli cells within one and the san1e rat 
testis, and that this variation is tightly correlated with the stages of the 
spermatogenic cycle (Bremner et al, 1994; Vornberger et aI., 1994). It has 
previously been shown that androgen action seems to be mainly required 
around stage VII of the rat spermarogenic cycle (Sharpe, 1994), and the 
pattern of androgen receptor immunoexpression indeed would be in 
agreement with this. However, the mechanism of regulation of androgen 
receptor expression in rat Sertoli cells is still largely unresolved. Androgen 
receptor expression is apparently mainly regulated at the level of gene 
transcription, as the androgen receptor mRNA level varies with the stages of 
the spermatogenic cycle in synergy with changes in the AR protein level 
(Shan et al., 1995). The stage dependence of expression of the androgen 
receptor suggests that germ cells may exert an important regulatory influence. 
Experiments using methoxyacetic acid (MAA) to induce degeneration of 
pachytene spermatocytes and round spermatids failed to disrupt the stage-
dependent expression of the androgen receptot in Sertoli cell nuclei, 
indicating that possibly the earlier germ cell types might be of pivotal 
importance for this regulation (Bremner et aI., 1994). However, our own 
unpublished data, regarding treatment of rats with busulfan resulting in the 
destruction of spermatogonia and primary spermatocytes, similarly did not 
result in disruption of the normal androgen receptor expression pattern 
(unpublished observations). Possibly, any part of the germ cell complement is 
capable of regulating this aspect of Sertoli cell function, and only full 
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elimination of all germ cells might induce a uniform androgen receptor 
expression pattern in Sertoli cells. Adult Sertoli cells taken out of their 
testicular milieu (ex vivo) and cultured in the presence of androgen, display a 
more or less uniform androgen receptor staining pattern (unpublished 
observations). 
Interestingly, our study described in Chapter 6 indicates that, contrary to the 
situation in the rat, Sertoli cells in the human testis display a pronounced, bur 
random variation in androgen receptor immunoexpression, not related to the 
stage of the spermatogenic cycle. The reason for this difference in androgen 
receptor expression in Sertoli cells of the human testis versus the rat is not 
clear. Possibly the different organization of the seminiferous epithelium in 
man compared to that in the rat, involves a more dynamic and heterogeneous 
series of Sertoli cell-germ cell interactions. Furthermore, the subdivision of 
the human spermatogenic cycle in only six stages may be too imprecise, 
obscuring stage dependent differences in Sertoli cell androgen receptor 
immunoexpression (Clermont, 1963). Further study will be required to 
comprehend the possible biological significance of these observations. 
The epididymis 
Our studies of the pattern of androgen receptor expression in the epithelial 
cells of the rat epididymis, disclosed a regional variation in nuclear androgen 
receptor imunoexpression (Chapter 7). In the efferenr ductules, androgen 
receptor immunoexpression in the nuclei of the epithelial cells was found to 
be very low. From the initial segment onwards, androgen receptor immuno-
expression was prominent. In situ hybridization studies of androgen receptor 
mRNA showed a high mRNA level in the initial segment, and much lower 
levels further distal. Apparently, the expression of androgen receptor in the 
epididymis is regulated, at least in part, at the translational level. 
Most intriguing in the study of androgen receptor expression in the nuclei of 
epididymal epithelial cells, was the observation that this expression was 
highly heterogeneous for different nuclei within a single tubule cross section, 
especially in the capur (Chapter 7). In situ hybridisation studies revealed a 
similar variation in cell-to-cell androgen receptor mRNA expression, 
suggesting that this seemingly cell-autonomous, differential expression might 
also be regulated at the transcriptional level. As the level of androgen receptor 
expression may be closely related to androgen driven cell activities, we per-
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formed double stammg experiments with antibodies targeting mouse 
epididymal protein 10 (MEP 10), a mouse homologue of tat proteins B/C 
(Rankin et al., 1992a; Rankin et al., 1992a). The expression of proteins B/C 
in the rat epididymis, is highly regulated by androgen (Brooks and Higgins, 
1980). Surprisingly, a considetable number of cells expressing proteins B/C 
expressed a very low level of androgen receptor. 
It is important ro note, that in the studies described in Chapter 7, the 
epididymides were fixed in Bouin's solution. In our experience, androgen 
receptor immunoexpression is slightly less prominent in tissues fixed in 
Bouin's compared to formalin. Nevertheless, variation of androgen receptor 
exptession in the epithelial cells of the tat epididymis was also observed in 
formalin-fixed tissue, albeit with less variation in intensity. Because all our 
results wete highly reproducible, with a cleat regional pattern in the 
heterogeneity of androgen receptor immunoexpression, we are confident that 
our results are robust and not due to artifact. 
Other non-malignant tissue 
Not many teports have attested to similar pronounced cell-to-cell variation in 
AR expression in other tissues. Articles by Janssen et al. (1992) and Kimura et 
at. (I994), do not mention any heterogeneity in androgen receptor 
expression in any of the tissues studied. A report by Ruizeveld de Wintet et al. 
(1991) includes a number of cell types in human organs, whete immuno-
expression of androgen receptor, observed using a mouse mono-clonal 
antibody (F39.4), was found to be slightly vatiable, indicated by +1- or ++1-. 
These cell types ate: myoid cells and fibroblasts in the testis, fibroblasts and 
smooth muscle cells in the accessory sex organs, foreskin fibroblasts, 
squamous cells and fibroblasts in the ectocervix and vagina, and the ducts and 
acini of the mammary gland. Contrary to our findings, the later report 
classified Sertoli cells as invariably positive. A teport by Takeda et al. (I 990) 
classifies a numbet of rat cell types and tissues as having heterogeneic 
immunoexpression of androgen receptor in a qualitative manner. These 
include the stroma and smooth muscle of the prostate, the stroma of the 
seminal vesicles, the epithelium of the coagulating gland, the sttoma and 
smooth muscle of the epididymis, the epithelium of the urerus, female (but 
not male) hepatocytes, and the endoctine cells and pituicytes of the pituitary. 
However, Takeda et al. (I990) have classified Sertoli cell androgen receptor 
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immunoexpression to be posItIve, without heterogeneity. Although the 
reports by Ruizeveld de Winter et al. (1991) and Takeda et aL (1990) indicate 
a limited degree of heterogeneity of androgen receptor immunoexpression in 
several cell types (the above-mentioned cells varied in androgen receptor 
immunoexpression from no expression at all, to a variable level of expression), 
their results acrually indicate a much wider range of cell types that vary from 
low expression to high levels of androgen receptor immunoexpression, 
indicated by +++/ + or ++/ +. It is very likely that upon closer scrutiny many 
more androgen receptor positive tissues will display a marked heterogeneity 
in androgen receptor expression. A recent article reporting on androgen 
receptor immunoexpression in human hepatocytes indicates a heterogeneous 
expression, with 50% to 90% ofhepatocyres staining positively (Hinchliffe et 
al., 1996). It is presently not clear whether all androgen taget tissues display a 
heterogeneic pattern of androgen receptor expression. In addition, the 
functional significance of intercellular varialtion in expression of the 
androgen receptor in various tissues remains to be disclosed. 
Malignancies 
Heterogeneity of androgen receptor expression has for some time been 
observed in malignancies, in particular in prostate adenocarcinoma. 
Androgen ablation therapy is the indicated treatment in advanced prostate 
cancer, resulting in only a temporary remission of rumor growth (Schroder, 
1998). Prostate rumors that progress under androgen ablation and/or 
blockade, have become androgen independent. As the androgen signal must 
involve the androgen receptor, a great deal of effort has been put into trying 
to correlate the degree of androgen receptor expression in prostate tumors 
and prognosis, with varying results (Sadi et aL, 1991; Prins et al., 1998). 
An interesting study where androgen receptor immunostaining was com-
bined with immunostaining for prostate-specific antigen (PSA; a highly 
androgen dependent protein) in prostate carcinoma, revealed no correlation 
between androgen receptor positive cells and PSA positive cells (Ruizeveld de 
Winter et at., 1994). These findings are strikingly similar to out observations 
in the rat epididymis (Chapter 4). Although malignant tissue is in many ways 
very different from non-malignant tissue, the mechanism behind the 
observed variation in androgen receptor expression, and the apparent non-
association with the expression of androgen dependent proteins may be 
similar. 
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Heterogeneity of androgen receptor expression has also been found in other 
malignancies including ovarian tumors (Chadha et at., 1993). 
Malignant tissue is very different fom healthy tissue, and alternative 
mechanisms possibly are involved in cellular heterogeneity of androgen 
receptor expression. Tumor cells vary in the degree of cell differentiation, 
which may explain the lack of androgen receptor in a part of the tumor cell 
population. This notwithstanding, it remains remarkable that androgen 
receptor negative prostate tumor cells continue to express PSA (Ruizeveld de 
Winter et al., 1994). This observation, and the present observation (Chapter 
4), that some androgen receptor-negative epididymal epithelial cells in rats 
express a highly androgen-dependent protein, may point to a cyclic activity of 
androgen-dependent cells. This cyclic activity would involve, in a temporal 
sequence, expression of tbe androgen receptor, followed by expression of an 
androgen-dependent protein, where finally the latter protein will still be 
prominent also after the androgen receptor exptession has disappeared. Thete 
is, however, very little experimental evidence to support this view. Conversely, 
the androgen-dependent protein in both the epididymis and in prostate 
cancer cells might be tegulated by factors that can override androgen 
influence (Ruizeveld de Winter et at., 1994). Further research is needed to 
clarifjr this point. 
The genetic integrity of the paternal gamete 
Why explore the genes within the spermatozoon? 
Although male factor infertility is often difficult to treat, the development of 
artificial reproductive techniques [intra-uterine insemination, in vitro 
fertilization (TVF), intra cytoplasmic sperm injection (TCST), with or without 
testiculat sperm extraction (TESE) or microsurgical epididymal sperm 
aspiration (MESA)] have opened up the way for men even with vety low 
sperm counts to father a child. With the advent of these protocols, howevet, 
have come concerns with regard to the health of the offspring. Particularly 
TCST, where a laboratory technician singles out a spermatozoon with which 
to fertilize an oocyte, has attracted criticism, because natural barriers to 
fertilization and possible sperm selection mechanisms are circumvented 
(Vogt, 1995b). The rCST technique is indeed one of the very few widely 
implemented medical treatments, for which the safety has not been 
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demonstrated. Only recently, animal studies have started to investigate the 
fundamental aspects ofICSI in mice (Yanagimachi, 1998). 
Sperm chromosomal and other genetic deflcts 
Cytogenetic studies of spermatozoa have shown large differences in the 
genetic quality of spermatozoa from fertile and infertile men. Pang et al. 
(1995) have shown a more than la-fold increase in the frequency (19.6% 
versus l.5%) of diploidy, autosomal disomy, autosomal nullisomy, sex 
chromosome number disorder, and the total number of chromosomal 
abnormalities for oligo-astheno-teratozoosperm.ic males versus fertile donors 
(Pang et al., 1995). Moosani et al. (1995) found an increase in the ftequency 
of disomy for chromosome 1 and a highet ftequency of XY disomy in 
spermatozoa of infertile men. Noteworthy is that all the infertile men studied 
in the above two teports had a normal somatic karyotype, indicating that the 
chromosomal abberrations in the spetmatozoa are the tesult of impaired 
spermatogenesis. This implicates that when ICSI is employed to concieve a 
child using sperm from a sevetely oligozoospermic man, chances of cteating 
offspring with chromosomal abnormalities are increased. A large number of 
autosomal aneuploidies are not viable and will result in abortion. Sex 
chromosome aneuploidy, however, is compatible with life. Indeed it has been 
shown that application of ICSI may result in increased incidence of sex 
chromosome aberrations in the offspring (In't Veld et al., 1995; Liebaers et 
ai, 1995; In't Veld etal, 1997). 
Next ro chromosomal abnormalities that ate created during deficient 
spermatogenesis, constitutional genetic anomalies are themselves also the 
cause of male infertility. It is estimated that about 600 to 700 genes ate 
involved in the reproductive cycle (Vogt, 1995a), although this numbet may 
be conservative. Some of these genes are involved in the organogenesis of the 
male reproductive tissues, while others are involved in a variety of functions 
in adulthood including gametogenesis. Recent estimates indicate that about 
30% of spermatogenic defects are genetically determined (Vogt, 1997b). If 
these figures are correct, genetically determined male infertility would 
account for the majority of cases of 'idiopathic infertility'. If spermatozoa can 
be retrieved from these men and used in artificial reproductive techniques, 
the defective genes may be passed on to the offspring. 
A large number of genetic defects resulting in some form of male infertility 
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have been identified (see Chaptet 5). This lengthy list, however, entails only a 
small number of men that are seen at an andrology clinic. Recent discoveries 
of the importance of deletions in specific regions of the long arm of the Y 
chromosome, are important advances due to intensive investigation and 
search for the genetic determinants of male infertility (Vogt, 1995; Vogt et aI., 
1996; Dohle etal., 1998; Roberts, 1998). Although earlier reports suggest an 
important role for androgen receptor mutations in otherwise normal infertile 
males (Aiman et aI., 1979; Aiman and Griffin, 1982; Morrow et al., 1987), 
our own study (Chapter 6) and those of others do not support this data (Eil 
et al., 1985; Bouchard et aI., 1986). The putative role of the polymorphic 
polyglutamine stretch in exon 1 of the androgen receptor in the regulation of 
its transcriptional activity, with long polyglutamine stretches being associated 
with relatively poor spermatogenesis, is highly interesting (Tut et aI., 1997). 
More research is needed to disclose whether a mild androgen receptor defect 
may play an important role in the pathogenesis of infertility in otherwise 
normally androgenized males. 
IdentifYing the genetic defects behind male subfertility is vital for adequate 
diagnosis, genetic councelling, and ultimately for the development of 
treatment modalities. In light of the above, it seems prudent that all couples 
undergoing I CSI because of spermatogenic defects, regardless of the cause, 
undergo genetic counselling. It is equally compelling that techniques are 
developed with which certain aspects of the integrity of the sperm DNA can 
be evaluated prior to referral of the couple for ICS!. 
Spermatogenic derailment: can clues be found within the sperm nucleus? 
Spennatogenesis involves complex changes in chron1atin arrangement 
(Baarends et aI., 1998). Probably before meiosis commenses, genomic 
imprints are erased after which a paternal mode of genomic imprinting is 
embedded into the DNA. Subsequently, homology search of the autosomes, 
synapsis and homologous recombination takes place. Finally, the entire 
nucleoprotein strucrure is altered by first partly replacing somatic histones by 
testis-specific histones, followed by replacement of histones by transition 
proteins, and subsequently by protamines (Meistrich and Brock, 1987). 
Derailment of anyone of these processes may well result in isolated male 
infertility as is elegantly illustrated by a number of transgenic and knockout 
mouse models (see Chapter 5). Targeted disruption of the HR6B gene (an 
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ubiquitin-conjugating DNA repair enzyme) in the mouse, results in a 
spermatogenic defect at the level of post-meiotic condensation of spermatids 
(Roest et aI., 1996). Ectopic expression of avian protamine (galline) in 
spermatids of transgenic mice, results in disruption of sperm nuclear 
condensation, and infertility (Rhim et aI., 1995). 
It is well known that, contrary to other mammals studied, 15% of human 
sperm protein content is comprised of histones rather than protamines 
(Tanphaichitr et aI., 1978). Whether these histones are associated with 
specific DNA sequences and act as markers for genes that are poised for early 
expression after fertilization (Sawicki et aI., 1981; Gardiner-Garden et aI., 
1997), or whether the sperm histones are a sign of imperfection of human 
spermatogenesis, is unknown. The study of the nucleoprotein composition of 
human spermatozoa and its relation to infertility is still in its early stages. 
Numerous studies using a number of different tecbniques have indicated the 
presence of a larger histone fraction in the spermatozoa of infertile males 
(Chevaillier et al., 1987; Hofmann and Hilscher, 1991; Foresta et al., 1992). 
Suboptimal rearrangement of nucleoproteins during spermatogenesis or 
sperm maturation, resulting in a relatively higher sperm histone content 
undoubtedly has a multitude of possible causes. It is highly likely that a 
number of genetic mutations can, directly or indirectly, result in a defective 
step in the histone-to-protamine transition process. Further evidence for 
defective processes in nucleoprotein rearrangements during human 
spermatogenesis is given by a number of studies that have shown differences 
in the protamine l/protamine 2 ratio in spermatozoa from fertile and sub-
fertile males (Khara et aI., 1997; Yebra et aI., 1998). Mutations in transition 
proteins or protamines, however, have not yet been found in infertile males 
(Schlickeretal., 1994). 
It has been shown that a number of endogenous and exogenous factors can 
result in the production of morphologically abnormal spermatozoa or in a 
higher fraction of spermatozoa with DNA damage, none of these studies have 
attempted to elucidate specific changes in sperm nuclear protein content (el-
Gothamy and el-Samahy, 1992; Foresta et al., 1992; Hou et aI., 1995; Shen 
et aI., 1997). Differences in the sperm nuclear protein content of subfertile 
males may provide an insight in human spermatogenic dysfunction. We have 
characterized an antibody that specifically targets testis-specific histone 2B 
(TH2B) in human testis tissue and human spermatozoa (Chapter 7). Our 
studies indicate a highly variable inter-individual sperm TH2B content, that 
marginally correlates with sperm morphology. Furthermore, a highly hetero-
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geneous expression of TH2B was observed in spermatozoa of a single 
ejaculate. It is tempting to speculate that certain causes of spermatogenic 
dysfunction (such as genetic or hormonal dysregulation, or exposure to heat 
or toxins) may result in deviation from normal sperm nuclear protein 
composition. If this indeed proves to be the case for even a small number of 
causes of male infertility, determination of the sperm nuclear protein 
composition may become a useful diagnostic tool. 
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Summary 
Spermatogenesis and sperm maturation afe both processes that require fine-
tuned interplay of a large number of processes. The mechanisms involved in 
control of male reproductive physiology have been the subject of intensive 
research and many important factors have now been identified and studied in 
laboratory animals and in man. A brief introduction to the current 
understanding of male sexual development and reproductive physiology is 
given in Chapter 1. 
In Chapter 2 a review is presented, regarding the regulation of spermato-
genesis and sperm maturation by androgens. Many years ago, it was realized 
that testosterone is one of the prilne regulators of male reproductive function. 
Testosterone is synthesized by rhe Leydig cells of the testis under the 
influence of pituitary LH, and is of vital importance for the morphogenesis of 
the male phenotype, including the initiation and maintenance of spermato-
genesis and sperm maturation. The prime targets for testosterone in the testis 
are the Sertoli cells, the peritubular myoid cells, and the Leydig cells. Germ 
cells do not express the androgen receptor and are thus unlikely to be directly 
influenced by androgens. The precise role of androgens in spermato-genesis, 
however, remains unclear. The testis needs a much higher level of testosterone 
for normal spermatogenesis, compared to what is needed for normal function 
of other androgen-dependent organs, such as the prostate and seminal 
vesicles. In many androgen dependent tissues, testosterone is converted into 
the more potent 5a-dihydrotestosterone (DHT) through the activity of 50.-
teductase. The activity of 5a-reductase is very low in the testis. The 
epididymis, which is highly dependent on 5a-reductase activity for normal 
function, is a unique organ, in that it obtains testosterone directly frOlll the 
testicular fluids via the ductuli efferentes, and indirectly via the bloodstream. 
Stimulation by androgens is essential for the synthesis and secretion of a 
number of proteins by the epithelial cells of the epididymis, that are vital for 
sperm maturation and sperm storage. 
In Chapter 3 a study is presented, aimed at disclosing the role of testosterone 
metabolism and androgen binding protein (ABP) in the rat testis. In order to 
create an animal model, ro specifically study the effect of varying doses of 
androgen on spermatogenesis, mature Leydig cells were destroyed using 
ethane dimethane sulfonate (EDS). A GnRH antagonist (GnRHa; Org 
30267) was given to reduce LH stimulation, and thereby the differentiation, 
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of remaining immature Leydig cells. To ensure adequate FSH levels in all 
treatment groups, all rats were supplemented with recombinant human FSH 
(rec-hFSH; Org 32489). Rats were treated with different doses of either 
testosterone propionate (Tp) or methyltrienolone (RI881). RI881 is a 
synthetic androgen that is not metabolized and does not bind to ABP. The 
dose-response curve (maintenance of testis weight) of the accessory sex organ 
weight of rats treated with Tp showed a far more pronounced rise to 
increasing Tp doses, compared to that of testis weight. At a serum testos-
terone (T) level of 1.6 nglml, the accessory sex organ weight was not different 
from that of control animals. Testis weight, however, was less effectively 
maintained, and was still significantly lower than control at a serum T level of 
6.1 ngl m!, indicating that the rat testis needs much a higher level of 
testosterone for maintenance of organ weight, compared to the accessory sex 
organs. Similar dose-response curves were observed, however, for the 
accessory sex organs and the testis of rats treated with R1881. Additional 
experiments, in which Leydig cell depleted rats were sup-plemented with Tp 
and treated with finasteride (a potent 5a-reductase inhibitor), showed a 
similar response of the testis and accessory sex organs. These obsevations 
indicate that the difference in 5a-reductase activity in the accessory sex 
organs, compared to the testis, results in the need for a relatively high level of 
testosterone in the testis for normal function. 
Epididymal cell function is highly dependent on stimulation by androgens. 
Chapter 4 describes results of experiments on the expression of androgen 
receptor mRNA and protein, as studied in the rat epididymis. Androgen 
receptor immunoexpression in the epididymal epithelial cell nuclei is weak in 
the efferent ducts. The nuclei of the epithelial cells of the initial segment, 
caput, corpus, and cauda show a more intense immunosigna1. Ligation of the 
efferent ducts did not result in a lower intensity of expression of androgen 
receptor in the caput or cauda as studied by immunoblotting. Withdrawal of 
testosterone by castration, resulted in a marked decrease of androgen receptor 
immunoexpression in all epididymal cells. Interestingly, adjacent and 
morphologically identical, epithelial cells, display a heterogeneous expression 
of androgen receptors. Androgen receptor mRNA was visualised by in situ 
hybridisation in control rat epididymis. AR mRNA level was hight in the 
intial segment, and is relatively lower further distal. In consecutive 8am 
sections, alternately stained for AR protein and AR mRNA, regions with high 
AR immunoexpression appeared to correlate with regions of high AR mRNA 
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content, indicating that the cell-to-cell heterogeneity in AR expression may 
be regulated at the transcriptional leveL In addition, double-staining studies 
were performed using antibodies targeting the AR and a highly androgen 
dependent protein; proteins B/C. Surprisingly, no correlation was found 
between the cellular expression of AR and proteins B/C. High levels of 
nudear AR staining were observed in epithelial cells devoid of proteins B/C, 
and vice versa. The implications of these observations are discussed in 
Chapters 4 and 8. 
When any part of the intricately regulated series of molecular events within 
the male reproductive system dysfunctions, male infertility may ensue. It is 
estimated that, world-wide, about 60 to 80 million couples are unable to 
conceive a child. In 50% of these couples, the male partner has abnormal 
semen parameters according to the WHO criteria. While a number of 
primary and secondary causes of male infertility are known, a large portion of 
infertile men who visit the andrology dinic have subnormal semen 
parameters, for which no cause can be found (idiopathic infertility). It is 
increasingly clear that many men with idiopathic infertility may have an 
underlying genetic defect, resulting in spermatogenic impairment. Modern 
assisted reproductive techniques, especially intracytoplasmic sperm injection 
(ICSI), may result in transfer of genetic defects to the offspring, possibly 
resulting in infertility in the male progeny. A better understanding of the 
genetic determinants of male infertility and possible secondary effects of testis 
dysfunction on the integrity of sperm DNA, is highly desirable. This 
lmowledge may help the medical community to provide couples with 
adequate counselling, and assisted reproductive techniques with the lowest 
possible risk to the offspring. 
Androgen insensitivity has been implicated as a causative factor in otherwise 
well androgenized men. In previous studies on the role of androgen 
insensitivity in male infertility, the androgen receptor was studied in llOll-
testicular tissue. As shown in Chapter 3, the testis responds differently from 
other androgen dependent organs when it comes to the response to testos-
terone. In Chapter 6, a study is presented where androgen receptor immuno-
expression was studied in testes of 37 subfertile men, using a polyclonal 
antibody. Androgen receptor immunoexpression is observed in the nuclei of 
Sertoli cells, Leydig cells, peri tubular myoid cells and in cells associated with 
arterioles. Germinal cell nuclei are negative in every stage of development. 
Interestingly, while in the rat testis the intensity of androgen receptor 
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immunoexpression in Sertoli cell nuclei is dependent on the stage of the 
spermatogenic cycle, no such phenomenon could be discerned in the human 
testis. In all stages of the human spermatogenic cycle, Sertoli cell nuclei could 
be found that showed either intense or weak staining. The intensity of 
androgen receptor immunostaining in Serroli cell nuclei was not related to 
the quality of spermatogenesis, as assessed by the Johnsen criteria. There was 
a wide variation of androgen receptor immunoexpression in Serroli cells in 
testes of men with all gradations of spermatogenic defects. A clear relation of 
androgen receptor expression and male infertility could not be established in 
this population. 
Impairment of testicular function Inay cause a decrease in sperm production, 
together with a decrease in sperm motility and morphology; a condition 
known as oligo-astheno-teratozoospermia. Many infertile men presenting 
with such selnen parameters have no apparent other abnormalities) nor can a 
cause for this condition be found. Derailment of spermatogenesis, indepen-
dent of its cause, often results in imperfections in the replacement of his tones 
by protamines in the sperm nucleus, possibly resulting in a higher risk of 
sperm DNA damage. In Chapter 7, a study is presented where an antibody 
targeting tyrosine hydroxylase, which cross-reacts with rat testis-specific 
histone 2B (TH2B), was used to study the expression ofTH2B in the human 
testis. First, it was established that the antibody indeed specifically stains 
TH2B in the human testis, using Western blot, acid-urea-Triton gels and 
immunohistochemistry. TH2B immunoexpression was found in all human 
germinal cells, including spermatogonia. In condensed spermatids and 
spermatozoa, TH2B immunoexpression could only be discerned after decon-
densation of the nuclei. Spermatozoa of 35 infertile men were analysed for 
TH2B content. Using Western blot, a marked inter-individual variation of 
TH2B content in spermatozoa was found, that marginally correlated with 
sperm morphology. The lower the fraction of morphologically normal sperm 
within an ejaculate, the more prominent the TH2B signal. Furthermore, 
using immunocytochelnistry, a clear intercellular heterogeneity in sperm 
TH2B signal was observed within ejaculates. The significance of this observa-
tion, and the fertilising ability of spermatozoa with high TH2B content 
remains to be established. 
In Chapter 8, the findings presented in this thesis, and their clinical implica-
tions are discussed in relation to current literature and knowledge, in the area 
of molecular and clinical andrology. 
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Spermatogenese en zaadcelrijping zijn afhankelijk van een nauwkeurig 
gestuurde wisselwerking tussen een groot aantal moleculaire processen. De 
moleculair biologische grondslag van de mannelijke voortplantingsfYsiologie 
is al jarenlang onderwerp van intensief wetenschappelijk onderzoek. Vee! van 
de factoren die hierbij zijn betrold<en zijn inmiddels bekend en bestudeerd, in 
mensen en proefdieren. Hoofdstuk 1 betreft een korte introductie van de 
huidige kennis met betrekking tot de mannelijke geslachtsontwikkeling en 
voortplantingsfYsiologie. 
Hoofdstuk 2 geeft een overzicht van de regulatie van de spermatogenese en 
zaadcelrijping door androgenen. Het is inmiddels vele jaren bekend dat het 
steroidhorrnoon testosteron, een androgeen, cen van de belangrijkste 
regulatoren van mannelijke voortplantingsfnncties is. Testosteron wordt door 
de Leydig cellen in the testis aangemaakt en uitgescheiden, na stimulatie van 
de Leydig cellen door het hypofYsaire LH (lute"iniserend hormoon). Het 
hormoon testosteron is van essentieel belang voor de ontwikkeling van het 
mannelijk fenotype, inclusief de totstandkoming en regulatie van de 
spermatogenese en zaadcelrijping. In de testis zijn het met name de Sertoli 
cellen, de perirubulaire myoid cellen en de Leydig cellen, die in hun 
functioneren door testosteron worden be1nvloed. De germinale cellen 
brengen geen androgeenreceptor tot expressie, zodat het niet waarschijnlijk is 
dat hun functie direct door androgenen wordt gereguleerd. De preciese rol 
van androgenen in de regulatie van de spermatogenese is echter nog steeds 
cen raadsel. De testikels bevatten een zeer hoge concentratie testosteron, en 
het blijkt dat een hoge concentratie nodig is om spermatogenese te laten 
plaatsvinden. Andere androgeenafhankelijke organen, zoals de prostaat of de 
zaadblazen, kunnen normaal functioneren bij een relatief lage testosteron 
concentratie, zoals die in de circulatie wordt aangetroffen. In de meeste 
androgeengevoelige organen wordt testosteron door het enzym Sa-reductase 
omgezet in een meer actieve metaboliet, Sa-dihydrotestosteron (DHT), maar 
in de testis is de Sa-reductase activiteit laag. De epididymis (meervoud: 
epididymides), die voor adequate functie wel afhankelijk is van Sa-reductase 
activiteit, is cen uniek orgaan, omdat het via twce routes testosteron krijgt 
aangeboden. Hoge concentraties testosteron komen vanuit de testis de 
epididymis binnen, via de ductuli efferentes. Tevens wordt de epididymis 
gestimuleerd door testosteron afkomstig uit de bloedvoorziening. Stimulatie 
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door androgen en is een absolute noodzaak voor de normale zaadcel-rijpings 
en -opslag functies van de epididymis. 
In Hoofdstuk 3 wordt een studie gepresenteerd, die beoogt een beter inzicht 
te geven in de rol van het metabolislne van testosteron, en de rol van 
androgeen bindend eiwit (ABP), in de spermaragenese. Om een proefdier-
model te verkrijgen, waarmee specifiek het effect van verschillende hoeveel-
heden androgeen op spermatogenese kon worden bestudeerd, werden de 
mature Leydig cellen verwijderd door behandeling van volwassen ratten met 
EDS. Vervolgens werd een GnRH antagonist (GnRHa; Org30267) 
toegediend om de LH secretie, en daarmee de differentiatie van immature 
Leydig cellen, te remmen. Om adequate FSH spiegels te behouden, werden 
aIle ratten met een humaan recombinant FSH (rec-hFSH; Org32489) 
behandeld. De ratten werden gesupplementeerd met verschillende doses 
testosteron propionaat (Tp) of een synthetisch androgeen, methyltrienolon 
(RI88I). Van belang bij dit experiment, is dat RI881 niet wordt 
gemetaboliseerd en niet bindt aan ABP. Voor het effect van Tp op behoud van 
gewicht, was de dosis-response curve van de accessoire geslachtsklieren was 
beduidend steiler dan die van de testis. Dit impliceerd dat de testis minder 
gevoelig is voor testosteron dan de andere androgeen-afhankelijke organen. 
Echter de dosis-respons curves toonden in met RI881 behandelde ratten een 
vrijwel identieke helling, waarmee werd aangeraond dat de testis en de 
accessoire geslachtsklieren in gelijke mate gevoelig zijn voor dit synthetisch 
androgeen. Aanvullende experimenten, waarbij ratten werden behandeld met 
EDS en gesupplementeerd met Tp, met of zander finasteride (een krachtige 
Sa-reductase remmer), maakten aannemelijk dat het verschil in testosteron-
gevoeligheid tussen testikels en andere geslachtsklieren groten-deels wordt 
veroorzaakt door een verschil in 5a-reductase activiteit. 
De epididymale epitheliale cellen zijn voor hun functie sterk afhankelijk van 
androgeen. In de experimenten beschreven in Hoofdstuk 4 word de expressie 
van de androgeenreceptor (AR) onderzocht, door bestudering van de 
aanwezigheid van het AR mRNA en eiwit in de epididymis. De immuno-
expressie van AR eiwit in de celkernen van de epitheelellen van de ductuli 
efferenres was zwak. De nuclei van de epitheliale cellen van de rest van de 
epididymis was duidelijk sterker gekleurd. Ligatie van de ductuli efferentes 
had geen duidelijk effect op de intensiteit van immunoexpressie van AR in de 
epididymis. Bij sterke verlaging van de serum testosteron waarden door 
middel van castratie, werd een duidelijke afname van de intensiteit van AR 
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immunoexpressie in aile epididymale cellen waargenomen. De epitheliale 
cellen van epididymides van onhehandelde ratten toonden een opvallende 
heterogeniteit in de mate van AR immunoexpressie. De intensiteit van de 
immunokleuring vetschilde sterk, voor kernen van naast elkaar gelegen 
morfologisch identieke cellen. Expressie van androgeenrecepor mRNA in 
onhehandelde ratten, wetd geanalyseetd door middel van in situ hyhridisatie. 
AR mRNA expressie was hoog in de ductuli efferentes, en lager in de rest van 
de epididymis, waarbij eveneens een rclatief intercellulaire heterogeniteit van 
de hoeveelheid AR mRNA werd gezien tussen aanliggende epitheliale cellen. 
Met opeenvolgende 8 flm dikke coupes, die alternerend werden gekleurd op 
AR immunoexpressie en AR mRNA exptessie, werd aannemelijk gemaakt dat 
cellen met een lage intensiteit van AR immunoexpressie ook een lage AR 
mRNA expressie hebben. Dit zou een indicatie zijn dat de variatie in 
nucleaire AR eiwit expressie, in epididymale epitheliale ceUen, op het niveau 
van de transcriptie wordt gereguleerd. Tevens werden er dubbelkleuringen 
uitgevoerd waarbij op dezefde coupes AR werd gekleurd alsmede het 
androgeenafhankelijke eiwit Proteins B/C. OpvaUend genoeg was er geen 
enkele correlatie tussen de expressie van de AR en de expressie van Proteins 
B/C. Over implicaties van deze bevindingen worden in Hoofdstuk 4 en 8 
gedisCllssieerd. 
Het nauwkeurig gestuurde moleculaire samenspel dat ten grondslag ligt aan 
de mannelijke voortplantingsfuncies, kan ontregeld raken, resulterend in 
mannelijke subfertiliteit. Wereld-wijd, zijn naar schatting ongeveer 60 tot 80 
miljoen paren onvruchtbaar. Bij de helft van deze paren heeft de mannelijke 
partner, volgens criteria van de werldgezondheidsorganisatie (WHO), 
semenafWijkingen. Ook al is tegenwoordig een groot aantal oorzaken van 
mannelijke infertiliteit bekend, een groot deel van de mann en die naar een 
andrologie polikliniek komen hebben semenafWijkingen met onbekende 
oorzaak (idiopathische infertiliteit). Het wordt in toenemende mate duidelijk 
dat een genetische afWijking ten grondslag ligt aan een groot percentage 
infertiliteitsproblemen hij mannen. Moderne geassisteerde voortplantings-
technieken, met name intracytoplasmatische sperma injectie (ICS!), zuUen er 
zonder twijfel aan bijdragen dat enkele defecten worden doorgegeven aan het 
nageslacht, met als mogelijk resultaat infertiliteit bij mannelijke 
nakomelingen. Een beter begrip van de genetische determinanten van 
mannelijke infertiliteit, en van mogelijke effecten van een afWijkende 
spermatogenese op het DNA van zaadcellen, is van groot belang om paren 
met een nog onvervulde kinderwens goed te kunnen informeren, alsmede om 
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de meest geschikte en veilige geassisteetde voortplantingstechnieken aan te 
kunnen bevelen. 
Androgeenongevoeligheid door mutatie van de AR is een van de genetische 
afWijkingen die mogelijk aan mannelijke infertiliteit ten grondslag ligt. 
Voorgaande studies die soms wel en SOlTIS niet een verband aantoonden 
tussen een verminderde expressie van de androgeenreceptor en mannelijke 
infertiliteit, maakten gebruik van (genitale) huidfibroblasten. Zoals in 
Hoofdstuk 3 werd aangetoond, is de respons op testosteron van de testis 
anders dan die van andere androgeen-afhankelijke organen. Mogelijk komt 
een mild androgeenreceptor defect, dat kan leiden tot infertiliteit zonder 
aanrasting van andere aspecten van het mannelijke fenotype, duidelijker rot 
uiting in de testis. In Hoofstuk 6 wordt een studie beschreven waarbij, in 
testisbiopten van infertiele mannen, middels immunohistochemie androgeen 
teceptor eiwit werd geldeurd en geanalyseerd. AR immunoexpressie werd 
waargenomen in de kemen van Sertoli cell en, Leydig cellen, petitubulaire 
myoid cellen en cellen geassocieetd met arteriolen. Germinale cellen waren 
negatief tijdens aile ontwikkelingsstadia van de spermatogenese. Tijdens de 
z.g. spermatogenetische cyelus werd geen stadium-afhankelijke variatie in 
intensiteit van AR immunoexpressie in de kernen van de Sertoli cellen 
aangetroffen, zoals dat wei bij knaagdieren wordt gevonden. Vanuit k1inisch 
perspectief, was het interessant dat de intensiteit van AR immunoexpressie in 
de humane Sertoli cellen niet was gecorreleerd met de kwaliteit van de 
spermatogenese, zoals beoordeeld middels de Johnsen criteria. Er was een 
groot interindividueel verschil in de mate van AR immunoexpressie in aile 
gradaties van hypospermarogenese en microscopisch normale spermato-
genese. Een duidelijke relatie tussen de mate van AR immunoexpressie en 
mannelijke infertiliteit kon in deze groep niet worden aangetoond. 
Een aangetaste spetmatogenese, door welke oorzaak dan ook, kan een 
vetminderd aantal, vermindetde beweeglijkheid, en een verslechterde mor-
fologie van zaadcellen teweeg brengen; een beeld dat bekend staat als oligo-
astheno-teratozoospennie. Mannen met een dergelijk semenbeeld hebben 
meestal geen andere afwijkingen, en vaak kan geen oorzaak voor deze situatie 
worden gevonden. Een aangetaste spermatogenese, oak al is de oorzaak niet 
primair genetisch, kan imperfecties in de compactie van het DNA in de 
zaadcellen veroorzaken, met een minder volledige vervanging van hisronen 
door protamines. Dit zou een vergroting van de kans op zaadcel-DNA schade 
kunnen veroorzaken. In Hoofdstuk 7 wordt een studic gcpresenteerd waarin 
immunoexpressie van testis-spccifiek histon 2B (TH2B) in menselijke testis 
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en zaadceUen is bestudeerd, middels een antilichaam tegen tyrosine 
hydroxylase, dat een kruisreactie vertoond met TH2B van de tat. Allereerst 
werd aangetoond dat anti-tyrosine hydroxylase inderdaad ook kruisreageert 
met menselijke TH2B met behulp van 'SDS-PAGE' en Western blot, 'acid-
urea-Triton gels', en immunohistochemie. TH2B werd aangetoond in aUe 
germinale celstadia, inclusief de spermatogonia. In geeondenseerde zaadeeUen 
was de TH2B immuno-expressie zichtbaat decondensatie van de zaadee!kern. 
Zaadcellen van 35 mannen werden geanalyseerd op TH2B inhoud. Door 
midde! van Western blot werd een duidelijke variatie in zaadee! TH2B 
inhoud russen de ejaculaten van de verschillende mann en gevonden, met een 
geringe corre!atie met zaadeelmorfologie. Hoe beter de zaadce!morfologie, 
hoe minder de TH2B inhoud. Tevens was er een duidelijke heterogeniteit in 
TH2B immunoexptessie in gedecondenseerde zaadeeUen uit een ejaculaat. 
Het belang van deze waarnemingen, en of er een verschil in bevruchtend 
vermogen is russen zaadeeUen met een hoge danwe! een lage TH2B inhoud, 
n10et nog worden onderezocht. 
In Hoofstuk 8 worden de in dit proefsehrift besehreven bevindingen 
besproken, in relatie tot de huidige literatuur en kennis, en in relatie tot 
klinisehe implicaties van het uitgevoerde onderzoek. 
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